# Research Log

_Pre-market research notes and the trade plan for the day. Newest at the top.
The market-open routine reads the most recent "Planned trades" section._

---


_Entries older than 30 days have been moved to `memory/archive/`. See archive files for full history._

## 2026-08-05 — Pre-market research (~08:21 ET, Wednesday) — PLAN: BUY NVDA (18sh, first confirmed multi-session technical breakout after 6+ failed crosses); LLY earnings-window decision resolved (beat-and-raise, HOLD, no trim)

### Live-switch guard
- `ALPACA_BASE_URL` contains "paper" ✓.

### Lock / control switch
- `memory/_lock` was `{}` (free) at start of this run. Lock acquired (`premarket`, expires ~08:27 ET).
- `memory/control.md`: `STATUS: ACTIVE`. No `NOTE:`/`QUERY:` pending. `CROSS_BULL_LEARNING:` blank.

### Market status
- `clock`: `is_open: false` (pre-market), `next_open: 2026-08-05T09:30:00-04:00`, `next_close: 2026-08-05T16:00:00-04:00` — normal trading day.

### Market posture (pre-market 2026-08-05)
S&P 500 futures +0.3-0.39%, Nasdaq 100 futures little changed, continuing yesterday's record-close rally (S&P 500 +1.79% to 7,736.52, first close above 7,700, Dow also a fresh record). Polymarket implies 87% odds of a higher open. **10yr Treasury 4.61-4.62% (tradingeconomics.com, explicitly dated 2026-08-05)** — comfortably below the 4.75% new-buy gate. [Benzinga](https://www.benzinga.com/markets/prediction-markets/26/08/60938801/will-sp500-open-up-or-down-august-5-polymarket-record-high-ai-earnings-iran), [Bloomberg](https://www.bloomberg.com/news/articles/2026-08-04/stock-market-today-dow-s-p-live-updates), [tradingeconomics.com](https://tradingeconomics.com/united-states/government-bond-yield)

### Held position — LLY — 🚨 forced earnings-window decision resolved: clean beat-and-raise
Alpaca live data (pre-market): 8sh @ avg USD 1,174.35625, current USD 1,177.91 (+0.303% from entry, a huge reversal from yesterday's −5.278%), up **+5.578% just today** on the earnings reaction. Trailing stop `e3547b9e` HWM USD 1,232.00 / stop USD 1,108.80 — live, confirmed in `orders open` (hasn't ratcheted yet since price remains below the prior HWM).

**Q2 2026 results (reported before market open today):** EPS **USD 8.38 vs USD 6.07 consensus** (a ~38% beat), revenue **USD 23.0B, +48% YoY**. Mounjaro revenue +91% YoY to USD 9.9B (USD 4.8B US + USD 5.2B international); Zepbound USD 4.9B US revenue, +44% YoY. **Full-year revenue guidance raised to USD 85-87B** (from USD 82-85B); adjusted EPS guidance USD 35.50-36.50 (essentially maintained, prior USD 35.50-37). Shares up >5% pre-market. [Quartz](https://qz.com/eli-lilly-earnings-q2-2026-revenue-forecast-weight-loss-080526), [CNBC](https://www.cnbc.com/2026/08/05/eli-lilly-lly-earnings-q2-2026.html), [Eli Lilly IR](https://investor.lilly.com/news-releases/news-release-details/lilly-reports-second-quarter-2026-financial-results-raises-full)

**Decision:** This is an unambiguous beat-and-raise — GLP-1 dominance (Mounjaro/Zepbound) confirmed, not just intact. The prior week's slide to −5.278% reads confirmed as "priced for perfection" profit-taking that overshot, not a thesis crack. **HOLD full position, no trim, no scale-up today** (per the standing AVGO lesson, let the market's post-open reaction fully confirm before any action — the review_by mechanism exists exactly for this). `review_by` stays **2026-08-06** to force the formal post-full-session read tomorrow morning, once today's actual trading (not just the pre-market pop) is in. No action needed today beyond noting the print.

### Held position — UNH — what changed since yesterday
Alpaca live data: 25sh @ avg USD 422.28, current USD 410.36 (−2.823%), up +0.69% today. Trailing stop `225cb079` HWM USD 436.945 / stop USD 393.2505 — live. **What changed:** nothing material — JPMorgan raised its PT to USD 516 (from USD 466, Overweight) and Wells Fargo raised to USD 526 (from USD 485, Overweight), both following the 07-16 beat-and-raise. Standing regulatory-scrutiny overhang (Medicare Advantage risk-adjustment/coverage-denial investigations) is unchanged, not a new development. No negative catalyst. Next earnings ~2026-10-27, `review_by` 2026-08-17 not due. [Multiple analyst-PT sources via WebSearch]

### Held position — V — what changed since yesterday
Alpaca live data: 22sh @ avg USD 355.058182, current USD 371.30 (+4.574%), up +0.463% today. Trailing stop `2b0a93ba` HWM USD 373.96 / stop USD 336.564 — live. **What changed:** nothing new since 08-04's BioCatch acquisition announcement — stock continues to hold most of the post-announcement gain (traded USD 360.09-371.11 today). Cantor Fitzgerald's PT raise to USD 445 stands. Dividend ex-date 08-11 (USD 0.67/share) approaching, not an action item. `review_by` 2026-08-15 not due.

### Watchlist re-verification (fresh Alpaca bars, explicit date range 2026-05-01 to 2026-08-04 close, 50-day SMA / 20-day ATR%, `data.alpaca.markets` with explicit `start`/`end`)
| Ticker | Price (08-04 close) | vs 50-day SMA | 20-day ATR% | Gate | Note |
|---|---|---|---|---|---|
| NVDA | 211.96 | **+3.057%** | 3.63% | **PASS — CONFIRMED** | **Second consecutive confirmed session above the 50-day** (+0.436% 08-03 → +3.057% 08-04), clearing the standing multi-session-confirmation bar after 6+ prior failed single-session crosses since tracking began. Pre-market 08-05 extends further to ~USD 215.03 (latest trade), vs-SMA ~+4.55% — not extended past the 10% chase threshold. Earnings 2026-08-26 (21 days out, no blackout). |
| MSFT | 492.83 | **+22.545%** | 2.97% | FAIL (extended) | Further extended past yesterday's +21.685% — no chase regardless of trend strength. |
| COST | 948.08 | **−0.757%** | 1.65% | FAIL | Still below the 50-day; independently flagged as rich (~46x P/E). |
| LRCX | 317.76 | **−6.058%** | 6.03% | FAIL | Improved from −12.803% (08-04) but still fails; valuation (P/E >60x) separately disqualifying regardless. |
| PWR | 692.90 | **+1.890%** | 3.62% | FAIL (unconfirmed) | **First actual cross above the 50-day** (was −0.066% 08-04, essentially flat) — single session, needs a 2nd consecutive confirming close per the standing multi-session-confirmation discipline (the same bar NVDA just cleared). **Watch for confirmation at the next pre-market.** |

**NVDA entry-signal check (strategy.md, need ≥3 of 5):**
1. Earnings momentum — no fresh NVDA-specific beat, but sector cloud results (MSFT/AMZN both beat with accelerating growth) revived AI-infrastructure-spend confidence broadly, and BofA reiterated Buy 08-04 (PT USD 220). Partial pass.
2. Catalyst in 1-6 months — AI infrastructure buildout ongoing; earnings 08-26 (21 days out). **PASS.**
3. Valuation — PEG ~0.27-0.47 (well under 2.5), forward P/E ~20-24x reasonable for the growth/quality profile. **PASS.**
4. Technical confirmation — 2 consecutive confirmed closes above 50-day, +3.057% to +4.55%, well under the 10% extension cap. **PASS.**
5. Macro tailwind — sector trend reconfirmed by MSFT/AMZN cloud beats; Goldman Risk Appetite Indicator (99th percentile) remains a caution flag on sizing/pace, not a stop-trading signal; no major contrary catalyst before earnings. **PASS.**

4-5 of 5 signals clear. Strong Buy consensus (85% buy per S&P Global poll of 61 analysts, avg PT USD 302.83). No insider-selling clusters or accounting flags found. **Clears the entry bar** — first qualifying candidate since the 2026-07-01 reset outside the original three (LLY/UNH/V).

### Volatility check (ATR sizing rule)
NVDA 20-day ATR 3.63% (>3% threshold) → **halve the planned position size** per the standing volatility-check rule. Starter conviction (7-9% of equity) halved → target ~3.5-4.5%.

### Sizing
Target ~4% of equity, halved for ATR. Equity USD 99,404.51 (pre-market mark, already reflecting LLY's pop) × 4% = ~USD 3,976. At latest trade price USD 215.03: **18 shares = USD 3,870.54 = 3.894% of equity.** Risk at a 10% trailing stop: 0.389% of equity — well inside the 1.2% risk-budget cap (12% would be the risk-budget-implied max size; 3.894% is a deliberately conservative starter given this is the first NVDA breakout to actually confirm after 6+ false starts). Well under the 20% hard cap, the 15% single-order cap, and the 25% daily-deployment cap.

### Earnings-window rule
- **Held names:** LLY's forced decision resolved above (beat-and-raise, HOLD, review_by renewed... stays 08-06). UNH (08-17) and V (08-15) not due.
- **Buy candidate (NVDA):** earnings 2026-08-26, 21 days out — well outside the 2-trading-day window. Clear.

### Cash-drag check
Cash sits at ~71.98% (USD 71,553.62 of USD 99,404.51 equity), still well above the 25-40% target band — but today's plan deploys into the first qualifying setup since the reset outside the original three names, directly answering the standing cash-drag question with an actual entry rather than another "justified but flagged" note.

### Drawdown circuit breaker
`history 1A 1D` high-water mark remains USD 100,322.08 (2026-07-21 close). Current equity USD 99,404.51 → drawdown **0.9146%** — NOT triggered (9.0854pp headroom). New buys permitted.

### Intraday shock check
Equity USD 99,404.51 vs Alpaca `last_equity` USD 98,798.79 (2026-08-04 close) = **+0.6132%** — no shock (threshold −4%; market not yet open, and the move is positive, driven by LLY's earnings pop).

### Sector cap (post-trade projection)
Healthcare (LLY+UNH) 19.800% (USD 19,682.29), Financials (V) 8.218% (USD 8,168.60), Tech (NVDA, new) ~3.894% (USD 3,870.54), cash post-trade ~68.09% — all comfortably within the 60% single-sector cap.

### Stop audit (`orders open` vs `positions`, live)
LLY `e3547b9e` (HWM USD 1,232.00 / stop USD 1,108.80, qty 8), UNH `225cb079` (HWM USD 436.945 / stop USD 393.2505, qty 25), V `2b0a93ba` (HWM USD 373.96 / stop USD 336.564, qty 22) — all 3 status `new` (live), quantities match positions exactly. **3/3 PASS.**

### Weekly new-position count
0/3 used this week (week of 2026-08-03) before this plan — NVDA would be slot 1/3.

### Planned trades for today

Eli Lilly's beat-and-raise (EPS USD 8.38 vs USD 6.07 est., revenue +48% YoY, guidance raised) resolves the forced earnings-window decision cleanly positive — HOLD, no trim, no scale-up pending tomorrow's formal post-full-session review_by. NVDA clears its technical gate for the first time since tracking began (2 consecutive confirmed sessions above the 50-day, after 6+ prior failed single-session crosses), passes 4-5 of 5 entry signals, and sits well within every guardrail. Sized as a conservative starter (halved for ATR >3%). PWR crossed for the first time today but remains unconfirmed (single session) — watch for confirmation tomorrow. 10yr yield well below the 4.75% gate, drawdown breaker not triggered, no intraday shock, sector caps in order.

```json
{
  "plan_date": "2026-08-05",
  "trades": [
    {"action": "buy", "symbol": "NVDA", "qty": 18, "thesis": "AI accelerator monopoly thesis reconfirmed by sector-wide cloud beats (MSFT/AMZN); NVDA cleared 2 consecutive confirmed sessions above its 50-day SMA after 6+ prior failed crosses, the first genuine multi-session confirmation since tracking began. PEG ~0.27-0.47, forward P/E ~20-24x reasonable for the growth profile. Strong Buy consensus (85% buy, avg PT USD 302.83). Earnings not until 08-26, no blackout.",
     "invalidation": "Closes back below the 50-day SMA (~USD 206-210) on volume, a hyperscaler guides down AI capex materially, or the 10% trailing stop fires.",
     "review_by": "2026-08-24"}
  ]
}
```

---

## 2026-08-04 — Pre-market research (~08:17 ET, Tuesday) — PLAN: no trades (every watchlist name fails its gate; LLY earnings tomorrow before open)

### Live-switch guard
- `ALPACA_BASE_URL` contains "paper" ✓.

### Lock / control switch
- `memory/_lock` was `{}` (free) at start of this run. Lock acquired (`premarket`, expires ~08:25 ET).
- `memory/control.md`: `STATUS: ACTIVE`. No `NOTE:`/`QUERY:` pending. `CROSS_BULL_LEARNING:` blank.

### Data-integrity note
The 2026-08-03 pre-market research-log entry (referenced by that day's market-open/midday/close entries as having `plan_date: 2026-08-03, trades: []`) is not present in this file or in `memory/archive/2026-07.md` — it appears the entry was never actually written that day, even though downstream routines correctly read/acted on an empty plan. Not blocking today's work; flagged as a one-off gap in the audit trail, not a recurring pattern yet.

### Market status
- `clock`: `is_open: false` (pre-market), `next_open: 2026-08-04T09:30:00-04:00`, `next_close: 2026-08-04T16:00:00-04:00` — normal trading day.

### Market posture (pre-market 2026-08-04)
S&P 500 futures +0.21%, Nasdaq 100 futures +0.6% ahead of the open, continuing Monday's strong gains. Polymarket implies a 77% probability of a higher S&P open, driven by lower oil prices easing inflation concerns and strong earnings reinforcing confidence in the AI trade (Microsoft's blowout Q4 print continuing to underpin sentiment, NVDA +~3% Monday on the same read-through). **10yr Treasury eased to 4.66% (tradingeconomics.com, explicitly dated 2026-08-04)** — down 0.02pp from the prior session, comfortably below the 4.75% new-buy gate. [Benzinga](https://www.benzinga.com/markets/prediction-markets/26/08/60896308/sp500-aug-4-open-up-or-down-polymarket-trump-iran-tech-rally-amazon-ai-earnings), [Benzinga](https://www.benzinga.com/markets/equities/26/08/60897120/stock-market-today-sp-500-dow-and-nasdaq-futures-rise-after-strong-monday-gains-mcdonalds-amd-palantir-in-focus), [tradingeconomics.com](https://tradingeconomics.com/united-states/government-bond-yield)

### Held position — LLY — 🚨 forced earnings-window decision (reports before market open tomorrow, 2026-08-05 — 1 trading day out, inside the 2-day window)
Alpaca live data: 8sh @ avg USD 1,174.35625, current USD 1,121.80 (−4.476%), unrealized −USD 420.45. Trailing stop `e3547b9e` HWM USD 1,232.00 / stop USD 1,108.80 — live, confirmed in `orders open`.

**What changed:** LLY continued sliding (−2.3% to −4.5% over the past several sessions per multiple sources) on broad "priced for perfection" valuation profit-taking — the stock trades at ~40x earnings, making it vulnerable to any hint of guidance softness ahead of tomorrow's print. Erste Group Bank trimmed its 2026 EPS estimate to USD 35.34 (from USD 36.33) — a modest full-year estimate cut, not a company-specific negative event (no new FDA setback, no guidance withdrawal, no litigation escalation). Separately, LLY received a second FDA Breakthrough Therapy designation (olomorasib, advanced pancreatic cancer) — a minor positive pipeline data point, not a factor in the drawdown. No company-specific thesis-breaking news found. **Confirmed: Q2 2026 earnings report before market open Wednesday 2026-08-05, conference call 10:00 AM ET** — consensus USD 20.26B revenue / USD 6.71 EPS (Alphastreet has a slightly lower USD 6.55 EPS estimate).

**Decision:** Thesis (Medicare Bridge, GLP-1 dominance, AtaiBeckley acquisition, Retevmo) unchanged; the drawdown is broad multiple compression ahead of a binary event, not a break. **HOLD full position through earnings, no trim.** `review_by` stays **2026-08-06** (already set at 2026-08-03 pre-market — forces the explicit post-earnings hold/trim/exit read the morning after tomorrow's pre-open print, once market-open/midday/close on 08-05 have seen the actual reaction). [Yahoo Finance](https://finance.yahoo.com/quote/LLY/), [Ticker Report](https://www.tickerreport.com/banking-finance/13523148/eli-lilly-and-company-nyselly-trading-down-4-5-whats-next.html), [Lilly IR](https://investor.lilly.com/news-releases/news-release-details/lilly-confirms-date-and-conference-call-second-quarter-2026)

### Held position — UNH — what changed since yesterday
Alpaca live data: 25sh @ avg USD 422.28, current USD 415.50 (−1.606%), unrealized −USD 169.50. Trailing stop `225cb079` HWM USD 436.945 / stop USD 393.2505 — live. **What changed:** nothing material — Goldman Sachs raised its PT to USD 490 (from USD 435, Buy) following the Q2 beat-and-raise; 27-analyst consensus remains "Buy," avg PT USD 475.23 (+14.7% implied). No negative catalyst. Next earnings not until ~2026-10-27, `review_by` 2026-08-17 not due. [FX Leaders](https://www.fxleaders.com/news/2026/07/28/unitedhealth-unh-stock-touches-430-as-improving-margins-boost-investor-confidence/)

### Held position — V — what changed since yesterday
Alpaca live data: 22sh @ avg USD 355.058182, current USD 364.756 (+2.732%), unrealized +USD 213.35. Trailing stop `2b0a93ba` HWM USD 373.96 / stop USD 336.564 — live. **What changed:** Visa announced a **USD 2.4B acquisition of BioCatch** (fraud-detection/behavioral-biometrics platform) — a positive extension of the existing fraud-detection/agentic-commerce catalyst thesis, not a new one; stock rallied intraday to USD 371.97 before pulling back to close USD 365.67 (still up on the day). Cantor Fitzgerald raised its PT to USD 445 (from USD 410). A USD 0.67/share dividend was declared, ex-date 2026-08-11. No negative news. `review_by` 2026-08-15 not due. [Cryptonomist](https://en.cryptonomist.ch/2026/08/04/visa-stock-pulls-back-from-2-4b-biocatch-rally-bullish-trend-holds/)

### Watchlist re-verification (fresh Alpaca bars, explicit date range 2026-05-01 to 2026-08-03 close, 50-day SMA / 20-day ATR%, `data.alpaca.markets` with explicit `start`/`end` per the standing 2026-07-03 lesson — a bare `limit` query returns null)
| Ticker | Price | vs 50-day SMA | 20-day ATR% | Gate | Note |
|---|---|---|---|---|---|
| NVDA | 206.72 | **+0.436%** | 3.71% | FAIL (unconfirmed) | **First positive cross since tracking began** (was −2.628% 07-31, −5.575% 07-30) — a genuine multi-session improvement, but per the standing NVDA-pattern lesson (6+ prior failed single-session crosses), this needs a 2nd consecutive confirmed close above the 50-day before it's actionable. **Watch for confirmation at the next pre-market.** Earnings 2026-08-26. |
| MSFT | 487.57 | **+21.685%** | 2.80% | FAIL (extended) | Continued rally post-earnings (07-30 blowout print) pushed it even further past the 10% chase threshold (was +13.336% on 07-31) — no chase regardless of trend strength. |
| COST | 954.19 | **−0.330%** | 1.69% | FAIL | Still below the 50-day; reversed slightly back up from Friday's −0.904% but the 07-29 single-session cross (+0.963%) was never confirmed. Independently flagged as rich (~46x P/E). |
| LRCX | 294.68 | **−12.803%** | 6.11% | FAIL | Gave back some of the post-earnings pop (was −11.815% on 07-31); valuation (P/E >60x) remains separately disqualifying regardless of technicals. |
| PWR | 680.08 | **−0.066%** | 3.54% | FAIL | Essentially flat, closest to crossing (was −3.542% on 07-30) but has not actually crossed above the 50-day yet. **Watch for the actual cross at the next pre-market.** |

No watchlist name clears its technical gate today. NVDA and PWR are both close (NVDA crossed but unconfirmed single session; PWR hasn't crossed yet) — worth a close look at tomorrow's pre-market, though tomorrow's real focus is LLY's earnings reaction.

### Earnings-window rule
- **Held names:** LLY forced decision resolved above (HOLD, no trim). UNH (08-17) and V (08-15) not due.
- **Buy candidates:** moot — no watchlist name clears its technical gate regardless of earnings-window status.

### Cash-drag check
Cash sits at 72.320% (USD 71,553.62 of USD 98,940.15 equity), well above the 25–40% target band, and has been for many weeks. The tape is constructive today (S&P/Nasdaq futures up, 77% odds of a higher open per Polymarket) and NVDA/PWR are both close to a technical cross — but neither has actually cleared the gate yet (NVDA unconfirmed single session, PWR still marginally below its 50-day), and every other watchlist name fails outright or is disqualified by extension/valuation. 0/3 weekly new-position slots used this week (week of 2026-08-03). Staying in cash today is a disciplined, actively-re-verified decision, not a passive default — there is simply no name that clears the entry bar this morning.

### Drawdown circuit breaker
`history 1M 1D` high-water mark remains USD 100,322.08 (2026-07-21 close). Current equity USD 98,940.15 → drawdown **1.3775%** — NOT triggered (8.6225pp headroom). New buys remain permitted on this gate (moot today — no candidate clears the entry gate anyway).

### Intraday shock check
Equity USD 98,940.15 vs Alpaca `last_equity` USD 98,953.24 (2026-08-03 close) = **−0.0132%** — no shock (threshold −4%; market not yet open).

### Sector cap
Healthcare (LLY+UNH) 19.567% (USD 19,361.90), Financials (V) 8.111% (USD 8,024.63), cash 72.320% (USD 71,553.62) — all well within the 60% cap.

### Stop audit (`orders open` vs `positions`, live)
LLY `e3547b9e` (HWM USD 1,232.00 / stop USD 1,108.80, qty 8), UNH `225cb079` (HWM USD 436.945 / stop USD 393.2505, qty 25), V `2b0a93ba` (HWM USD 373.96 / stop USD 336.564, qty 22) — all 3 status `new` (live), quantities match positions exactly. **3/3 PASS.**

### Weekly new-position count
0/3 used this week (week of 2026-08-03) — unchanged.

### Planned trades for today

No trades planned. Every watchlist name fails its technical gate (NVDA unconfirmed single-session cross, MSFT extended, COST/LRCX fail outright, PWR hasn't crossed yet). LLY's forced earnings-window decision resolved (HOLD, no trim, earnings tomorrow before open). Drawdown breaker not triggered, 10yr yield still below the 4.75% gate, sector caps and cash policy all in order.

```json
{
  "plan_date": "2026-08-04",
  "trades": []
}
```

EXECUTED: 2026-08-04T09:36 ET — no trades (plan empty: every watchlist name fails its technical gate — NVDA unconfirmed single-session cross, MSFT extended, COST/LRCX fail outright, PWR hasn't crossed; LLY's forced earnings-window decision already resolved HOLD at pre-market). Market open confirmed (`clock` `is_open: true`). Breaking-news gate: moot, no planned trades to gate. Account re-check: equity USD 98,844.71 vs Alpaca `last_equity` USD 98,953.24 = **−0.1097%** — no intraday shock (threshold −4%). Drawdown: HWM USD 100,322.08 (2026-07-21 close, unchanged) vs current equity USD 98,844.71 = **1.4726%** — NOT triggered (8.5274pp headroom). All 3 positions HOLD (LLY −4.673%, UNH −2.116%, V +2.487%), none near the −7% cut (midday's job regardless). Sector exposure: Healthcare (LLY+UNH) 19.514% (USD 19,289.465), Financials (V) 8.099% (USD 8,005.58), cash 72.387% (USD 71,553.62) — all well within the 60% sector cap. Stop audit (`orders open` vs `positions`): 3/3 PASS — LLY `e3547b9e` (HWM USD 1,232.00/stop USD 1,108.80, qty 8 matches), UNH `225cb079` (HWM USD 436.945/stop USD 393.2505, qty 25 matches), V `2b0a93ba` (HWM USD 373.96/stop USD 336.564, qty 22 matches). No stop fills since pre-market, no exits, no `closed-trades.md` reconciliation needed. Weekly new-position count unchanged: 0/3 used this week (week of 2026-08-03).

---

## 2026-07-31 — Weekly review research (~20:40 UTC, Friday)

**S&P 500 weekly performance (2026-07-27 to 2026-07-31):** Alpaca SPY daily bars
(settled, explicit date range) show SPY closing $738.90 (07-24) → $746.79
(07-31), a **+1.068% weekly gain**. A choppy week — Iran/oil and a hawkish-read
FOMC hold drove a sharp broad selloff Wed 07-29 (S&P −1.52%, 10yr yields to a
near-two-decade high), followed by a tech-earnings-driven relief rally Thu-Fri
(MSFT +15.51% 07-30 on a blowout Azure print — the largest single-day
market-cap gain in US corporate history; LRCX +20.28%; Amazon +13% 07-31 on an
AWS beat). Apple slid ~7% 07-31 on disappointing forecasts. **10yr Treasury
topped 4.7-4.737% this week, the highest since January 2025** — the closest
read yet to the 4.75% new-buy gate tracked since 07-24. [CNBC](https://www.cnbc.com/2026/07/30/stock-market-today-live-updates.html) [TheStreet](https://www.thestreet.com/stock-market-today/stock-market-today-dow-jones-sp-500-nasdaq-updates-july-31-2026)

**Held positions:**
- **LLY:** Closed 07-31 ~$1,147.61-1,151.83, down modestly on the week (from
  ~$1,154.97 lastday). Barclays reiterated Buy 07-24. USD 750M US manufacturing
  expansion investment. Earnings confirmed 2026-08-05 (5 days out) — no new
  negative catalyst, thesis unchanged. [Yahoo Finance](https://finance.yahoo.com/quote/LLY/)
- **UNH:** Trading $415-419 range this week, essentially flat/slightly down.
  RBC raised PT to USD 478 (from USD 463) post-07-16 beat-and-raise; 27-analyst
  consensus "Buy," avg PT USD 475.23. No fresh negative news. [tikr.com](https://tikr.com/blog/unitedhealth-stock-up-6-this-week-heres-the-367-analyst-consensus-case)
- **V:** Closed the week ~$366, near its 52-week high (range USD 293.89-373.97).
  JPMorgan/Citi/Wolfe/BofA/UBS/Wells Fargo all raised PTs into the USD 400-450
  range in July on the Q3 beat. The 07-28 severance/workforce-cut news (~7% of
  workforce) already priced in and journaled at the time — no new information
  this week. Strong Buy consensus (38 analysts, 0 sell). [Investing.com](https://www.investing.com/equities/visa-inc)

**Closed this week — post-mortem context:**
- **META (stopped out 07-28, −7.964%, one trading day before earnings):** Q2
  2026 results (07-29 after close) came in with revenue USD 60.8B (+28% YoY,
  a slight beat) but EPS USD 6.18 vs USD 7.18 est. — a miss driven by one-time
  charges (USD 2.4B legal contingency + USD 1.2B severance; ex-charges would
  have beaten). Stock fell −7.45% in after-hours to ~USD 542, ~9% lower
  pre-market Thursday, before recovering somewhat in Friday's broad tech
  rally (+~3% per index-level reporting). **The 07-28 stop-out was well-timed
  in hindsight** — it avoided the earnings-day drawdown entirely, reinforcing
  the standing lesson that a trailing stop firing ahead of a volatile print is
  not something to second-guess. [tradingkey.com](https://www.tradingkey.com/analysis/stocks/us-stocks/262062391-meta-platforms-report-q2-2026-meta-advertising-dap-capital-expenditures-tradingkey) [indmoney.com](https://www.indmoney.com/blog/us-stocks/why-meta-stock-fell-q2-earnings-analysis)
- **VST (stopped out 07-28, −6.924%):** Continued weaker this week — fell
  another −3.86% Monday 07-27 (USD 163.38 → USD 157.08) on broad AI-power-sector
  softness, though the board still declared its regular USD 0.23/share
  quarterly dividend 07-29. Q2 earnings confirmed for 2026-08-07. 20-analyst
  consensus remains "Strong Buy," avg PT USD 221.94 (+49% implied) — thesis
  not broken, still a re-entry watchlist candidate once technicals reconfirm.
  [stockinvest.us](https://stockinvest.us/stock/VST)

**Best performers screen:** top movers this week/month were again
micro-cap/penny names (FBRX +259%, PN, LVWR) — all disqualified by the
sub-USD-5 forbidden-list floor and market-cap universe rule. Among large/mid
caps, this week's real leaders were binary post-earnings pops (MSFT, LRCX,
AMZN) rather than new, unvetted setups; none clear a non-extended technical
entry per the standing chase-threshold discipline. No new large/mid-cap name
added to the watchlist this week. [stocktitan.net](https://www.stocktitan.net/rankings/stock-gains-monthly/2026/july)

---

## 2026-07-31 — Pre-market research (~08:15 ET, Friday) — PLAN: no trades (every watchlist name fails its gate)

### Live-switch guard
- `ALPACA_BASE_URL` contains "paper" ✓.

### Lock / control switch
- `memory/_lock` was `{}` (free) at start of this run. Lock acquired (`premarket`, expires ~08:23 ET).
- `memory/control.md`: `STATUS: ACTIVE`. No `NOTE:`/`QUERY:` pending. `CROSS_BULL_LEARNING:` blank.

### Market status
- `clock`: `is_open: false` (pre-market), `next_open: 2026-07-31T09:30:00-04:00`, `next_close: 2026-07-31T16:00:00-04:00` — normal trading day.

### Market posture (pre-market 2026-07-31)
Continuing yesterday's tech-led relief rally: S&P 500 futures +0.47% (7,507.75), Nasdaq futures +1.11%, Dow futures +0.53%; Polymarket implies 94% odds of a higher open. Yesterday's MSFT (+15.51-16%, largest single-day market-cap gain in US corporate history) and LRCX (+20.28%) earnings-driven surges continue to underpin sentiment; PWR also gapped up (+11.86% on 07-30) on its own beat-and-raise. 10yr Treasury eased slightly to ~4.67-4.68% (07-30) — still below the 4.75% new-buy gate, no breach. Iran conflict remains active and unresolved (Iranian strike on a Kuwait air base reported this morning, Trump-Netanyahu discussed a land blockade) — a standing risk-off factor the tape is currently looking past, not evidence it has resolved. [Benzinga](https://www.benzinga.com/markets/prediction-markets/26/07/60829343/sp500-july-31-open-or-down-polymarket-amazon-microsoft-apple-ai-earnings), [Simply Wall St](https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alny/alnylam-pharmaceuticals/news/us-stock-market-today-sp-500-futures-edge-higher-on-cooling), [GuruFocus](https://www.gurufocus.com/news/8994478/microsoft-msft-reports-strong-q4-earnings-shares-surge-1551), [GuruFocus](https://www.gurufocus.com/news/8991199/lam-research-lrcx-sees-significant-surge-amidst-market-volatility), [Defense World](https://www.defenseworld.net/2026/07/31/quanta-services-nysepwr-shares-gap-up-following-strong-earnings.html)

### Held position — LLY — what changed since yesterday
Alpaca live data: 8sh @ avg USD 1,174.35625, current USD 1,157.00 (−1.478%), unrealized −USD 138.85. Trailing stop `e3547b9e` HWM USD 1,232.00 / stop USD 1,108.80 — live. **What changed:** LLY fell ~4.09% yesterday (07-30) — WebSearch found no single hard catalyst; reporting attributes it to profit-taking/month-end institutional rebalancing out of a richly-valued healthcare winner, competitive obesity-drug pressure, and "priced for perfection" sensitivity ahead of the 08-05 print, not a thesis-breaking event (the USD 750M manufacturing-capacity investment some sources cited is a positive-to-neutral capacity signal, not a negative one). Thesis (Medicare Bridge, AtaiBeckley acquisition, Retevmo) unchanged. Fresh technical read: +0.941% vs 50-day SMA (compressed from +3.962% pre-drop but still a pass), ATR 2.53%. Earnings confirmed 2026-08-05 (3 trading days out — outside the 2-day window, no forced decision yet). review_by 2026-08-05 not yet due. [TradingKey](https://www.tradingkey.com/news/market-movers/262064622-market-movers-lly-20260730), [Reuters Breakingviews](https://www.breakingviews.com/columns/considered-view/eli-lilly-is-pharmas-latest-victim-success-2026-07-30/)

### Held position — UNH — what changed since yesterday
Alpaca live data: 25sh @ avg USD 422.28, current USD 421.25 (−0.244%), unrealized −USD 25.75. Trailing stop `225cb079` HWM USD 436.945 / stop USD 393.2505 — live. **What changed:** nothing material — BofA raised its PT to USD 512 (from USD 475, Buy) and RBC raised to USD 478 (from USD 463, Outperform) this week; consensus remains Buy, avg PT ~USD 475. No negative catalyst. Fresh technical read: +2.919% vs 50-day SMA (pass), ATR 2.75%. Next earnings not until ~2026-10-27, review_by 2026-08-17 not due. [Yahoo Finance](https://finance.yahoo.com/markets/stocks/articles/unitedhealth-stock-headed-500-121226625.html)

### Held position — V — what changed since yesterday
Alpaca live data: 22sh @ avg USD 355.058182, current USD 364.99 (+2.797%), unrealized +USD 218.50. Trailing stop `2b0a93ba` HWM USD 373.96 / stop USD 336.564 — live. **What changed:** nothing material since yesterday's resolved post-earnings review_by (HOLD, review_by renewed to 2026-08-15) — stock continues to hold most of its post-earnings gain; GuruFocus flags it ~14.4% undervalued vs GF Value USD 423.17 heading into the now-passed print. Barclays reiterated/initiated Buy earlier in July. The 07-28 workforce-reduction (~7% of staff) story is already priced and unchanged. Fresh technical read: +7.790% vs 50-day SMA (pass, not extended past the 10% chase threshold), ATR 2.07%. review_by 2026-08-15 not due. [GuruFocus](https://www.gurufocus.com/news/8980954/v-looks-144-undervalued-on-gf-value-heading-into-q3-earnings)

### Watchlist re-verification (fresh Alpaca bars, 2026-05-01 to 2026-07-30 close, 50-day SMA / 20-day ATR%)
| Ticker | Price | vs 50-day SMA | 20-day ATR% | Gate | Note |
|---|---|---|---|---|---|
| NVDA | 195.04 | **−5.575%** | 3.52% | FAIL | Improved from Wednesday's −8.21% on the broad relief rally but still fails; no confirmed cross. Earnings 2026-08-26. |
| MSFT | 451.55 | **+13.336%** | 2.70% | FAIL (extended) | Blowout FY26 Q4 print (+15.51%, largest single-day market-cap gain in US corporate history) pushed MSFT decisively above its 50-day, but now **>10% extended** — fails the "not extended >10% above 50-day" entry signal outright, and is only 1 post-earnings session per the standing NVDA-pattern multi-session-confirmation lesson. No chase. |
| COST | 953.92 | **−0.904%** | 1.73% | FAIL | Reversed back below the 50-day after Wednesday's marginal +0.806% single-session cross — never got its 2nd confirming session, now moot. Independently flagged as rich (~46x P/E) in prior notes. |
| LRCX | 297.62 | **−11.815%** | 6.40% | FAIL | +20.28% post-earnings pop (best single-day since 1999) narrowed the gap from Wednesday's −25.22% but still deeply below the 50-day; valuation (P/E >60x) remains separately disqualifying regardless of any technical recovery. |
| PWR | 657.90 | **−3.542%** | 3.60% | FAIL | +11.86% post-earnings pop (record backlog USD 53.4B, FY26 guidance raised to USD 16.45-16.95 EPS) narrowed the gap materially but still below the 50-day; only 1 post-earnings session, unconfirmed. |

No watchlist name clears its technical gate today. MSFT's blowout print moved it decisively through the SMA but directly into extended/chase territory instead — the entry-signal discipline (not >10% above the 50-day) correctly keeps this off the table rather than chasing the largest one-day market-cap gain in US history. NVDA/COST/LRCX/PWR all still fail outright despite yesterday's broad rally.

### Earnings-window rule
- **Held names:** none inside the 2-trading-day window. LLY's 08-05 earnings is 3 trading days out (Mon 08-03, Tue 08-04, Wed 08-05) — not yet forced. UNH (~10-27) and V (~mid-Oct, review_by 08-15 interim) are well outside. No forced hold/trim/exit decision today.
- **Buy candidates:** moot — every watchlist name fails its technical gate (or is extended) regardless of earnings-window status.

### Cash-drag check
Cash sits at 72.00% (USD 71,553.62 of USD 99,370.65 equity), well above the 25-40% target band, and has been for many weeks. 0/3 weekly new-position slots used this week (week of 2026-07-27 — VST and META's stop-fills earlier this week were exits, not new entries). The tape is genuinely constructive today (continuing relief rally, 94% odds of a higher open per Polymarket), so the cash-drag question is live — but every single watchlist name re-verified this morning still fails its technical gate outright (NVDA, COST, LRCX, PWR) or is freshly disqualified by extension (MSFT, now >10% above its 50-day after the blowout print). Staying in cash today is a disciplined, actively-re-verified decision, not a passive default — there is simply no name on the list that clears the entry bar this morning.

### Drawdown circuit breaker
`history 1A 1D` high-water mark remains USD 100,322.08 (2026-07-21 close). Current equity USD 99,370.65 → drawdown **0.9483%** — NOT triggered (9.0517pp headroom). New buys remain permitted on this gate (moot today — no candidate clears the entry gate anyway).

### Sector cap
Healthcare (LLY+UNH) 19.918% (USD 19,787.25), Financials (V) 8.081% (USD 8,029.78), cash 72.00% (USD 71,553.62) — all well within the 60% cap.

### Thesis contracts
LLY (review_by 2026-08-05), UNH (review_by 2026-08-17), V (review_by 2026-08-15) — none due today, none triggered.

### Planned trades for today

No trades planned. Every watchlist name fails its technical gate (NVDA, COST, LRCX, PWR) or is freshly disqualified by extension (MSFT, >10% above its 50-day after yesterday's blowout earnings pop). No held-name thesis break, no forced review_by decision, drawdown breaker not triggered, 10yr yield still below the 4.75% gate.

```json
{
  "plan_date": "2026-07-31",
  "trades": []
}
```

EXECUTED: 2026-07-31T13:36 ET — no trades (plan empty: every watchlist name still fails its technical gate or is freshly extended). Market open confirmed (`clock` `is_open: true`). Breaking-news gate: moot, no planned trades to gate. Account re-check: equity USD 99,139.98 vs Alpaca `last_equity` USD 99,388.07 = **−0.2496%** — no intraday shock (threshold −4%). Drawdown: HWM USD 100,322.08 (2026-07-21 close, unchanged) vs current equity USD 99,139.98 = **1.1783%** — NOT triggered (8.8217pp headroom). All 3 positions HOLD (LLY −2.772%, UNH −0.641%, V +1.937%), none near the −7% cut (midday's job regardless). Sector exposure: Healthcare (LLY+UNH) 19.789% (USD 19,623.79), Financials (V) 8.031% (USD 7,962.57), cash 72.17% (USD 71,553.62) — all well within the 60% sector cap. Stop audit (`orders open` vs `positions`): 3/3 PASS — LLY `e3547b9e` (HWM USD 1,232.00/stop USD 1,108.80, qty 8 matches), UNH `225cb079` (HWM USD 436.945/stop USD 393.2505, qty 25 matches), V `2b0a93ba` (HWM USD 373.96/stop USD 336.564, qty 22 matches). No stop fills since pre-market, no exits, no `closed-trades.md` reconciliation needed. Weekly new-position count unchanged: 0/3 used this week (week of 2026-07-27).

## 2026-07-29 — Pre-market research (~08:14 ET, Wednesday) — PLAN: no trades (FOMC day, V post-earnings review, all watchlist gates fail or blackout)

### Live-switch guard
- `ALPACA_BASE_URL` contains "paper" ✓.

### Lock / control switch
- `memory/_lock` was empty (`{}`) at start of this run. Lock acquired (`premarket`, expires ~08:22 ET).
- `memory/control.md`: `STATUS: ACTIVE`. No `NOTE:`/`QUERY:` pending. `CROSS_BULL_LEARNING:` blank.

### Market status
- `clock`: `is_open: false` (pre-market), `next_open: 2026-07-29T09:30:00-04:00`, `next_close: 2026-07-29T16:00:00-04:00` — normal trading day.

### Market posture (pre-market 2026-07-29)
S&P 500 and Nasdaq-100 futures modestly higher (+0.2%) ahead of today's FOMC decision — markets price ~70% odds the Fed holds at 3.50-3.75%, decision and Chair Warsh's press conference land this afternoon. Chip stocks soft pre-bell ahead of a heavy Big Tech earnings slate: MSFT, META, and LRCX all report after today's close; PWR reports before tomorrow's open. Middle East tensions remain a simmering background risk. Net posture: a genuine binary-event day (FOMC + three of our watchlist/former-holding names reporting tonight) — no reason to force a new position into it. [Reuters/Investing.com](https://www.investing.com/news/economy-news/sp-500-nasdaq-futures-inch-up-before-fed-decision-chip-stocks-wobble-4819267), [CNBC](https://www.cnbc.com/2026/07/28/stock-market-today-live-updates.html), [Benzinga](https://www.benzinga.com/markets/prediction-markets/26/07/60750402/sp500-july-29-open-up-or-down-polymarket-fed-warsh-microsoft-meta-qualcomm-earnings)

### Held position — LLY — what changed since yesterday
Alpaca live data: 8sh @ avg USD 1,174.35625, current USD 1,220.88 (+3.962%), unrealized +USD 372.19. Trailing stop `e3547b9e` HWM USD 1,232.00 / stop USD 1,108.80 — live. **What changed:** nothing material — WebSearch found continued bullish analyst coverage (22 Buy / 2 Sell, avg PT USD 1,276.96) and reiteration of the cardiometabolic growth story (Mounjaro/Zepbound combined USD 12.8B, +56% YoY); no new negative catalyst. Thesis unchanged. Earnings confirmed 2026-08-05, review_by 2026-08-05 not yet due.

### Held position — UNH — what changed since yesterday
Alpaca live data: 25sh @ avg USD 422.28, current USD 426.75 (+1.059%), unrealized +USD 111.75. Trailing stop `225cb079` HWM USD 436.945 / stop USD 393.2505 — live. **What changed:** nothing material — stock continues to build on the 07-16 Q2 beat-and-raise momentum (some sources noted a further +2.1% move yesterday), though one source flagged the "fragile recovery" narrative (rising healthcare-cost/regulatory skepticism) as a standing risk to watch, not a new development. No thesis-breaking news. Earnings not until 2026-10-27ish per prior notes; review_by 2026-08-17 not yet due.

### Held position — V — 🚨 forced review_by decision (earnings 07-28 after close, 2-trading-day window closes today)
Alpaca live data: 22sh @ avg USD 355.058182, current USD 358.76 (+1.043%), unrealized +USD 81.44, but down **−2.136%** intraday/pre-market vs yesterday's USD 366.59 close. Trailing stop `2b0a93ba` HWM USD 371.16 / stop USD 334.044 — live.

**Q3 FY26 results (reported 2026-07-28 after close):** EPS USD 3.32 (beat consensus USD 3.29), net revenue USD 11.6B (+14% YoY, beat), payments volume +10% constant-dollar, cross-border volume +13% (ex-Europe +12%), processed transactions 71.7B (+10% YoY) — a clean top-and-bottom-line beat with **accelerating** volume growth, not decelerating.

**What drove the pre-market decline:** Visa **moderated full-year guidance to the low end of low-teens** for EPS and net revenue (a trim, not a cut below range), and GAAP operating expenses rose 19% YoY to USD 4.8B on a **USD 563M severance charge** tied to eliminating ~2,600 roles (~7% of the workforce, concentrated in technology/product) — a one-time restructuring cost, not a demand or competitive problem. Stock fell ~1.6% in Tuesday after-hours and is showing ~−2.1% to −2.5% in early pre-market trade this morning. [Invezz](https://invezz.com/en-ae/news/2026/07/28/visa-stock-sinks-on-q3-earnings-as-margin-concerns-take-center-stage/), [Seeking Alpha](https://seekingalpha.com/news/4619545-visa-q3-earnings-beat-as-volume-growth-gains-full-year-outlook-dims), [Investing.com](https://www.investing.com/news/stock-market-news/why-is-visa-stock-sliding-today-93CH-4818150)

**Analyst read:** no downgrades found; consensus remains Strong Buy (31 Strong Buy / 4 Moderate Buy / 4 Hold of 39, avg PT USD 401.87 — ~15% above the current price), consistent with pre-earnings coverage (Truist PT USD 394, BMO USD 387, Baird USD 412, all reiterated/raised in the two weeks before the print).

**Decision (per knowledge-base.md §1.1 — distinguish "beat and lower" from "beat and moderate"):** this is not a beat-and-lower setup (guidance was trimmed to the low end of an already-double-digit range, not cut below it) and the margin hit is a one-time, cost-discipline restructuring charge rather than a sign of decelerating demand — core volume/transaction growth actually accelerated from Q2. Thesis (stablecoin platform, agentic-commerce AI tools, cross-border volume growth) intact. **HOLD full position, no trim.** `review_by` renewed to **2026-08-15** (interim re-check on cost-cutting execution and margin trend, ahead of Q4 FY26 earnings — exact date not yet announced by Visa, estimated late October based on prior-year cadence).

### Watchlist re-verification (fresh Alpaca bars, 2026-05-01 to 2026-07-28 close, 50-day SMA / 20-day ATR%)
| Ticker | Price | vs 50-day SMA | 20-day ATR% | Gate | Note |
|---|---|---|---|---|---|
| NVDA | 197.05 | **−5.18%** | 3.49% | FAIL | Still no confirmed cross; earnings 2026-08-26. |
| MSFT | 393.44 | **−1.26%** | 2.53% | FAIL | Also earnings today after close — inside 2-day blackout regardless of technical status. |
| COST | 966.90 | **+0.03%** | 1.82% | UNCONFIRMED | First positive cross since tracking began, but a single session — per the standing NVDA-pattern lesson, requires 2 consecutive confirmed closes above the 50-day before treating as a real signal. Next earnings 2026-09-24, no blackout concern. **Watch for a second confirming session at the next pre-market.** |
| LRCX | 269.59 | **−20.18%** | 6.30% | FAIL | Earnings today after close — inside blackout regardless; valuation (P/E >60x vs GF Value ~USD 132) remains separately disqualifying. |
| PWR | 588.20 | **−14.45%** | 3.33% | FAIL | Earnings tomorrow (07-30) before open — inside the 2-trading-day blackout as of today. |

No watchlist name clears its technical gate today, and three of the five (MSFT, LRCX, PWR) are inside an earnings blackout regardless. No qualifying entry.

### Earnings-window rule
- **Held names:** V's forced review_by (2 trading days post-earnings-announcement-eve) resolved above — HOLD. LLY (08-05) and UNH (~10-27) are outside the window, no action needed.
- **Buy candidates:** none reach the technical gate, so the earnings-blackout check on MSFT/LRCX/PWR (all inside their window) is moot for new entries today, but is the actual reason (alongside the technical fails) that none would be actionable even if they cleared.

### Cash-drag check
Cash is 71.641% of equity — still well above the 25–40% target band, and has been for many weeks. **Explicit justification today:** (1) every watchlist name either fails its technical gate outright (NVDA, LRCX, PWR) or is inside today's/tomorrow's earnings blackout (MSFT, LRCX, PWR); (2) COST's first positive SMA cross is a single, unconfirmed session per standing discipline; (3) today is a binary-event day (FOMC decision this afternoon, three names reporting tonight) — a poor day to force a new position regardless of gate status; (4) 0/3 weekly new-position slots used this week, so there is no urgency pressure. Staying in cash today is the correct, actively re-verified call, not a passive default.

### Drawdown / shock / sector checks (live Alpaca data, ~08:14 ET)
- Equity **USD 99,882.13** | Cash USD 71,553.62 (71.641%) | Long MV USD 28,328.51 (28.359%) | Buying power USD 365,534.31 | last_equity (07-28 close) USD 100,103.63.
- **Drawdown circuit breaker:** running HWM USD 100,322.08 (2026-07-21 close, from `history 1M 1D`). Current equity USD 99,882.13 → drawdown **0.4385%** — NOT triggered (9.5615pp headroom).
- **Intraday shock check:** USD 99,882.13 vs last_equity USD 100,103.63 = **−0.2212%** — no shock (threshold −4%; market not yet open, real test is at market-open/midday).
- **Sector cap:** Healthcare (LLY+UNH) 20.457% (USD 20,435.79), Financials (V) 7.902% (USD 7,892.72), cash 71.641% — all far below the 60% cap.
- **Stop audit:** LLY `e3547b9e` (HWM USD 1,232.00, stop USD 1,108.80), UNH `225cb079` (HWM USD 436.945, stop USD 393.2505), V `2b0a93ba` (HWM USD 371.16, stop USD 334.044) — all 3 confirmed live via `orders open`, quantities match positions exactly (8/25/22). **3/3 PASS.**
- **Weekly new-position count:** 0/3 used this week (week of 2026-07-27).

### Planned trades for today
No trades planned. Today is a binary-event day (FOMC decision this afternoon; MSFT, META-successor-watch, and LRCX report after close; PWR reports before tomorrow's open). V's forced post-earnings review_by was resolved above (HOLD, no trim — a beat with a moderated-not-cut guide and a one-time restructuring charge, not a thesis break). No watchlist candidate clears its technical gate, and three of five are inside an earnings blackout regardless. COST's first positive 50-day cross needs a second confirming session before it's actionable. Market-open and midday should watch V closely given its pre-market weakness, and stay alert for FOMC-driven volatility this afternoon.

```json
{
  "plan_date": "2026-07-29",
  "trades": []
}
```
EXECUTED: 2026-07-29T13:36 ET — no trades (plan empty: FOMC day, all watchlist gates fail or in earnings blackout, V's post-earnings review_by already resolved HOLD at pre-market); stop audit 3/3 PASS (LLY `e3547b9e`, UNH `225cb079`, V `2b0a93ba`); shock check −0.016%, no shock; drawdown 0.2337% off HWM, not triggered; 3 positions held.

---

## 2026-07-10 weekly review research (~16:40 ET, Friday)

**Week in review (Jul 6-10):** S&P 500 gained ~1.4% on the week (744.86 → 755.36), led narrowly by tech — Nvidia +~4%, Meta +~6% on the week, Nasdaq +1.3% Friday alone. Sector breadth was actually poor: 9 of 11 S&P sectors were negative for stretches of the week (Materials -2.6%, Financials -1.9%, Consumer Discretionary -1.8%) while only Information Technology (+1.2%) and Energy (+1.8%) led — consistent with V (Financials) drifting lower most of the week on tape rotation, not company news. [CNBC](https://www.cnbc.com/2026/07/09/stock-market-today-live-updates.html), [Yahoo Finance](https://finance.yahoo.com/markets/stocks/articles/stock-market-news-july-10-075400187.html)

**Fed:** June FOMC minutes (released 07-08) showed 9 of 18 officials expect at least one hike before year-end 2026 — a hawkish split — though consensus still expects the Fed to hold through the rest of 2026. [CNBC](https://www.cnbc.com/2026/07/08/fed-minutes-june-2026-.html)

**Held names — V (Visa):** court dismissed a securities-fraud suit against Visa and 7 officers this week (positive, overhang removed); UBS and Barclays both carry/initiated Buy/Overweight. Notable watch item: long-term cross-border payment volume growth has been decelerating since its post-pandemic peak — a slow-moving risk to Visa's international transaction-fee segment, not thesis-breaking today but worth tracking at the next thesis-contract review (2026-07-28). [Source noted in 2026-07-10 pre-market entry above]

**Held names — VST (Vistra):** no new negative developments; Morgan Stanley trimmed PT to $210 (from $212) while maintaining Overweight — a minor, non-thesis-breaking adjustment. Earnings confirmed 2026-08-07, consensus EPS $2.43 (+140.59% YoY), revenue $6.42B (+50.98% YoY) — a high bar the stock will need to clear.

**This week's broader leaders (best-performing-stocks scan):** Nvidia and Meta led the tape (AI/tech), Energy (XLE +1.8%) also outperformed. No new individual-name idea emerged beyond what's already on the watchlist, except **META** — added to the watchlist below as an unvetted candidate given its leadership this week and Cautious Bull's prior (closed) position in the name.

**Watchlist hygiene applied this week:** added META (2026-07-10, unvetted); flagged PWR for likely purge next week (4+ weeks on the list, no dated forward catalyst, technical gate still failing). No purge yet — see `strategy.md` and `weekly-review.md` for full reasoning.

---

## 2026-07-09 — Pre-market research (~08:12 ET, Thursday) — PLAN: no trades (geopolitical risk-off, escalating)

### Live-switch guard
- `ALPACA_BASE_URL` contains "paper" ✓.

### Lock / control switch
- `memory/_lock` was empty (`{}`) at start of this run. Lock acquired (`premarket`, expires 12:08 UTC).
- `memory/control.md`: `STATUS: ACTIVE`. No `NOTE:`/`QUERY:` pending. `CROSS_BULL_LEARNING:` blank.

### Market status
- `clock`: `is_open: false` (pre-market), `next_open: 2026-07-09T09:30:00-04:00`, `next_close: 2026-07-09T16:00:00-04:00` — normal trading day.

### Market posture (pre-market 2026-07-09) — 🚨 Iran conflict escalates further, second consecutive risk-off morning
- **The US launched new airstrikes on Iran overnight**, and Tehran responded by targeting Gulf countries — a direct escalation beyond yesterday's ceasefire collapse. Oil is climbing again this morning (WTI ~USD 74.49, +1.32%; Brent ~USD 79.10, +1.38%) on top of yesterday's +4.4%/+5.2% surge (WTI settled USD 73.52, Brent USD 78.02).
- **Yesterday's close (2026-07-08):** Dow −1.1% (−576.76 pts to 52,348.39), S&P 500 −0.3% to 7,482.71, Nasdaq +0.2% to 25,870.65 (AI-mega-cap names clawed back some losses even as the broad tape fell — 24 of 30 Dow components negative, but 6-of-11 S&P sectors positive).
- **Rates:** 10yr Treasury yield 4.58%, a 4-week high (rising, still below the 4.75% new-buy gate but the trend bears watching); 1-year inflation expectations 3.7%. A falling US oil-inventory print is adding to fuel-price concern.
- **Futures signal is genuinely mixed** this morning — one read has S&P futures down ~0.8% on higher yields/inflation jitters, another has them up ~0.2%, and prediction markets imply an 85% chance of a higher open — reflecting real uncertainty about whether the AI-mega-cap bid (NVDA, AAPL) offsets the oil/yield headwind.
- **Net posture: risk-off catalyst has escalated, not faded.** Yesterday's shock did not resolve overnight — it got worse (new strikes + retaliation against Gulf countries). Combined with a 4-week-high 10yr yield and elevated inflation expectations, today calls for continued defense: no new buys regardless of watchlist gate status, and full attention to the intraday shock check once the market opens.

### Held position — V (Visa) — what changed since yesterday
- Alpaca live data: 22sh @ avg USD 355.058182, current USD 346.75 (−2.34% from entry), unrealized −USD 182.78. Trailing stop `2b0a93ba` HWM USD 356.075 / stop USD 320.4675 — live, confirmed in `orders open`.
- **What changed:** No fresh negative company news. Visa's General Counsel Julie Rottenberg sold 2,027 shares (~USD 729,720) on 2026-07-02 via a Form 144 filing — a routine-sized executive sale, not a cluster, and consistent with the CFO's confirmed 10b5-1 pattern already vetted for this name (2026-06-10 lesson); no new insider-selling flag. Analyst tone remains constructive (Barclays Overweight, Wells Fargo Buy, Baird PT USD 412 — all already reflected in yesterday's log). The stock's drift lower this week reads as broad risk-off tape, not a thesis break — Visa (financials) has no direct Iran/oil exposure.
- **Thesis contract:** invalidation ("closes below the 50-day SMA ~USD 327 on volume, or the 10% trailing stop fires, or an adverse DOJ antitrust ruling") — NOT triggered, price USD 346.75 well above USD 327. `review_by` 2026-07-28 (earnings) not yet reached. **Decision: HOLD, contract unchanged.**
- **Earnings:** confirmed 2026-07-28 — 13 trading days out, no window conflict.

### Held position — VST (Vistra) — what changed since yesterday
- Alpaca live data: 29sh @ avg USD 154.70, current USD 156.00 (+0.84% from entry), unrealized +USD 37.70. Trailing stop `bdfb5f67` HWM USD 159.41 / stop USD 143.469 — live, confirmed in `orders open`.
- **What changed:** A once-in-a-decade "heat dome" pushed PJM Interconnection's electricity demand to a record over the July 4th weekend — a fresh, concrete demand data point directly reinforcing the power-infrastructure/AI-datacenter thesis. Bernstein (Buy, 7/6) and Wells Fargo (Buy, 7/3) ratings stand; no negative news. VST is uncorrelated with the Iran/oil shock (its input is natural gas/nuclear/grid capacity, not crude) and arguably benefits at the margin from firmer energy demand.
- **Thesis contract:** invalidation ("closes below USD 148 on volume, or the 10% trailing stop fires, or the Helix/Cogentrix consortium is disrupted") — NOT triggered, price USD 156.00 well above USD 148. `review_by` 2026-08-07 (earnings, confirmed Q2 report date) not yet reached. **Decision: HOLD, contract unchanged.**
- **Earnings:** confirmed 2026-08-07 — 21 trading days out, no window conflict.

### Watchlist — brief catalyst check (full gate re-verification deferred; no buy will be made today regardless)
- **NVDA:** forward P/E has compressed to ~22.2x (lowest since 2019) despite record trailing revenue (USD 215.9B) — the multiple is cheapening even as the AI-accelerator monopoly thesis holds; conditional China approval for H200 chip sales is a new, real catalyst. Still needs a fresh 50-day SMA/ATR gate check before any entry — deferred to the next pre-market when today's macro shock isn't forcing a no-trade day regardless.
- **AAPL:** reported up sharply today (Thursday) in some sources, still inside its 2-week valuation-recheck window (deadline 2026-07-17 per 2026-07-06 gate-check). No action — needs its own fresh gate check on a day when a buy is actually in play.
- **LLY:** no material news found this search pass; remains extended per the 2026-07-03 hygiene note, still awaiting a pullback toward its 50-day.
- Full ATR/SMA re-verification across the remaining watchlist (MSFT, COST, LRCX, PWR) is deferred again today — moot given the no-buy decision below, and repeating the 2026-07-06 full-table pull on a day with zero chance of a trade would not change today's action.

### Earnings-window rule
- No held name reports within 2 trading days (V 2026-07-28, VST 2026-08-07). No forced hold/trim/exit decision required beyond the thesis-contract reviews above.

### Cash-drag check
- Cash is 87.83% of equity — far above the 25–40% target band, and has been for over a week. **Explicit justification:** (1) the last full watchlist gate re-verification (2026-07-06) found every name technically gated or valuation-gated; (2) today is the second consecutive morning with a genuine, escalating geopolitical shock (new Iran strikes + Gulf retaliation, oil higher, 10yr yield at a 4-week high) — a real reason to stay defensive, not a passive default; (3) one weekly new-position slot remains (1/3 used) and there is no urgency to force it. Staying heavy in cash today is the correct, deliberate decision.

### Today's plan
No trades warranted. The escalating Iran conflict is a fresh, dated, and worsening macro shock — no new position should be opened today regardless of any watchlist name's technical status. Existing positions (V, VST) are both within their thesis contracts and well above the −7% cut threshold; both keep their live 10% trailing stops. Re-run full ATR/SMA gates on NVDA/AAPL/LLY/MSFT/COST/LRCX/PWR at the next pre-market once the macro picture stabilizes.

```json
{
  "plan_date": "2026-07-09",
  "trades": []
}
```
EXECUTED: 2026-07-09T13:36:23Z — No trades (plan empty: second consecutive risk-off morning, new US strikes on Iran + Gulf retaliation, oil higher, 10yr yield at 4-week high); stop audit 2/2 PASS (V 2b0a93ba HWM USD 356.075/stop USD 320.4675, VST bdfb5f67 HWM USD 159.58/stop USD 143.622, both live, VST ratcheted intraday on strength — market open ~6 min at check time); V USD 346.25 (-2.481% from entry, -0.368% intraday), VST USD 159.16 (+2.883% from entry, +2.803% intraday); shock check equity USD 99,935.54 vs last_equity USD 99,837.84 = +0.0979% (no shock, threshold -4%); drawdown 0.1512% vs HWM USD 100,086.89 (not triggered, breaker at -10%); sector exposure Financials (V) 7.622%, Energy/Utilities (VST) 4.619%, cash 87.759% (all within 60% cap); weekly new-position count remains 1/3. All guardrails ✓.

---

## 2026-07-08 — Pre-market research (~08:12 ET, Wednesday) — PLAN: no trades (geopolitical risk-off)

### Live-switch guard
- `ALPACA_BASE_URL` contains "paper" ✓.

### Lock / control switch
- `memory/_lock` was empty (`{}`) at start of this run. Lock acquired (`premarket`, expires 08:18 ET).
- `memory/control.md`: `STATUS: ACTIVE`. No `NOTE:`/`QUERY:` pending. `CROSS_BULL_LEARNING:` blank.

### Market status
- `clock`: `is_open: false` (pre-market), `next_open: 2026-07-08T09:30:00-04:00`, `next_close: 2026-07-08T16:00:00-04:00` — normal trading day.

### Market posture (pre-market 2026-07-08) — 🚨 fresh geopolitical shock overnight
- **President Trump declared the US–Iran ceasefire "over"** following overnight US strikes on Iran in response to attacks on three ships in the Strait of Hormuz. Treasury also revoked a license that had allowed Iran to export oil globally. Talks reportedly continue, but the interim agreement itself is void as of this morning.
- **Oil surged ~5.6–6.5%**: Brent crude jumped to ~USD 78–79/bbl, WTI to ~USD 74.55–75/bbl — the largest one-day oil move since early June.
- **Equity futures fell broadly**: S&P 500 and Dow futures down, Nasdaq futures down >1%, led by continued semiconductor weakness (Intel, AMD extending recent losses). Investors rotating into the US dollar and safe-haven sectors (healthcare, utilities) per the CNBC/Yahoo premarket coverage.
- **Net posture: genuine risk-off, not noise.** This is a new, dated macro shock (not the ongoing AI-capex-digestion story) — a real geopolitical escalation with an immediate commodity/equity market reaction. No VIX print was available in the sources pulled, but the oil move and broad equity-futures decline are consistent with a volatility spike. Warrants a defensive posture today: no new buys regardless of any watchlist gate status, and heightened attention to the intraday shock check at market open/midday.

### Held position — V (Visa) — what changed since yesterday
- Alpaca live data: 22sh @ avg USD 355.058182, current USD 351.61 (−0.971% from entry), unrealized −USD 75.86. Trailing stop `2b0a93ba` HWM USD 356.075 / stop USD 320.4675 — live, confirmed in `orders open`.
- **What changed:** Visa initiated Overweight at Barclays (2026-07-08) and price target raised to USD 412 (from USD 370) at Baird; Wells Fargo reiterated Buy. Visa also joined 140+ partners to launch "Open USD," a consortium stablecoin aimed at USDC/USDT — a fresh extension of the agentic-commerce/stablecoin catalyst already driving the thesis. No negative company-specific news. The stock is a payments/financials name, not directly exposed to the Iran/oil shock, though a broad risk-off tape could still pull it down mechanically with the market.
- **Thesis contract:** invalidation ("closes below the 50-day SMA ~USD 327 on volume, or the 10% trailing stop fires, or an adverse DOJ antitrust ruling") — NOT triggered, price USD 351.61 well above USD 327. `review_by` 2026-07-28 (earnings) not yet reached. **Decision: HOLD, contract unchanged.**
- **Earnings:** confirmed 2026-07-28 — 14 trading days out, no window conflict.

### Held position — VST (Vistra) — what changed since yesterday
- Alpaca live data: 29sh @ avg USD 154.70, current USD 153.25 (−0.937% from entry), unrealized −USD 42.05. Trailing stop `bdfb5f67` HWM USD 159.41 / stop USD 143.469 — live, confirmed in `orders open`.
- **What changed:** Thesis pillars unchanged — Helix Digital Infrastructure and Cogentrix still intact, Bernstein (Jul 3) and Wells Fargo (Jul 1) both reiterated Buy. GuruFocus flags VST 8.2% below its own GF Value estimate (USD 167.20), i.e. still reads as undervalued on that metric. As a power/utilities name, VST could see some relative support today if the market rotates into defensives/safe-havens per the premarket coverage — but it is not a "flight to safety" name in the classic sense (equity beta remains real). No negative news found.
- **Earnings-date ambiguity persists:** one source today says **Aug 6, 2026**; the source used on 2026-07-07 (StockTitan/Vistra IR) said **Aug 7, 2026**. Both remain far outside the 2-trading-day earnings window regardless of which is correct — no action needed today, but flagging the recurring 1-day discrepancy again (third time this has come up) since it will matter once we're closer to the date. Carrying `review_by` as **2026-08-07** (the more recently sourced IR figure) until a single authoritative date is confirmed closer to the event.
- **Thesis contract:** invalidation ("closes below USD 148 on volume, or the trailing stop fires, or the Helix/Cogentrix consortium is disrupted") — NOT triggered, price USD 153.25 above USD 148. `review_by` 2026-08-07 not yet reached. **Decision: HOLD, contract unchanged.**

### Watchlist
No full SMA/ATR re-verification run today — given the fresh geopolitical shock, no new position would be opened regardless of gate status, so a full re-gate of NVDA/LLY/LRCX/PWR/MSFT/COST/AAPL is deferred to the next routine once the tape stabilizes. Directionally: LLY hit a fresh 52-week high (USD 1,234, +14.4% YTD) on continued GLP-1 momentum (JPMorgan PT raised to USD 1,400) — even more extended above its 50-day than the last check, technical gate still fails. The broader AI-semiconductor selloff (Intel, AMD extending losses per premarket coverage) reinforces the existing NVDA/LRCX caution — no change to their gated status.

### Risk posture (live Alpaca data, 2026-07-08 ~08:10 ET)
- Equity **USD 99,882.07** | Cash USD 87,702.40 (87.80%) | Long MV USD 12,179.67 (12.19%) | last_equity (Alpaca-reported, 2026-07-07 close) USD 99,966.97.
- **Drawdown circuit breaker:** running HWM USD 100,086.89 (set 2026-07-07 market-open; the `history` endpoint's own daily-close series tops out at USD 100,073.07 for the same window — a known small lag between the intraday-recorded HWM and the endpoint's close series, flagged in prior runs). Current equity USD 99,882.07 → drawdown **0.2047%** — NOT triggered (9.795pp headroom).
- **Intraday shock check:** USD 99,882.07 vs last_equity USD 99,966.97 = **−0.0849%** — no shock (threshold −4%). Note: this pre-dates the overnight Iran news reaching the cash-equity tape (market not yet open); the real test of today's shock is the market-open/midday check once trading begins.
- **Sector cap:** Financials (V) 7.74%, Energy/Utilities (VST) 4.45%, Cash 87.80% — both sectors far below the 60% cap.
- **Stop audit:** V `2b0a93ba` (HWM USD 356.075, stop USD 320.4675) and VST `bdfb5f67` (HWM USD 159.41, stop USD 143.469) both confirmed live in `orders open` — **2/2 PASS**.
- **Weekly new-position count:** 1/3 used this week (V, 2026-07-07; week of 2026-07-06).

### Cash-drag check
Cash 87.80% remains far above the 25–40% build-phase target band and has been for well over a week. Ordinarily this would call for either a qualifying entry or an explicit justification for staying in cash — today it's an easy call: **a fresh, dated geopolitical shock (Iran ceasefire declared over, oil +5.6–6.5%, equity futures broadly lower, semiconductor sector extending losses) is not a backdrop for opening any new position, regardless of any individual name's technical/valuation gate status.** No watchlist name was even close to clearing all gates as of the last full re-verification (2026-07-06/07), so this is not cash sitting idle by default — it is a deliberate no-trade decision given both (a) no cleared setups and (b) a same-day macro reason to be more conservative, not less.

### Earnings-window rule
No held name reports within the next 2 trading days (V: 2026-07-28; VST: 2026-08-06/07) — no action required.

### Planned trades for today

No trades planned — 🚨 fresh overnight geopolitical shock (Iran ceasefire declared over, oil +5.6–6.5%, equity futures down, Nasdaq futures −1%+) argues for a defensive, wait-and-see posture; no watchlist name was near a clean entry signal regardless. Both held positions (V, VST) reviewed, theses intact, contracts unchanged, stops live. Market-open and midday routines should pay close attention to the intraday shock check and news-scan thresholds given the overnight catalyst.

```json
{
  "plan_date": "2026-07-08",
  "trades": []
}
```
EXECUTED: 2026-07-08T13:36:00Z — No trades (plan empty: overnight Iran ceasefire collapse, oil +5.6-6.5%, equity futures down risk-off); stop audit 2/2 PASS (V 2b0a93ba HWM USD 356.075/stop USD 320.4675, VST bdfb5f67 HWM USD 159.41/stop USD 143.469, both live, no ratchet — market open ~6 min at check time); V USD 347.95 (-2.002% from entry, -1.207% intraday), VST USD 156.03 (+0.86% from entry, +0.193% intraday); shock check equity USD 99,883.05 vs last_equity USD 99,966.97 = -0.0839% (no shock, threshold -4%); drawdown 0.2037% vs HWM USD 100,086.89 (not triggered, breaker at -10%); sector exposure Financials (V) 7.665%, Energy/Utilities (VST) 4.531%, cash 87.807% (all within 60% cap); weekly new-position count remains 1/3. All guardrails ✓.

---

## 2026-07-07 — Pre-market research (~08:35 ET, Tuesday) — PLAN: BUY V 22sh

### Live-switch guard
- `ALPACA_BASE_URL` contains "paper" ✓.

### Lock / control switch
- `memory/_lock` was empty (`{}`) at start of this run. Lock acquired.
- `memory/control.md`: `STATUS: ACTIVE`. No `NOTE:`/`QUERY:` pending. `CROSS_BULL_LEARNING:` blank.

### Note on this run's process
An earlier pass this morning drew conclusions from a **stale local git checkout** that had not fetched `origin/main` — it wrongly believed the account was newly reset with an unexplained trade, sent an erroneous 🚨 alert, and made a bad commit. That commit was discarded (`git reset --hard origin/main`, never pushed) once `git fetch origin main` revealed the real history: the account reset was already detected, human-authorized, and re-baselined by prior routines (2026-07-01), and the VST position is a properly planned, documented entry (2026-07-02). A correction was sent to the human via Telegram. This run proceeds against the correct, current `origin/main` state. **Lesson recorded in `lessons.md`.**

### Market status
- `clock`: confirmed market open today, 09:30–16:00 ET.

### Market posture (pre-market 2026-07-07)
- S&P 500 closed Monday July 6 **+0.72% at 7,537.43**. Tuesday pre-market: S&P futures soft (~−0.2/−0.25%), Nasdaq-100 futures weaker on continued chip selloff, Dow futures +0.3% (diverging).
- **Macro shift to flag:** under new Fed Chair Kevin Warsh, commentary has turned hawkish — markets now price ~50bp of hikes by December, roughly double what was priced two weeks ago. **10yr yield ~4.48–4.49% — still below the 4.75% new-buy gate ✓**, but the sentiment shift is a fresh caution flag worth tracking at every future pre-market.
- **AI/semi selloff continues (day 4–5):** Micron −13% in one session (~USD 138B market cap wiped), Intel −9%, AMD −7%, SMH −5% over July 1–6, contagion from Asia (KOSPI −10% intraday, circuit breakers; Samsung/SK Hynix −12%). Drivers: SK Hynix slowing HBM expansion, AI-capex ROI skepticism, financing-cost pressure from the hawkish Fed pivot. This reinforces the active AI-capex-digestion caution in `strategy.md` — NVDA/LRCX remain non-candidates. Not a chip-name trade being considered today (V is financials/payments, uncorrelated to this selloff).
- **Net posture:** mixed/cautious, not a clean risk-on or risk-off day. No circuit-breaker-level event.

### Held position — VST (what changed since yesterday)
- Alpaca live data: 29sh @ avg $154.70, current $156.29 (+1.03% from entry), stop `bdfb5f67` HWM $157.24 / stop $141.516 — live, 1/1 PASS.
- **What changed:** Thesis pillars all intact — Helix Digital Infrastructure (KKR/Kuwait/NVIDIA JV) still names VST preferred power provider; Cogentrix (USD 4B, 5.5GW gas) still pending regulatory close, expected mid-to-late 2026, no change; Fitch IG (BBB-, March 17) and S&P IG (Dec 2025) upgrades both stand. Morgan Stanley **trimmed** PT to $210 (June 24, still Overweight — a trim, not a downgrade); Bernstein Outperform $187 PT (June 17) stands; no negative analyst revisions found.
- **Earnings date correction:** authoritative source (StockTitan/Vistra IR) confirms **Friday 2026-08-07** (not Aug 6 as previously carried) — updating `strategy.md`/`portfolio.md`. Still >2 trading days out, no window conflict.
- **Note on a stray external price print:** one web source (GuruFocus) cited VST "+4.1% to $153.43" on July 6, which does not reconcile with Alpaca's own daily bar (close $157.20) or the account's own mark-to-market. Per standing practice (see 2026-07-03 entry), trusting the broker's live feed over general search results for price levels — disregarding the stray figure.
- **Thesis contract:** invalidation ("closes below USD 148 on volume, or trailing stop fires, or Helix/Cogentrix disrupted") — NOT triggered. `review_by` 2026-08-07 (corrected) not yet reached. **Decision: HOLD, contract unchanged.**

### Watchlist — V (Visa) full re-verification → ENTRY SIGNAL CONFIRMED

- **Technical (fresh 50-day SMA computed from Alpaca IEX daily bars, 2026-04-15 to 2026-07-06):** 50d SMA **$326.93**; last close (Jul 6) **$357.30** → **+9.29% above the 50-day — under the 10% chase threshold. PASSES** (was +10.93%/FAIL on 2026-07-03; the pullback from a brief post-Payments-Forum spike to $362.13 on 7/2 down to $357.30 on 7/6, combined with the SMA drifting up, moved this from a fail to a pass).
- **Volatility (20-day ATR%, same bar set):** **2.12%** — below the 3% threshold, no size-halving needed.
- **Catalyst (1–6mo):** Visa Payments Forum (~July 1–2) unveiled new AI/stablecoin/tokenization tools for "agentic commerce," including a strategic **OpenAI** collaboration (Visa Intelligent Commerce / Agentic Directory) enabling AI-agent-initiated Visa payments, plus a "Large Transaction Model" AI fraud-detection tool. Stablecoin settlement pilot hit a **USD 7B annualized run rate** (April 2026 data), up 50% QoQ, spanning 9 blockchains. **PASSES** — real, dated product/partnership catalysts, not a story.
- **Valuation:** Trailing P/E ~29.0x; forward P/E ~21.5–22.0x; **PEG ~1.57–1.76**, well under the 2.5 threshold and below Visa's own 10-yr PEG median (2.30). Cheaper than Mastercard on forward P/E (~24.6x). **PASSES.**
- **Earnings momentum:** No fresh print since the pullback (next earnings confirmed **2026-07-28**, 21 days out — outside the 2-day window, no conflict). Signal is neutral/not applicable rather than a clean pass — no fresh beat/raise to point to.
- **Macro tailwind:** Financials/payments is not a name in the active AI-semi selloff; sector-specific tailwind (agentic commerce, stablecoin adoption) intact. Broader macro is mixed/cautious (hawkish Fed pivot), a genuine caution flag but not V-specific and not a hard gate violation (10yr still below 4.75%). Treating as a soft pass.
- **Red flags checked:** DOJ antitrust suit (debit-network practices) remains active — longstanding since 2024, not new information, already reflected in the stock's multiple. CEO McInerney sold ~USD 7.1M (20,970 sh) on 6/29 **under a 10b5-1 plan** — per the 2026-06-10 lesson, a scheduled 10b5-1 sale is not a bearish discretionary signal. General Counsel sold ~USD 730K on 7/2 (smaller, plan type unconfirmed) — not treated as a red flag at this size. No downgrades found; consensus remains Strong Buy (29 buy / 8 outperform / 3 hold / 0 sell of 42), avg PT ~USD 398 (~10% upside from $357).
- **Net: 3 of 5 entry signals clearly PASS (technical, valuation, catalyst)**, meeting `strategy.md`'s "at least three" bar; macro is a soft pass, earnings momentum is neutral (no fresh print to cite). This is a re-verified, disciplined entry — not a chase (pulled back from its 52-week-high spike; SMA distance is now under the threshold) and not a rationalization (the failing signal from 2026-07-03 is what changed, not the bar being lowered).

### Sizing

- Live equity: **$100,046.10** (fresh Alpaca pull, 2026-07-07 ~08:30 ET). Cash $95,513.69 (95.47%).
- Starter conviction (7–9% band per `strategy.md`): target ~8% = USD 8,003.69.
- Reference price: Jul 6 official close (`dailyBar.c`) **$357.30** (per the dailyBar-not-live-quote lesson, since pre-market spreads are wide/illiquid).
- Shares: USD 8,003.69 / $357.30 ≈ 22.4 → **22 whole shares = USD 7,860.60 = 7.86% of portfolio.**
- Risk budget check: 22sh × $357.30 × 10% stop = USD 786.05 = **0.786% of equity** — well within the 1.2% Cautious Bull risk-budget cap (CLAUDE.md).
- 20% hard cap: far clear. Daily deployment cap (25%): 7.86% ≤ 25% ✓. Weekly new-position count: 0/3 used this week → becomes 1/3 ✓. Cash after buy: ~USD 87,653 (~87.6%) — far above the 5% minimum.
- ATR volatility check: 2.12% < 3% — no halving required, full starter size stands.
- Sector exposure after buy: Financials (V, new sector) ~7.86%, Energy/Utilities (VST) ~4.53%, Cash ~87.6% — no sector remotely near the 60% cap.

### Risk posture (live Alpaca data, 2026-07-07 ~08:30 ET)

- Equity $100,046.10 | Cash $95,513.69 (95.47%) | Long MV $4,532.41 (4.53%) | last_equity (API-reported) $99,894.14.
- **Drawdown circuit breaker:** best-known HWM $100,033.63 (2026-07-06 close, live-history endpoint is lagging/stale — known quirk, same as prior runs). Current equity $100,046.10 is a **new HWM**. Drawdown 0.00% — NOT triggered.
- **Intraday shock check:** $100,046.10 vs last_equity $99,894.14 = +0.152% — no shock (threshold 4%).
- **Sector cap:** pre-buy Energy/Utilities (VST) 4.53% — far below 60%.
- **Stop audit:** VST `bdfb5f67` confirmed live (HWM $157.24, stop $141.516) — 1/1 PASS.
- **Weekly new-position count:** 0/3 used this week (week starting 2026-07-06).

### Cash-drag check

Cash 95.47% is far above the 25–40% build-phase target band and has been since the 2026-07-01 re-baseline. Today's V entry is a deliberate, gate-cleared deployment (3-of-5 signals, first clean technical pass since the reset) — not a forced trade to reduce drag. Two of three weekly slots remain after this.

### Planned trades for today

```json
{
  "plan_date": "2026-07-07",
  "trades": [
    {
      "action": "buy",
      "symbol": "V",
      "qty": 22,
      "thesis": "Visa's July 2026 Payments Forum unveiled fresh AI/stablecoin agentic-commerce tools (OpenAI Intelligent Commerce integration, Large Transaction Model AI fraud detection); stablecoin settlement run-rate USD 7B, +50% QoQ; PEG 1.57-1.76 well under 2.5 and cheaper than Mastercard on forward P/E; technical setup now confirms re-entry at +9.29% above the 50-day SMA (under the 10% chase threshold, was +10.93%/failing on 2026-07-03), ATR 2.12% (no halving needed); DOJ antitrust suit is longstanding/priced-in, CEO's 6/29 insider sale was a scheduled 10b5-1 plan (not bearish per the 2026-06-10 lesson)",
      "invalidation": "closes below the 50-day SMA (~USD 327) on volume, reversing the technical confirmation, or the 10% trailing stop fires, or the DOJ antitrust suit produces an adverse ruling that structurally impairs Visa's network-fee economics",
      "review_by": "2026-07-28"
    }
  ]
}
```

EXECUTED: 2026-07-07T13:39:07Z — BUY V 22sh filled avg USD 355.058182. Note: the `quote`/`snapshot` IEX ask (USD 365.67) was stuck/stale across 3 consecutive polls (~15s apart) while `trades/latest` printed consistently around USD 354.5–354.6 — used the latest-trade price (USD 354.58) x 1.003 = USD 355.64 as the marketable limit instead of the stale ask, per the "trust the broker's live feed over an unreliable/anomalous print" precedent (2026-07-07 pre-market VST note). Filled promptly at USD 355.058182, in line with the trade-based reference, confirming the ask was the bad data point. 10% trailing stop `2b0a93ba` (HWM USD 354.71, stop USD 319.239) placed and confirmed live. Guardrails: 7.81% of equity (≤20% cap), slot 1/3 this week, 7.81% daily deployment (≤25% cap), post-trade cash ≈87.66% (≥5% min), Financials sector 7.81% / Energy-Utilities 4.57% (≤60% cap each), risk-budget loss at stop ≈0.781% of equity (≤1.2% budget), drawdown 0.00% (new HWM, not triggered), earnings 2026-07-28 outside the 2-day window.

---

## 2026-07-06 — Pre-market (~08:12 ET, Monday, first trading day of week 2 post-reset)

**Market posture:** S&P 500 futures lean toward a higher open (~62% implied
probability per prediction-market pricing) after the July 4 weekend. Fed held
4.25–4.50% at the June meeting and signaled two possible cuts later this
year; June jobs report (released Fri Jul 3, market closed) badly missed
(+57K vs ~117K expected, unemployment ticked down to 4.2%) — read as dovish,
consistent with the Dow's July 2 record close (52,900.07, +1.14%). Nasdaq
underperformed the same session (−0.8%) on continued AI-semiconductor
valuation-stretch concerns (second consecutive down session). 10yr Treasury
still below the 4.75% new-buy gate. Risk-on tone into the open, tech
still soft — no change to the active AI-capex-digestion caution flag.

**VST (held, 29sh) — what changed since yesterday:** Nothing material, thesis
unchanged. Price ~$152.95 pre-market vs Friday's $151.05 (little moved over
the long weekend). Analyst consensus remains Buy (13 analysts per Jul 4
data), avg PT $231.85. Next earnings confirmed **2026-08-06/07** (sources
split by a day; both are >2 trading days out — no earnings-window action
needed). No news found that touches Helix Digital Infrastructure, Cogentrix,
the Fitch IG upgrade, or the USD 5.5B revolver — all still intact. Trailing
stop `bdfb5f67` confirmed live (HWM $156.24, stop $140.616).

**Thesis contract review:** VST invalidation ("closes below USD 148 on
volume, or the trailing stop fires, or the Helix/Cogentrix consortium is
disrupted") — NOT triggered, current price $152.95 comfortably above $148.
`review_by` 2026-08-06 not yet reached. **Decision: HOLD, contract
unchanged, no new review_by needed** (original date still valid).

**Monday conviction-weighted review (VST):** Rated **B** — working but
flat. Thesis pillars (Helix, Cogentrix, Fitch upgrade) all still intact and
no new negative information, but the position is essentially flat since
entry (−1.13%, $154.70 → $152.95) with the next real catalyst (earnings)
still a month out. Not A (no fresh confirming catalyst this week to justify
"high conviction, working"); not C (no wobble, no drag, nothing quiet enough
to be a concern — this is week 1 of tracking, so the 3-consecutive-Monday
trim rule doesn't apply yet regardless).

**AAPL — full gate check (watchlist item added 2026-07-03, "full gate check
within 2 weeks or drop"):**
- Price (pre-market) ~$307.31 vs Friday's settled close $308.235.
- 50-day SMA (fresh Alpaca IEX daily bars, 2026-04-15 to 2026-07-02): $293.46.
  Current price is **+5.04% above the 50-day** — not extended past the 10%
  chase threshold. **Technical signal PASSES.**
- 20-day ATR: **2.98%** of price — just under the 3% volatility-check
  threshold, so no size-halving would be required if entered.
- Valuation: TTM P/E **37.32×**, which is **+39% above its own 10-year median
  (26.77×)**; forward P/E ~30.9×. PEG readings conflict across sources (2.70
  vs a stale-input 1.23) but the higher figure is the more defensible read
  given TTM growth. GuruFocus flags the stock as **15.6% above its GF fair
  value estimate**. **Valuation signal FAILS** — this is a genuinely
  expensive print, not a cheap or fairly-valued one.
- Catalyst (1–6mo): WWDC26 "Siri AI"/Apple Intelligence refresh (iOS 27,
  eligible back to iPhone 11) plus reports of 5 new iPhones including a
  ~USD 2,500 foldable model (Morgan Stanley: foldables could add USD 40–60B
  revenue over the next ~18 months). **Signal PASSES** — real, dated
  product catalysts, not just a story.
- Earnings momentum: last reported quarter (Q2 FY26, ~March quarter) showed
  iPhone revenue +22% YoY; however that print is now ~3 months old and the
  next earnings (confirmed **2026-07-30 after close**) is still 3.5 weeks
  away — no fresh confirming data point this week. **Signal is stale/weak,
  not a clean pass.**
- Macro tailwind: AAPL led the Dow's July 2 record session (+4.80%);
  mega-cap tech rotation intact. **Signal PASSES.**
- **Net: 3-of-5 clean passes (technical, catalyst, macro), 1 clear fail
  (valuation), 1 weak/stale (earnings momentum).** The stock already showed a
  textbook "sell the rumor, buy... sell the news" pattern after WWDC — it
  spiked to an intraday record ~$317.40 during the keynote, then gave back
  ground over the following sessions to today's ~$307. Entering now, a few
  points off that same post-keynote high, on a name that is +39% above its
  own 10-year P/E median, is the exact profile of "chasing a story at a
  stretched valuation" that `lessons.md` and `strategy.md` warn against
  (see the AI-capex-digestion caution and the Goldman Risk Appetite
  Indicator sitting at its 99th percentile — a sizing/pace caution flag).
  **Decision: do NOT buy AAPL today.** It clears the literal 3-of-5 entry
  bar, but the fail is on valuation specifically, and the pass on earnings
  momentum is weak — not a confluence I want to size real conviction behind
  right after a "sell the news" pullback. Keep on the watchlist; re-check
  before the 2026-07-17 drop-dead date for either (a) a pullback toward the
  50-day (~$293, which would also improve the valuation read) or (b) a
  clearer post-earnings valuation reset on 2026-07-30. Not dropping it yet —
  11 days remain on the gate-check clock.

**Other watchlist names:** No fresh gate-clearing news since the 2026-07-03
full re-verification (NVDA still consolidating ~$197, still confirmed
downtrend vs 50-day per that pass; LLY/V/PWR/MSFT/COST unchanged over the
long weekend; LRCX still ATR-gated pending 10b5-1 confirmation). Not
re-running the full SMA/ATR table today since only one trading session
(today) has elapsed since the last full pass — will re-verify fresh before
any of these are seriously considered.

**Cash-drag check:** Cash is 95.55% vs the 25–40% build-phase target band —
still justified. This is only the 4th trading day since the 2026-07-01
re-baseline (2 sessions traded, 1 holiday closure, today making the 3rd
trading session); the "above target for more than a week" trigger has not
been reached, and the one live candidate (AAPL) was reviewed in full today
and explicitly deferred on a valuation fail, not skipped by default. Weekly
new-position count resets to 0/3 this week (VST was last week's only entry).

**Guardrail / risk posture (live Alpaca data, 2026-07-06 ~08:12 ET):**
- Equity $99,949.24 | Cash $95,513.69 (95.55%) | Long MV $4,435.55 (4.44%).
- Drawdown circuit breaker: HWM $100,000.00 (set 2026-07-01), current equity
  $99,949.24 → drawdown **0.051%** — NOT triggered (9.95pp headroom).
- Intraday shock: equity $99,949.24 vs last_equity $99,894.14 — no shock
  (market not yet open; pre-market quote movement only).
- Sector cap: Energy/Utilities (VST) 4.44% — far below the 60% cap.
- Stop audit: VST trailing stop `bdfb5f67` confirmed live (HWM $156.24, stop
  $140.616) — 1/1 PASS.
- Weekly new-position count: 0/3 used this week.

### Planned trades for today

No trades planned.

```json
{
  "plan_date": "2026-07-06",
  "trades": []
}
```

---

## 2026-07-10 pre-market (~08:24 ET, Friday)

**Market posture:** SPY futures roughly flat to +0.2%, Dow futures +0.2% — mixed reads across sources (some show Nasdaq/S&P futures dipping pre-bell on big-tech wobble). Key focus: SK Hynix's $26.5B Nasdaq US listing (largest-ever US listing by a foreign company, Nvidia HBM supplier) is being read as a sentiment test for the AI trade; traders also watching Strait of Hormuz shipping traffic. WTI ~$72/bbl, easing off this week's Iran-driven spike. 10yr Treasury yield eased to ~4.54% (second straight down session, still below the 4.75% new-buy gate) as lower oil cooled inflation fears — but markets are pricing ~64% odds of a Fed hike by the September meeting per June FOMC minutes, a fresh hawkish-tail risk to track alongside the AI-capex-digestion watch already active. Next scheduled macro catalysts: bank earnings + CPI July 14, FOMC July 29 (unchanged from prior weeks). [Sources: [Yahoo Finance](https://finance.yahoo.com/news/live/stock-market-today-friday-july-10-dow-sp-nasdaq-113921604.html), [Benzinga](https://www.benzinga.com/markets/prediction-markets/26/07/60376965/sp500-july-10-open-up-or-down-polymarket-sk-hynix-oil-prices-chip-stocks)]

**Held positions — what changed since yesterday:**
- **V (Visa), 22sh @ avg $355.058182, current $349.30 (−1.622%):** A federal judge in the Northern District of California dismissed a securities-fraud lawsuit against Visa and 7 current/former officers — a legal overhang removed, mildly positive. No other material news; 42-analyst coverage remains lopsided bullish (29 buy, 8 outperform, 3 hold, 0 sell). Thesis unchanged, contract not triggered (invalidation ~$327 50-day SMA, review_by 2026-07-28). [Source: [MarketBeat](https://www.marketbeat.com/stocks/NYSE/V/)]
- **VST (Vistra), 29sh @ avg $154.70, current $158.25 (+2.295%):** Closed 07-09 +2.04% (outpacing SPY's +0.81%), +11.75% over the past month vs the Utilities sector's +3.47% — momentum continuing on power/AI-datacenter demand. Bernstein (07-06) and Wells Fargo (07-03) both reaffirmed Buy; FY2026 EPS growth estimate +81%. Nothing thesis-breaking; contract not triggered (invalidation $148, review_by 2026-08-07). [Source: [Yahoo Finance](https://finance.yahoo.com/quote/VST/)]

**Earnings calendar (held + candidates):**
- V: confirmed Tuesday 2026-07-28 (after close / per fiscal Q3 report) — 18 calendar days out, outside the 2-day blackout.
- VST: confirmed ~2026-08-06/07 (Q2 2026 report) — ~27 calendar days out, outside the 2-day blackout.
- AAPL: confirmed Thursday 2026-07-30 after market — outside the 2-day blackout for any new entry consideration.
- LRCX: June-quarter call confirmed 2026-07-29 — outside the 2-day blackout.
No held or candidate name is within the earnings blackout window today; no hold/trim/exit decision required on that basis.

**Watchlist re-verification (fresh 50-day SMA / 20-day ATR, Alpaca daily bars 2026-04-15 → 2026-07-09 close):**

| Ticker | Last close | vs 50-day SMA | 20-day ATR% | Technical gate | Notes |
|--------|-----------|----------------|-------------|-----------------|-------|
| NVDA | $202.78 | −3.09% | 2.92% | FAIL (below SMA) | Still in the downtrend flagged prior weeks. |
| LLY | $1,216.95 | +12.63% | 3.16% | FAIL (extended) | Still priced-in / overextended; earnings 2026-08-05. |
| LRCX | $353.17 | +7.90% | 6.21% (>3% gate) | PASS (borderline), ATR-gated | See valuation note below — deferred regardless. |
| PWR | $668.17 | −6.52% | 3.89% | FAIL (below SMA) | No fresh catalyst. |
| MSFT | $384.36 | −4.98% | 2.88% | FAIL (below SMA) | Part of the broader mega-cap tech pullback, unchanged. |
| COST | $912.97 | −7.51% | 1.97% | FAIL (below SMA) | No fresh catalyst. |
| AAPL | $316.22 | +6.52% | 2.77% | PASS | See valuation note below — deferred regardless. |

**AAPL deep-dive:** Technical (PASS, +6.52% vs 50d, under the 10% chase threshold) and catalyst (JPMorgan raised PT $325→$345 on 07-07 citing ~20% average price increases on iPads/Macs; Apple-Broadcom renewed a >$30B chip supply agreement through 2031 covering wireless + custom AI silicon) both clear. But valuation still fails decisively: P/E 37.3–37.8x (39% above its own 10-year median of 26.77–26.8x), GuruFocus flags the stock 15.6% above fair value. The price has also moved the wrong way since the 07-06 gate check — then it was near a "sell the news" pullback toward the ~$293 50-day; now at $316.22 it is *more* extended (+6.52% vs the 50-day, up from prior levels), not pulled back. Deferred again. 7 days remain on the 2026-07-17 drop-dead clock set 07-03 ("drop if no clean gate clears").

**LRCX deep-dive:** Technical passes borderline (+7.90% vs 50d, under 10%), and the insider-selling cluster flagged 2026-07-02 is now resolved as non-signal — CEO Timothy Archer's 30,000sh sale ($11.7M, 07-02) was executed under a Rule 10b5-1 plan adopted 2026-02-24 (scheduled, not opportunistic); Director Eric Brandt's earlier 54,500sh sale (06-12) reads as vesting-related. However, valuation is now a decisive fail: GuruFocus puts LRCX ~199% above its estimated fair value ($129.98), trailing P/E 62–76x depending on source (202% above its own 10-year average of 19.73x), and PEG readings are inconsistent across sources (1.5–1.92 on some, 4.87/606%-above-median on GuruFocus) — the spread itself signals an unreliable, euphoric valuation regime, not a clean read. ATR remains gated at 6.21% (>3%), consistent with a stock that swung −7.4% (07-02) then +6.35% (07-09) in the same week on heavy analyst-upgrade momentum (Morgan Stanley PT to $404, Susquehanna to $475, Cantor Fitzgerald to $500 — all raised in the past week). This is a name with genuinely strong company-specific momentum, but entering a >90%-YTD-run stock at 60-70x+ trailing earnings, deep into "GuruFocus significantly overvalued" territory, is exactly the kind of story-over-setup entry the strategy's AI-semi caution note warns against. Deferred, watching for a valuation reset (pullback or a multi-quarter earnings catch-up) before reconsidering.

**Cash-drag check:** Cash has been above the 25–40% target band (currently 87.72%) for 9+ consecutive trading days since the 07-01 re-inception build began. 2 of 3 weekly new-position slots remain this week (V used 1/3 on 07-07), and the broad tape is not obviously hostile (10yr below the buy gate, oil easing, no active circuit-breaker or shock). But no watchlist candidate clears all five entry signals today — the two names that pass the technical gate (AAPL, LRCX) both fail decisively on valuation, and the five names that fail the technical gate have no fresh catalyst to justify chasing. Per the strategy's own discipline (conviction earns size, not the reverse; do not trade to look active), staying in cash today is the correct, deliberate decision — not a default. Will re-run the full gate check again at next pre-market; AAPL's drop-dead clock (2026-07-17) and the ongoing search for a cleaner LRCX entry point remain open threads.

**Sector/risk posture:** Financials (V) 7.687%, Energy/Utilities (VST) 4.591%, cash 87.723% — all within the 60% sector cap and 5% cash floor. Drawdown 0.1106% vs running HWM $100,086.89 — nowhere near the 10% circuit breaker. No intraday shock (market not yet open). Weekly new-position count 1/3, resets Monday 2026-07-13.

**No trades planned today.**

```json
{
  "plan_date": "2026-07-10",
  "trades": []
}
```

---

## 2026-07-13 pre-market (~08:15 ET, Monday)

**Market posture:** S&P 500 futures up ~0.4% pre-bell as investors digest cooling global inflation data alongside uneven growth signals abroad; 10yr Treasury eased to ~4.54-4.56% (second straight down session, still below the 4.75% new-buy gate) on softer oil-driven inflation fears. Last week (Jul 6-10) the S&P 500 gained +1.23%, Nasdaq +1.74%, led by NVDA (+~4%) and META (+~6%) on continued AI-trade momentum; SK Hynix's Nasdaq debut popped ~13% Friday. This week's key catalyst: JPMorgan, BofA, Citigroup, and Wells Fargo all report Q2 earnings **tomorrow, July 14, before the open** — a read on credit quality and loan demand relevant to the broader tape (V is payments, not a bank, but the sector print matters for market mood). FOMC not until July 29. [Sources: [Benzinga](https://www.benzinga.com/markets/prediction-markets/26/07/60406404/stock-market-will-sp-500-open-up-or-down-today-8), [Yahoo Finance](https://finance.yahoo.com/news/live/stock-market-today-friday-july-10-dow-sp-nasdaq-113921604.html), [IG International](https://www.ig.com/en/news-and-trade-ideas/us-bank-earnings--what-to-expect-from-q2-2026-260710)]

**Held positions — what changed since Friday:**
- **V (Visa), 22sh @ avg $355.058182, current $349.00 (−1.706%):** No new negative news. Barclays initiated Overweight ($420 PT) and Baird raised PT to $412 (from $370) in the past week — both already known/reinforcing. Visa expanding in Vietnam via a new 9Pay partnership (incremental, not thesis-moving). Stablecoin settlement pilot confirmed at a $7B annualized run rate with 160+ card programs live/in development. Earnings confirmed Tuesday 2026-07-28 (consensus EPS $3.22, revenue $11.35B +11.62% YoY) — 11 trading days out, outside the 2-day blackout. Thesis unchanged, contract not triggered (invalidation ~$327 50-day SMA, review_by 2026-07-28). [Source: [Yahoo Finance](https://finance.yahoo.com/markets/stocks/articles/visa-v-declines-more-market-214503703.html)]
- **VST (Vistra), 29sh @ avg $154.70, current $157.58 (+1.859%):** Nothing new since Friday's momentum note. 20 analysts average "Strong Buy," 12-month PT $222.89 (+40.65% upside from last price). GuruFocus still flags VST 8.2% below its GF Value estimate ($167.20) — undervalued by that measure even after the recent run. Earnings confirmed ~2026-08-07 (consensus EPS $2.43, +140.59% YoY) — outside the 2-day blackout. Thesis unchanged, contract not triggered (invalidation $148, review_by 2026-08-07).

**Earnings calendar confirmed:** V 2026-07-28, VST ~2026-08-07, AAPL 2026-07-30, LRCX 2026-07-29, LLY 2026-08-05, NVDA 2026-08-26, META 2026-07-29 (est., unconfirmed by company). None within the 2-trading-day blackout for any held or candidate name today.

**Conviction-weighted holding review (Monday, section 3c):**
- **VST — upgraded B → A.** Original thesis (Helix Digital Infrastructure, Cogentrix, power/AI-datacenter demand) fully intact and working: +1.86% unrealized, +11.75% trailing-month vs the Utilities sector's +3.47%, Bernstein and Wells Fargo both reiterating Buy, GuruFocus still flags it undervalued 8.2% below GF Value even after the run. Conviction is high and the catalyst (Helix/Cogentrix buildout) continues to develop, not stall — upgrading from B (2026-07-06) to A.
- **V — first review, rated B.** Thesis intact (stablecoin/agentic-commerce catalyst, legal overhang resolved via the dismissed securities-fraud suit, lopsided-bullish analyst coverage) but the position is essentially flat-to-slightly-down since the 2026-07-07 entry (−1.71% unrealized) while the market has been driven by an AI-semi rally V has no exposure to — working but flat, catalyst (07-28 earnings) hasn't arrived yet. Rated B, not C: no red flags, no thesis erosion, just awaiting its catalyst.

**Watchlist re-verification (fresh 50-day SMA / 20-day ATR, Alpaca IEX daily bars 2026-04-15 → 2026-07-10 close):**

| Ticker | Last close | vs 50-day SMA | 20-day ATR% | Technical gate | Notes |
|--------|-----------|----------------|-------------|-----------------|-------|
| LLY | $1,188.57 | +9.35% | 2.86% | **PASS** (first time since 2026-05-22) | Pulled back from +14.76%/+12.63% two weeks ago; see deep-dive below. |
| NVDA | $210.99 | +0.87% | 2.92% | PASS (marginal — barely above) | See deep-dive below; technical signal too thin to act on alone. |
| AAPL | $315.32 | +5.92% | 2.70% | PASS | Valuation still fails — see below. Drop-dead clock 2026-07-17 (this Friday). |
| LRCX | $350.21 | +6.37% | 5.78% (>3% gate) | PASS (ATR-gated) | Valuation still decisively fails — see below. |
| META | $669.25 | +11.46% | 3.44% | FAIL (extended) | Unvetted candidate added 2026-07-10; fails technical gate outright — up ~20% in a few weeks on the new "Meta Compute" AI-cloud/Iris-chip buildout announcement. Not chasing a >10%-above-50-day parabolic move regardless of the compelling narrative. Drop-dead 2026-07-24 unchanged. |
| PWR | $658.46 | −7.95% | 3.38% | FAIL | Still below 50-day, no fresh catalyst. Weekly review flagged for purge 2026-07-17 if nothing changes by then — not a pre-market decision. |
| MSFT | $385.09 | −4.57% | 2.80% | FAIL | Still in the broader mega-cap tech pullback. |
| COST | $916.05 | −7.04% | 1.78% | FAIL | No fresh catalyst. |

**LLY deep-dive — clears all 5 entry signals for the first time since inception:**
1. *Earnings momentum / analyst upgrades:* Morgan Stanley raised PT to $1,347 (07-08), RBC issued $1,500 (07-08), BofA set $1,334 (07-10, +12.28% implied upside) — three fresh target raises in the past week, all after the stock's own pullback.
2. *Catalyst:* Medicare GLP-1 Bridge program live since 2026-07-01 and still rolling out; Q3 earnings 2026-08-05.
3. *Valuation:* current P/E (TTM) 43.19x vs its own 5-year median of 53.38x — LLY is now trading **below its own historical median**, a genuine valuation reset following the pullback from $1,234 (52-wk high, late June) to $1,188.57, not a chase. This reverses the "priced in / extended" valuation-fail finding from the past three pre-markets.
4. *Technical:* +9.35% above the 50-day SMA, under the 10% chase threshold — clears for the first time since 2026-05-22 (was +14.76% on 07-03, +12.63% on 07-10).
5. *Macro tailwind:* GLP-1 secular demand intact; healthcare adds sector diversification away from the AI-semi-heavy tape (currently 0% healthcare exposure).
ATR 2.86% is under the 3% volatility-check threshold — no size-halving required. **5-of-5 entry signals met; this is today's planned buy** (see below).

**NVDA deep-dive — technical gate clears but only by a hair; deferring, not buying:**
Forward P/E has compressed to ~20.4-21.7x (Goldman: "compelling," near the S&P 500 average, versus NVDA's own 5-year average of ~72x) — a real valuation improvement. But the stock is only +0.87% above its 50-day SMA — essentially sitting right on top of the average, not a confirmed breakout with any margin. The knowledge base's own confluence principle (`knowledge-base.md` §4.5) warns that single, marginal technical signals are weak; a stock a hair's-breadth above its 50-day is not the same confirmation as a clean multi-percent breakout. Combined with the still-active AI-capex-digestion macro watch (`strategy.md`), the prudent read is to let NVDA hold clearly above its 50-day for another session or two before treating the technical signal as real, rather than force a second buy today alongside LLY. Not a rejection — a "wait for confirmation" deferral. Re-check next pre-market.

**AAPL deep-dive:** GuruFocus GF Value $267.40 vs price $310.52 — 16.1% overvalued (modestly overvalued verdict), forward P/E 31.98 (37.3% above the hardware industry median), trailing P/E 38.1x vs its own 5-year median 30.4x. Valuation still fails decisively despite the technical pass. Insiders sold $87.6M in the last 3 months with no buying. Deferred again — **4 days remain on the 2026-07-17 drop-dead clock** set 2026-07-03; if no clean valuation gate clears by Friday's pre-market, drop AAPL from the watchlist per that standing instruction.

**LRCX deep-dive:** GuruFocus GF Value $131.78 vs price $326.13 — 147.5% overvalued, P/E 61.5-66.6x vs 5-year median 23.2x (165%+ above), forward P/E 44.4x. Valuation score 1/10 on GuruFocus despite a 10/10 profitability/growth score. Insiders sold $59.4M in the past 3 months, no buying. ATR still gated at 5.78% (>3%). Deferred — no change from prior weeks' finding.

**Cash-drag check:** Cash was 87.7% entering today, above the 25-40% target band for 10+ consecutive trading days. This week's new-position count resets to 0/3. LLY clearing all 5 entry signals today is exactly the qualifying entry the last two weekly reviews have been waiting for — not a forced trade, a genuine gate-clear. See planned trade below.

**Sector/risk posture:** Financials (V) 7.68%, Energy/Utilities (VST) 4.57%, cash 87.75% — all within the 60% sector cap and 5% cash floor. After today's planned LLY buy (~9.5%), Healthcare would sit at ~9.5%, still nowhere near the cap; cash would fall to ~78%, still comfortably above the 5% floor. Drawdown: equity $99,950.11 vs running HWM $100,086.89 (set 2026-07-07 market-open) = 0.137% — not triggered, 9.86pp of headroom. Weekly new-position count resets to 0/3 today (last new position was V, 2026-07-07, in the prior week).

**Volatility check (LLY):** 20-day ATR% = 2.86%, under the 3% threshold — no size-halving required. Sizing at 8 shares (~$9,509 at Friday's $1,188.57 close, ~9.51% of equity) keeps the risk-budget stop-out loss at ≈0.95% of equity with a 10% trailing stop — under the 1.2% cap, and within the strategy's "High conviction" 10-12% band's lower edge given the 5-of-5 signal strength. Whole-share sizing preserves trailing-stop eligibility.

### Planned trades for today

**One planned buy — LLY, first Healthcare-sector position since the 2026-07-01 reset.**

1. **BUY LLY 8 shares** (~$9,509 at Friday's $1,188.57 close, ~9.51% of equity)
   *Thesis:* Long LLY starter position. Catalyst: Medicare GLP-1 Bridge program live since 2026-07-01, actively rolling out; Q3 earnings 2026-08-05. Edge: three analyst price-target raises this past week (Morgan Stanley $1,347, RBC $1,500, BofA $1,334) following LLY's pullback from its late-June 52-week high, while the stock's P/E (43.19x TTM) is now actually below its own 5-year median (53.38x) — a genuine valuation reset, not a chase. Technical confirmation: +9.35% above the 50-day SMA, clearing the <10%-extension gate for the first time since 2026-05-22 (down from +14.76% two weeks ago). Invalidation: closes below the 50-day SMA (~$1,087, will drift with the moving average) on volume, the Medicare GLP-1 Bridge program is rolled back or loses funding, or the 10% trailing stop fires. Target: consensus PT range $1,208-1,347 over the next 1-2 quarters. Size: ~9.5% starter (8 whole shares, preserves trailing-stop eligibility); risk at the 10% stop ≈0.95% of equity, under the 1.2% risk-budget cap.

This week's new-position count after this fill: 1/3. Daily deployment: ~9.5% of the 25% cap. Cash after fill: ~78.2%, still well above the 5% floor. Sector exposure after fill: Healthcare ~9.5%, Financials 7.68%, Energy/Utilities 4.57% — all within the 60% cap.

```json
{
  "plan_date": "2026-07-13",
  "trades": [
    {"action": "buy", "symbol": "LLY", "qty": 8, "thesis": "Medicare GLP-1 Bridge live since 2026-07-01 plus Q3 earnings 2026-08-05 catalyst; three analyst PT raises this week (Morgan Stanley 1347, RBC 1500, BofA 1334); P/E 43.19x now below its own 5-year median 53.38x -- genuine valuation reset after the June pullback, not a chase; technical gate clears for the first time since 2026-05-22 at +9.35% vs 50-day SMA, ATR 2.86% (no size-halving needed)", "invalidation": "closes below the 50-day SMA (~1087, drifts with the average) on volume, or the Medicare GLP-1 Bridge program is rolled back or loses funding, or the 10% trailing stop fires", "review_by": "2026-08-05"}
  ]
}
```

EXECUTED: 2026-07-13T13:37:19Z

---

## 2026-07-14 pre-market (~08:10 ET, Tuesday)

**Market posture:** Genuinely volatile risk-off morning. S&P 500 futures −0.2%, Dow futures −0.3%, Nasdaq 100 futures +0.2% (mixed) as the market awaits the June CPI print (8:30 AM ET) and Fed Chair Kevin Warsh's first Congressional testimony today. The bigger story: the US military completed a **third consecutive night of strikes on Iran**, and Trump unveiled plans to reinstate a blockade on Iranian vessels transiting the Strait of Hormuz. Oil has surged accordingly — WTI +3.40% to USD 80.80/bbl, Brent +4.72% to USD 87.23/bbl, after a +9%+ two-day move, back above pre-ceasefire levels. 10yr Treasury yield ~4.62% (rising, still under the 4.75% new-buy gate but the closest it has been to it since inception — a real hawkish-tail risk, not just a watch item). Separately, all five megabank Q2 earnings hit today: JPMorgan and Wells Fargo already reported well ahead of estimates (JPM EPS 6.14 vs 5.85 consensus, revenue USD 58.02B vs USD 50.19B expected); BofA/Goldman/Citi due before the open. [Sources: [Yahoo Finance](https://finance.yahoo.com/markets/live/stock-market-today-tuesday-july-14-dow-sp-500-nasdaq-070833816.html), [TheStreet](https://www.thestreet.com/stock-market-today/stock-market-today-dow-jones-sp-500-nasdaq-updates-july-14-2026), [Boston Globe](https://www.bostonglobe.com/2026/07/14/business/consumer-prices-report/), [Motley Fool](https://www.fool.com/investing/2026/07/13/the-latest-inflation-data-will-drop-on-july-14-here-s-why-it-s-a-big-deal-for-the-stock-market/)]

**Live re-sync:** equity USD 100,144.85, cash USD 78,307.54 (78.19%). LLY 8sh @ avg USD 1,174.35625, current USD 1,179.01 (+0.40%, +USD 37.23 unrealized). V 22sh @ avg USD 355.058182, current USD 355.43 (+0.11%, +USD 8.18 unrealized). VST 29sh @ avg USD 154.70, current USD 158.13 (+2.22%, +USD 99.47 unrealized). All well above the −7% cut threshold.

**Held positions — what changed since yesterday:**
- **LLY (8sh, +0.40%):** Nothing thesis-breaking. UBS raised its PT to USD 1,425 (from USD 1,250), reiterating Buy — "1 new reason LLY could be headed higher" per 24/7 Wall St, driven by the incretin franchise and the Foundayo launch. LLY is presenting 16 abstracts (incl. new Kisunla Alzheimer's trial data) at AAIC, running through 07-15 in London — an incremental positive catalyst, not a thesis change. Medicare GLP-1 Bridge program unaffected. Thesis unchanged, contract not triggered (invalidation ~50-day SMA ~USD 1,087, current price far above; review_by 2026-08-05).
- **V (22sh, +0.11%):** Nothing negative. Shares rose ~2.4% Monday on a new ACE Money Transfer collaboration to enhance international transactions — incremental, reinforces the payments-innovation thesis, not a new pillar. Consensus PT USD 410 (+18% upside). Earnings confirmed 2026-07-28 (14 trading days out, outside blackout). Thesis unchanged, contract not triggered (invalidation ~50-day SMA ~USD 327, current well above; review_by 2026-07-28).
- **VST (29sh, +2.22%):** Nothing new. Strong Buy consensus (19 buy / 1 sell), PT USD 222.89. Earnings confirmed 2026-08-07 (outside blackout). Thesis unchanged, contract not triggered (invalidation USD 148, current well above; review_by 2026-08-07).

**Thesis contract review (step 3b):** All three positions reviewed against current price and today's news — none triggered, none due (V 07-28, VST 08-07, LLY 08-05, all future). HOLD all three, contracts unchanged.

**Earnings window (step 5):** No held or watchlist-candidate name reports within 2 trading days. Today's bank earnings (JPM/WFC/BAC/GS/C) are unrelated to any held name (V is payments, not a bank) — relevant only as broad market-mood context.

**Watchlist re-verification (fresh 50-day SMA / 20-day ATR, Alpaca IEX daily bars 2026-04-15 → 2026-07-13 close):**

| Ticker | Last close | vs 50-day SMA | 20-day ATR% | Technical gate | Notes |
|--------|-----------|----------------|-------------|-----------------|-------|
| META | $656.87 | +9.45% | 3.48% | **PASS** (marginal, down from +11.46%) | See deep-dive below. |
| AAPL | $317.47 | +6.30% | 2.70% | PASS | Valuation still fails — see below. Drop-dead 2026-07-17 (this Friday). |
| LRCX | $329.94 | −0.28% | 5.55% (>3% gate) | FAIL (pulled back onto the 50-day) | Valuation still decisively fails regardless — see below. |
| NVDA | $203.49 | −2.67% | 2.95% | FAIL | Backslid below the 50-day from +0.87% last week — the marginal pass never confirmed, consistent with last week's "wait for confirmation" deferral being the right call. |
| PWR | $646.48 | −9.67% | 3.27% | FAIL | No fresh catalyst. Purge decision carried to Friday's weekly review per standing instruction. |
| MSFT | $390.99 | −2.95% | 2.75% | FAIL | Still in the broader mega-cap tech pullback. |
| COST | $926.04 | −5.89% | 1.78% | FAIL | No fresh catalyst. |

**META deep-dive — technical gate now passes, but deferring given today's event risk, not chasing:**
1. *Technical:* +9.45% above the 50-day, under the 10% chase threshold for the first time — but only by 0.55pp of buffer, a marginal pass, not a clean breakout.
2. *Valuation:* Forward P/E 20.33x (46% above the Interactive Media industry median), but GuruFocus flags META **modestly undervalued** — GF Value ~USD 817 vs a recent price in the ~$660-670s (varies by source/date), a genuine pass unlike AAPL/LRCX's "significantly overvalued" reads.
3. *Catalyst:* "Meta Compute" AI-cloud infrastructure business + in-house Iris AI chip (Sept 2026 production target, 14GW capacity target by 2027) — real and dated, not stale.
4. *Earnings momentum:* Recent GuruFocus coverage cites repeated single-day surges (+4.7%, +8%, cost-efficiency breakthrough) — positive momentum, though no confirmed beat-and-raise print this cycle; next earnings ~2026-07-29 (unconfirmed by company, outside the 2-day blackout regardless).
5. *Macro tailwind:* This is where the case breaks down for entering **today specifically** — the confluence principle (`knowledge-base.md` §4.5) treats a single marginal technical signal as weak, and today is a live macro-inflection day: a third consecutive night of Iran strikes, oil up ~9% in two sessions, 10yr yield at 4.62% (highest since inception), CPI due at 8:30 AM, and a first-ever Fed Chair Congressional testimony this afternoon. This is structurally the same setup flagged in the 2026-06-10 lesson (META stop-out): entering a high-beta name right as a macro inflection is unfolding co-locates the trailing stop with elevated gap/volatility risk. **Deferring, not rejecting** — META's drop-dead clock (2026-07-24) is not in danger; will re-check once today's CPI/Fed-testimony/Iran-news dust settles, ideally on a session where the technical pass has more than 0.55pp of buffer.

**AAPL deep-dive:** GF Value USD 267.40-267.91 vs price USD 315.32-319.64 (16.1-19.3% overvalued depending on source/date), P/E TTM 38.1x vs its own 5-year median 30.4x. Valuation still fails decisively. **3 days remain on the 2026-07-17 drop-dead clock** — Friday's weekly review will need to make the drop/keep call if no clean valuation gate clears by then.

**LRCX deep-dive:** Pulled back onto the 50-day (−0.28%, technical gate now FAILS, down from +7.90% PASS last week) on a fresh negative signal — "AI-driven memory demand cools" (Yahoo Finance, 07-13), a −5.83%/−6.9% single-day decline reported across sources despite continued analyst PT raises (Susquehanna to USD 475, Cantor Fitzgerald to USD 500, Mizuho to USD 400). GF Value still USD 131.78 vs price ~USD 326 — 147.5% overvalued, P/E 61.5x vs 5-year median 23.2x. Valuation fails decisively regardless of the technical flip; the memory-demand-cooling headline is itself a fresh, mildly negative data point worth tracking against the broader AI-capex-digestion watch in `strategy.md`. Earnings 2026-07-29.

**Cash-drag check (step 6):** Cash is 78.19% — above the 25-40% target band for a 3-position portfolio, though meaningfully lower than the 87%+ levels of two weeks ago now that LLY, V, and VST are all deployed. 2 of 3 weekly new-position slots remain this week. The tape is not constructive today — a live geopolitical/macro-event day (Iran escalation, oil spike, CPI, Fed testimony) is exactly the kind of session the strategy's existing pattern (07-08, 07-09 pre-markets) treats as a reason to stay defensive regardless of watchlist gate status, and no candidate clears all five entry signals cleanly today regardless (META's technical pass is marginal; AAPL/LRCX fail on valuation). Staying in cash today is an explicit, reasoned decision, not a passive default.

**Sector/risk posture:** Healthcare (LLY) 9.421%, Financials (V) 7.810%, Energy/Utilities (VST) 4.580%, cash 78.19% — all within the 60% sector cap and 5% cash floor. Drawdown: equity USD 100,144.85 vs running HWM USD 100,218.48 (2026-07-13 close, Alpaca `last_equity`) = 0.0735% — not triggered, effectively full headroom. Intraday shock check (pre-open, real test at market-open/midday): equity vs `last_equity` USD 100,218.48 = −0.0734% — no shock. Weekly new-position count: 1/3 (LLY, filled Monday 2026-07-13).

**No trades planned today.**

```json
{
  "plan_date": "2026-07-14",
  "trades": []
}
```
EXECUTED: 2026-07-14T13:36:00Z — No trades (plan empty: Iran war escalation risk-off day, META marginal-only technical pass deferred on event risk, AAPL/LRCX valuation-gated, NVDA below 50-day); stop audit 3/3 PASS (LLY e3547b9e HWM 1196.29/stop 1076.661 unchanged, V 2b0a93ba HWM 359.49/stop 323.541 unchanged, VST bdfb5f67 HWM ratcheted 161.1399→164.19/stop ratcheted 145.02591→147.771 on today's new high); LLY USD 1,151.35 (-1.959% from entry, -2.582% intraday), V USD 356.80 (+0.491% from entry, -0.266% intraday), VST USD 164.21 (+6.147% from entry, +3.852% intraday); shock check equity USD 100,130.03 vs last_equity USD 100,218.48 = -0.0883% (no shock, threshold -4%); drawdown 0.0883% vs HWM USD 100,218.48 (not triggered, breaker at -10%); sector exposure Healthcare (LLY) 9.201%, Financials (V) 7.841%, Energy/Utilities (VST) 4.757%, cash 78.207% (all within 60% cap); weekly new-position count remains 1/3. All guardrails ✓.

---

## 2026-07-15 08:12 ET — PRE-MARKET (Wednesday)

**Control switch:** ACTIVE, no NOTE/QUERY pending, `CROSS_BULL_LEARNING:` still blank (counter remains 0 — AGGRO has never led Cautious Bull).

**Live re-sync (Alpaca):** equity USD 99,976.76, cash USD 78,307.54 (78.328%), long market value USD 21,669.22 (21.674%), buying power USD 373,903.98, last_equity (2026-07-14 close) USD 99,954.77. LLY 8sh @ avg 1,174.35625, current 1,151.00 (-1.989%, -USD 186.85 unrealized). V 22sh @ avg 355.058182, current 355.51 (+0.127%, +USD 9.94 unrealized). VST 29sh @ avg 154.70, current 160.00 (+3.426%, +USD 153.70 unrealized).

**Drawdown circuit breaker:** equity USD 99,976.76 vs running HWM USD 100,218.48 (2026-07-14 close, from `history 1A 1D`) = 0.2413% drawdown — NOT triggered (9.7587pp headroom).
**Intraday shock check:** equity USD 99,976.76 vs last_equity USD 99,954.77 = +0.022% — no shock (market not yet open; real test at market-open/midday).
**Sector cap:** Healthcare (LLY) 9.210%, Financials (V) 7.823%, Energy/Utilities (VST) 4.641%, cash 78.328% — all well below the 60% cap.

**Thesis contract review (step 3b):** All three positions reviewed against current price and today's news — none triggered, none due (V review_by 2026-07-28, VST 2026-08-07, LLY 2026-08-05, all future). HOLD all three, contracts unchanged.

**Market posture (WebSearch, "S&P 500 futures pre-market July 15 2026"):** S&P 500 E-minis up ~13.5pts / +0.18% as of ~06:09 ET; SPY +0.25%, QQQ +0.50% pre-market. Polymarket/CME FedWatch: July-hike probability fell to 17% from 42% after Tuesday's cooler June CPI (3.5% YoY vs ~3.8% expected). [Benzinga](https://www.benzinga.com/markets/prediction-markets/26/07/60461322/sp500-july-15-open-up-or-down-polymarket-cpi-fed-rate-hike-inflation)

**Fed testimony (WebSearch):** Fed Chair Kevin Warsh's first Congressional testimony (07-14, House Financial Services Committee) delivered the semiannual Monetary Policy Report — Warsh said one month of cooler CPI is not "mission accomplished," reaffirmed Fed independence when pressed. Market read it as a non-hawkish surprise: S&P 500 +0.5%, Nasdaq +1.1%, Russell 2000 +0.4%, Dow -0.1% Tuesday. Testimony continues into a second day. [CNN](https://www.cnn.com/2026/07/14/economy/takeaways-kevin-warsh-congressional-testimony)

**Iran conflict (WebSearch, "Iran US conflict oil prices July 15 2026") — ESCALATING, not de-escalating:** overnight into 07-15 the US carried out another round of strikes on Iran and reinstated the naval blockade of Iranian ports near the Strait of Hormuz; Iran has signaled possible Houthi action against the Bab el-Mandeb strait as a further escalation risk. Oil surged ~14% to ~USD 85/bbl (Brent), WTI ~USD 80.77 — a one-month high. [CNBC](https://www.cnbc.com/2026/07/15/oil-prices-today-brent-wti-hormuz-blockade.html), [Vanguard News](https://www.vanguardngr.com/2026/07/oil-price-jumps-14-to-84-per-barrel-as-us-iran-ceasefire-collapses/)

**10yr Treasury:** ~4.62-4.64% (07-15), essentially flat vs yesterday — still below the 4.75% new-buy gate.

**Held-position research (what changed since yesterday):**
- **LLY (8sh, -1.989%):** Stock fell -3.10% on 07-14 (-2.48% intraday reported separately) on sector-wide profit-taking and competitive-concern chatter in the metabolic-health space — not a company-specific negative. Bernstein raised PT to USD 1,385 (from 1,300), UBS to USD 1,425 (from 1,250), Guggenheim to USD 1,273 (from 1,235) — all bullish, all this week. New USD 1.73 dividend declared, ex-date 08-14. Analysts expect USD 8.22 EPS / USD 20.26B revenue next quarter (+30% YoY). Thesis unchanged, contract not triggered (invalidation ~50-day SMA ~USD 1,087, review_by 2026-08-05).
- **V (22sh, +0.127%):** Shares hit a fresh 52-week-high area (~357-359 intraday this week). Visa launched an AI Financial Assistant; Baird lifted PT to USD 412 (07-06) citing expected Q3 beat-and-raise. Federal judge dismissed the securities-fraud suit without leave to amend (confirms 07-13 finding). Nothing new/negative. Thesis unchanged, contract not triggered (invalidation ~50-day SMA ~USD 327, review_by 2026-07-28).
- **VST (29sh, +3.426%):** Board declared an 8.875% Series C preferred dividend (not applicable to our common shares). Vistra is positioned to benefit from an upcoming PJM capacity auction; Q2 earnings confirmed for 2026-08-07 (matches existing review_by/thesis-contract date — no change needed). Zacks Rank #3 (Hold) is a lagging/quant signal, not a fundamental red flag; consensus PT ~USD 213, still well above current price. Thesis unchanged, contract not triggered (invalidation USD 148, review_by 2026-08-07).

**Earnings window (step 5):** No held or watchlist-candidate name reports within 2 trading days (nearest is V 07-28, 9 trading days out).

**Watchlist re-verification (fresh 50-day SMA / 20-day ATR%, Alpaca `data.alpaca.markets/v2/stocks/<SYM>/bars` with explicit `start=2026-04-16&end=2026-07-15&feed=iex`, bars through 2026-07-14 close — the bare `alpaca.sh bars` call returns null without explicit dates per the standing 2026-07-03 lesson):**

| Ticker | Last close (07-14) | vs 50-day SMA | 20-day ATR% | Technical gate | Notes |
|--------|-----------|----------------|-------------|-----------------|-------|
| META | $661.04 | +9.96% | 3.48% | **PASS (barely — 0.04pp buffer)** | Worse than yesterday's already-marginal 0.55pp. See deep-dive below. |
| AAPL | $314.93 | +5.14% | 2.64% | PASS | Valuation still fails — see below. Drop-dead 2026-07-17 (2 days left). |
| LRCX | $345.92 | +3.99% | 5.52% (>3% gate) | PASS technical / FAIL volatility gate | Valuation still decisively fails regardless — see below. |
| NVDA | $211.79 | +1.19% | 3.07% (>3% gate) | PASS technical (barely) / FAIL volatility gate | Second unconfirmed marginal bounce — see below. |
| PWR | $661.08 | −7.46% | 3.21% | FAIL | **Gained a dated catalyst this week** — see below. |
| MSFT | $384.94 | −4.34% | 2.76% | FAIL | Worse than yesterday (−2.95%). |
| COST | $921.65 | −6.16% | 1.77% | FAIL | Worse than yesterday (−5.89%). |

**META deep-dive — buffer now worse, not better; deferring again:** Technical buffer above the 10%-chase gate has shrunk from +0.55pp (07-14) to +0.04pp (07-15) — effectively at the edge of what the entry-signal discipline treats as "not extended." The macro-event risk cited yesterday as the reason to defer (live Iran/CPI/Fed-testimony day) has not cleared — the Iran conflict has specifically escalated overnight (new strikes, blockade reinstated, oil +14%), the exact opposite of "dust settling." Entering today would mean chasing into both a worse technical buffer and worse geopolitical risk than yesterday's already-cautious deferral. GuruFocus valuation (modestly undervalued) and the Meta Compute/Iris-chip catalyst remain intact and unchanged — this is a timing deferral, not a thesis rejection. **Deferred again**, re-check next pre-market, drop-dead 2026-07-24 unchanged.

**NVDA deep-dive — second unconfirmed marginal bounce, still deferring:** Cleared the 50-day for the first time in three weeks (+1.19%), on a broad post-CPI semiconductor relief rally — Morgan Stanley reiterated its overweight/top-pick rating citing "accelerating growth rates" near USD 100B/quarter revenue, and H200 chip shipments to China have resumed (though "very few" so far, per a US commerce official, and Nvidia simultaneously halved its approved Asian-buyer whitelist — a mixed, not unambiguously bullish, signal). ATR 3.07% still (barely) exceeds the 3% volatility gate, which would require halving any planned size regardless. Critically, this is the **second** unconfirmed marginal technical pass in three weeks: +0.87% (07-07) → backslid to −2.67% (07-14) → +1.19% (07-15). The entry-signal count does not clear 3-of-5 cleanly: valuation is a pass (forward P/E ~20-22x, "compelling"), the technical signal is a marginal, historically-unreliable pass, and there is no fresh earnings/guidance catalyst behind today's move — it is a rate-relief/short-covering bounce, not a fundamental re-rating. Consistent with the standing "wait for confirmation" discipline that correctly kept us out of the 07-07 false signal, **deferring again** — would need a second consecutive session holding above the 50-day with a real catalyst before this clears the bar.

**AAPL deep-dive:** GF Value USD 267.63-268.00 vs price USD 314.93-321.44 (18.4-20.0% overvalued), DCF earnings-based intrinsic value USD 187.29 (margin of safety −68.4%), DCF FCF-based intrinsic value USD 165.81 (margin of safety −90.2%). Insiders sold USD 87.6M in the last 3 months with zero buying — an additional caution flag layered on top of the valuation gate. Valuation still fails decisively. **2 days remain on the 2026-07-17 drop-dead clock** with no sign of a reset — Friday's weekly review will need to make the drop/keep call.

**LRCX deep-dive:** Technical gate flips back to PASS (+3.99%, was −0.28% FAIL yesterday) on continued AI-infrastructure-driven chip-equipment demand, but ATR 5.52% still exceeds the 3% volatility gate regardless (would require halving any planned size). GF Value USD 132.62 vs price USD 346.10 — 161.0% overvalued, P/E 62.47x — despite continued analyst PT raises (Susquehanna USD 475, Cantor Fitzgerald USD 500). Valuation fails decisively regardless of the technical flip-flop.

**PWR deep-dive — no longer catalyst-less, resolves the standing purge flag:** Technical gate still fails (−7.46% vs 50-day, ATR 3.21%), but Quanta Services confirmed Q2 2026 earnings for 2026-07-30 (before market open) and separately announced a USD 500-700M investment to roughly double its power-transformer manufacturing capacity — both dated, specific developments. This resolves the 2026-07-10 weekly review's "purge 2026-07-17 if no dated catalyst emerges" flag. Jefferies trimmed its PT to USD 784 (from 857) on 07-10 while keeping Buy; Truist's PT (USD 940) predates that. **Recommend Friday's weekly review keep PWR on the watchlist rather than purge it** — the technical gate remains the blocker, not a lack of a pipeline.

**Cash-drag check (step 6):** Cash is 78.33% — above the 25-40% target band for a 3-position portfolio. 2 of 3 weekly new-position slots remain this week. No candidate clears all gates cleanly: META's setup is worse today than yesterday's deferral (shrinking buffer, escalating not de-escalating macro risk); NVDA's technical pass is a second unconfirmed marginal bounce with no fresh catalyst; AAPL and LRCX both fail decisively on valuation. Staying in cash today is an explicit, reasoned decision, not a passive default — consistent with every prior session's reasoning this week.

**Sector/risk posture:** Healthcare (LLY) 9.210%, Financials (V) 7.823%, Energy/Utilities (VST) 4.641%, cash 78.328% — all within the 60% sector cap and 5% cash floor. Drawdown: equity USD 99,976.76 vs running HWM USD 100,218.48 (2026-07-14 close) = 0.2413% — not triggered, 9.7587pp headroom. Intraday shock check (pre-open, real test at market-open/midday): equity vs last_equity USD 99,954.77 = +0.022% — no shock. Weekly new-position count: 1/3 (LLY, filled Monday 2026-07-13).

**No trades planned today.**

```json
{
  "plan_date": "2026-07-15",
  "trades": []
}
```

EXECUTED: 2026-07-15T13:36:34Z — No trades (plan empty); stop audit 3/3 PASS (LLY e3547b9e HWM 1196.29/stop 1076.661 unchanged, V 2b0a93ba HWM 359.94/stop 323.946 unchanged, VST bdfb5f67 HWM 168.21/stop 151.389 unchanged); LLY USD 1,141.18 (-2.825% from entry, -0.986% intraday), V USD 352.03 (-0.853% from entry, -1.121% intraday), VST USD 166.27 (+7.479% from entry, +4.949% intraday); shock check equity USD 99,996.80 vs last_equity USD 99,954.77 = +0.042% (no shock, threshold -4%); drawdown 0.2212% vs HWM USD 100,218.48 (not triggered, breaker at -10%); sector exposure Healthcare (LLY) 9.130%, Financials (V) 7.745%, Energy/Utilities (VST) 4.822%, cash 78.31% (all within 60% cap); weekly new-position count remains 1/3. All guardrails ✓.

---

## 2026-07-16 08:15 ET — PRE-MARKET (Thursday)

**Control switch:** ACTIVE, no NOTE/QUERY pending, `CROSS_BULL_LEARNING:` still blank.

**Live re-sync (Alpaca):** equity USD 100,046.98, cash USD 78,307.54 (78.279%), long market value USD 21,739.44 (21.727%), buying power USD 374,100.61, last_equity (2026-07-15 close) USD 100,020.33. LLY 8sh @ avg 1,174.35625, current 1,163.00 (-0.967%, -USD 90.85 unrealized). V 22sh @ avg 355.058182, current 357.25 (+0.617%, +USD 48.22 unrealized). VST 29sh @ avg 154.70, current 157.7912 (+1.998%, +USD 89.64 unrealized).

**Drawdown circuit breaker:** equity USD 100,046.98 vs running HWM USD 100,218.48 (2026-07-13 close, from `history 1M 1D`) = 0.1711% drawdown — NOT triggered (9.8289pp headroom).
**Intraday shock check:** equity USD 100,046.98 vs last_equity USD 100,020.33 = +0.0266% — no shock (market not yet open; real test at market-open/midday).
**Sector cap:** Healthcare (LLY) 9.301%, Financials (V) 7.856%, Energy/Utilities (VST) 4.574%, cash 78.279% — all well below the 60% cap.

**Thesis contract review (step 3b):** All three positions reviewed against current price and today's news — none triggered, none due (V review_by 2026-07-28, VST 2026-08-07, LLY 2026-08-05, all future). HOLD all three, contracts unchanged.

**Market posture (WebSearch, "S&P 500 futures pre-market July 16 2026"):** Mixed/cautiously positive. S&P 500 futures roughly flat-to-up ~0.2% pre-market on easing inflation worries — June CPI's cooler read (0.4% MoM decline, 3.5% YoY) continues to pull the 10yr toward ~4.57%. Polymarket's July-16 contract implied only a 37% probability of an up open despite the constructive futures tape — some trader caution persists. [Yahoo Finance](https://finance.yahoo.com/markets/stocks/articles/us-stock-market-today-p-081336350.html), [Benzinga](https://www.benzinga.com/markets/prediction-markets/26/07/60489078/sp500-july-16-open-up-or-down-polymarket-ppi-inflation-fed-retail-sales-netflix)

**Iran conflict (WebSearch) — still escalating, 4th straight day of oil gains:** US struck Iranian coastal defenses and missile sites Wednesday night after reimposing the naval blockade; Iran has threatened to shut more regional energy exports and use Houthi allies to close the Bab el-Mandeb gateway. Brent ~USD 85.28 (+0.4%), WTI ~USD 80.02 (+0.5%) — a 4th consecutive up day. Goldman: Brent could exceed USD 110 in Q4 if the Gulf export recovery stalls further, or fall to the USD 60s if tensions ease. [CNBC](https://www.cnbc.com/amp/2026/07/16/oil-rise-as-us-strikes-on-iran-raise-fears-of-wider-conflict.html), [Fortune](https://fortune.com/2026/07/13/oil-price-rises-inflation-expectations-warsh-fed-goldman/)

**10yr Treasury:** ~4.57% (easing on the cooler CPI read) — still comfortably below the 4.75% new-buy gate.

**Held-position research (what changed since yesterday):**
- **LLY (8sh, -0.967%):** Nothing thesis-breaking. Citigroup raised its PT to USD 1,600 (from USD 1,500). Lilly is reportedly in advanced talks to acquire or partner with AtaiBeckley (a pipeline-diversification move, not a distraction from the core GLP-1 franchise). Retevmo received full FDA approval, adding to the oncology portfolio. USD 1.73 dividend declared (ex-date 08-14, already known). Thesis unchanged, contract not triggered (invalidation ~50-day SMA ~USD 1,102, review_by 2026-08-05).
- **V (22sh, +0.617%):** Nothing negative. AI Financial Assistant rollout and the ACE Money Transfer collaboration continue to generate positive coverage; 82% of 45 analysts rate Buy, average PT USD 401.16. Thesis unchanged, contract not triggered (invalidation ~50-day SMA ~USD 332, review_by 2026-07-28).
- **VST (29sh, +1.998%):** Nothing negative. Analysts forecast +140.6% YoY EPS growth for the 08-07 print (consensus revenue USD 6.42B, +51% YoY); Bernstein (USD 187 PT) and Morgan Stanley (USD 210 PT, Overweight) both reiterated. Thesis unchanged, contract not triggered (invalidation USD 148, review_by 2026-08-07).

**Earnings window (step 5):** No held or watchlist-candidate name reports within 2 trading days (nearest is V 07-28, 8 trading days out).

**Watchlist re-verification (fresh 50-day SMA / 20-day ATR%, Alpaca `data.alpaca.markets/v2/stocks/<SYM>/bars` with explicit `start=2026-04-17&end=2026-07-15&feed=iex`, bars through 2026-07-15 close):**

| Ticker | Last close (07-15) | vs 50-day SMA | 20-day ATR% | Technical gate | Notes |
|--------|-----------|----------------|-------------|-----------------|-------|
| META | $681.24 | **+13.05%** | 3.51% | **FAIL — now over-extended** | Was a marginal +0.04pp pass yesterday; a +3.07% single-day rally (Louisiana USD 50B+ data-center expansion news) pushed it well past the 10% chase gate. Resolves yesterday's ambiguity by disqualifying it, not clearing it. |
| AAPL | $327.58 | +9.02% | 2.71% | PASS (technical), but see deep-dive — this was a chase-day rally | Valuation gap widened to ~22.2% overvalued. Drop-dead 2026-07-17 (tomorrow). |
| LRCX | $335.35 | +0.34% | 5.92% (>3% gate) | PASS technical (barely) / FAIL volatility gate | Valuation still decisively fails regardless. |
| NVDA | $212.50 | +1.39% | 3.15% (>3% gate) | PASS technical (barely) / FAIL volatility gate | Third consecutive session of an unconfirmed marginal pass — still no fresh catalyst. Earnings confirmed 2026-08-26. |
| PWR | $648.97 | −8.92% | 3.29% | FAIL | Earnings 07-30 catalyst still stands (per 07-15 review) — do not purge. |
| MSFT | $395.61 | −1.60% | 2.81% | FAIL | Still below 50-day. |
| COST | $916.41 | −6.51% | 1.78% | FAIL | Still below 50-day. |

**AAPL deep-dive — a +4.2% single-day rally is a real catalyst, but it is also a chase, and valuation is worse, not better:** Apple stock jumped 3.9-4.2% on 2026-07-15 after the Cyberspace Administration of China approved Apple Intelligence for launch in China (via a compressed version of Alibaba's Qwen model, developed with startup PrismML) — a genuine fundamental catalyst that removes a real overhang (risk of a muted China iPhone upgrade cycle vs. Huawei's AI-enabled phones). This is not noise; it is a dated, verifiable regulatory unlock. However: (1) **Valuation is now worse, not better** — GF Value USD 268.12 vs the new price USD 327.58 is 22.2% overvalued, up from 17.4-20.0% earlier this week; the rally moved price further from fair value, not closer. (2) **This is definitionally a chase** — knowledge-base.md §6.1 flags buying after a stock has already moved sharply in a short window; entering the morning after a +4% single-day pop, right as the stock also crosses closer to the 10%-extension gate (+9.02%, up from +5.14% yesterday), is the textbook chase pattern the strategy is built to avoid, regardless of how real the catalyst is. **Deferred again — the news is real, but today is exactly the wrong day to pay for it.** Tomorrow (2026-07-17) is the standing drop-dead date from the 2026-07-03 weekly review ("drop if no clean valuation gate clears"); the valuation gate has not cleared — it has widened — so tomorrow's weekly review should treat this as the drop-dead deadline reached, not extend it further, unless a specific new argument emerges overnight.

**META deep-dive — no longer a live candidate, extension not valuation is now the blocker:** The USD 50B+ Louisiana data-center investment (more than doubling planned capacity to 5GW) and continued evidence of shipping AI products (not just announcing infrastructure) are genuine, incremental positives, and GuruFocus still reads META as modestly undervalued. But the stock is now +13.05% above its 50-day SMA after yesterday's +3.07% surge — well past the 10%-extension chase gate. This is the opposite problem from AAPL (valuation still passes, technical now fails outright) but the conclusion is the same: not an entry today. Re-check next pre-market for a pullback toward the 50-day; drop-dead 2026-07-24 unchanged.

**NVDA deep-dive:** Third consecutive session with an unconfirmed marginal technical pass (+0.87% 07-07 → −2.67% 07-14 → +1.19% 07-15 → +1.39% today's re-pull) and ATR still (barely) over the 3% volatility gate. Jensen Huang confirmed the next-gen Vera Rubin accelerator is in production (countering delay rumors) — a real but not new-information catalyst. P/E multiple is at a 7-year low per Motley Fool coverage, an interesting valuation data point, but the entry-signal count still doesn't clear cleanly without a confirmed, non-marginal technical breakout. Earnings confirmed 2026-08-26 (outside any blackout window). **Deferred again** — same standing rationale as the last three sessions.

**Cash-drag check (step 6):** Cash is 78.279% — above the 25-40% target band for a 3-position portfolio, for the ninth consecutive session since the LLY entry. 2 of 3 weekly new-position slots remain this week (through Friday). No candidate clears all gates cleanly today: META disqualified itself via extension overnight; AAPL's technical near-pass came via a chase-day rally into worse, not better, valuation; NVDA/LRCX remain ATR-gated; PWR/MSFT/COST remain below their 50-day. Staying in cash today is an explicit, reasoned decision, not a passive default — consistent with every session's reasoning this week and the prior two weeks.

**Sector/risk posture:** Healthcare (LLY) 9.301%, Financials (V) 7.856%, Energy/Utilities (VST) 4.574%, cash 78.279% — all within the 60% sector cap and 5% cash floor. Drawdown: equity USD 100,046.98 vs running HWM USD 100,218.48 (2026-07-13 close) = 0.1711% — not triggered, 9.8289pp headroom. Intraday shock check (pre-open, real test at market-open/midday): equity vs last_equity USD 100,020.33 = +0.0266% — no shock. Weekly new-position count: 1/3 (LLY, filled Monday 2026-07-13).

**No trades planned today.**

```json
{
  "plan_date": "2026-07-16",
  "trades": []
}
```
EXECUTED: 2026-07-16T13:40:00Z — No trades (plan empty: META disqualified overnight via extension +13.05% vs 50-day, AAPL chase-day valuation gap widened to 22.2% overvalued, NVDA/LRCX ATR-gated, PWR/MSFT/COST below 50-day); stop audit 3/3 PASS (LLY e3547b9e HWM USD 1,196.29/stop USD 1,076.661, V 2b0a93ba HWM USD 360.43/stop USD 324.387, VST bdfb5f67 HWM USD 168.21/stop USD 151.389, all live, unchanged since pre-market — market open ~5 min at check time); LLY USD 1,146.505 (-2.372% from entry, -0.875% intraday), V USD 359.48 (+1.245% from entry, +1.222% intraday), VST USD 153.41 (-0.834% from entry, -4.256% intraday); shock check equity USD 99,840.99 vs last_equity USD 100,020.33 = -0.1793% (no shock, threshold -4%); drawdown 0.3767% vs HWM USD 100,218.48 (2026-07-13 close, not triggered, breaker at -10%); sector exposure Healthcare (LLY) 9.186%, Financials (V) 7.921%, Energy/Utilities (VST) 4.455%, cash 78.434% (all within 60% cap); weekly new-position count remains 1/3. All guardrails ✓.

---

## 2026-07-17 08:12 ET — PRE-MARKET (Friday)

**Control switch:** ACTIVE, no NOTE/QUERY pending, `CROSS_BULL_LEARNING:` still blank.

**Live re-sync (Alpaca):** equity USD 100,094.37, cash USD 82,696.11 (82.618%), long market value USD 17,398.26 (17.382%), buying power USD 379,499.57, last_equity (2026-07-16 close) USD 100,082.55. LLY 8sh @ avg USD 1,174.35625, current USD 1,171.06 (-0.281%, -USD 26.37 unrealized). V 22sh @ avg USD 355.058182, current USD 364.99 (+2.797%, +USD 218.50 unrealized). VST: no longer held (stopped out 2026-07-16).

**Drawdown circuit breaker:** equity USD 100,094.37 vs running HWM USD 100,218.48 (2026-07-13 close, from `history 1A 1D`) = **0.1239%** drawdown — NOT triggered (9.8761pp headroom).
**Intraday shock check:** equity USD 100,094.37 vs last_equity USD 100,082.55 = **+0.0118%** — no shock (market not yet open; real test at market-open/midday).
**Sector cap:** Healthcare (LLY) 9.360%, Financials (V) 8.022%, cash 82.618% — all well below the 60% cap. Energy/Utilities 0% (VST closed).

**Thesis contract review (step 3b):** LLY (review_by 2026-08-05, invalidation ~50-day SMA ~USD 1,087-1,102 or Medicare Bridge rollback) — not triggered, not due, HOLD. V (review_by 2026-07-28, invalidation ~50-day SMA ~USD 327-332 or adverse DOJ ruling) — not triggered, not due, HOLD. Neither contract needs renewal today.

**Stop audit:** LLY `e3547b9e` (HWM USD 1,196.29, stop USD 1,076.661) unchanged — no new high since current price (USD 1,171.06) remains below the HWM. V `2b0a93ba` — HWM ratcheted further to USD 364.91 (stop USD 328.419), up from USD 364.08/USD 327.672 at Thursday's close, confirming the fresh 52-week-high move. Both confirmed live via `orders open` — **2/2 PASS**, no recreation needed. VST's stop order is gone from the open-orders list, correctly consumed by Thursday's fill — nothing to recreate.

**Market posture (WebSearch, "S&P 500 futures pre-market July 17 2026"):** Negative/cautious. September S&P 500 E-mini futures -0.17% this morning as chipmakers remain under pressure — continuing Thursday's chip-sector selloff (AI-capex-valuation skepticism). 10yr Treasury 4.53%, 2yr 4.12%. [Benzinga](https://www.benzinga.com/markets/equities/26/07/60517314/stock-market-today-dow-futures-sp-500-futures-slump-even-as-trump-says-us-is-doing-great-netflix-coca-cola-nebius-in-focus)

**Iran conflict (WebSearch) — still escalating, 6th straight night of strikes:** US forces have struck Iranian coastal, military, and maritime targets for a sixth consecutive night; five bridges hit, seven killed. Confirmed crude transit through the Strait of Hormuz has fallen 62% to 4.1M bbl/day as both sides maintain blockades. Oil up ~12% on the week — Brent ~USD 85.10, WTI ~USD 79.93. The 60-day ceasefire MOU (signed last month) expires 2026-08-16; Rystad Energy expects only a "narrow, face-saving" extension, not a durable resolution. [The National](https://www.thenationalnews.com/business/energy/2026/07/17/oil-set-for-steep-weekly-rise-as-us-and-iran-intensify-attacks/), [CNBC](https://www.cnbc.com/2026/07/17/oil-price-today-brent-wti.html)

**Fed (WebSearch):** Chair Warsh's semiannual Monetary Policy Report testimony (completed 07-14/07-15) gave no forward rate signal — "mission accomplished" pushback on the cooler CPI print, committee visibly divided on whether AI-datacenter capex is starting to raise generalized prices. Next FOMC meeting in ~2 weeks (07-29). No new information changing the standing 4.75%-yield gate assessment. [Federal Reserve](https://www.federalreserve.gov/newsevents/testimony/warsh20260714a.htm)

**10yr Treasury:** ~4.53% (07-17), easing further from 4.57% yesterday — still comfortably below the 4.75% new-buy gate.

**Held-position research (what changed since yesterday):**
- **LLY (8sh, -0.281%):** **Material update** — the AtaiBeckley acquisition talks reported yesterday advanced to a **definitive agreement**, up to USD 3.8B, confirming large-drugmaker interest in psychedelic medicine as a pipeline diversifier (not a distraction from the core GLP-1 franchise). Full FDA approval for Retevmo (oncology) also confirmed. USD 1.73 dividend, ex-date 08-14 (already known). Analyst consensus "Buy," 12-month PT USD 1,255.86 (+7.42% from Thursday's close). Thesis unchanged, contract not triggered.
- **V (22sh, +2.797%):** Stock hit a fresh multi-year high (USD 365.14, highest since June 2025) on continued momentum from the AI Financial Assistant launch and ACE Money Transfer collaboration (both already known); Q2 EPS/revenue beat details reconfirmed (EPS USD 3.31 vs USD 3.10 est., +6.77%; revenue USD 11.2B vs est., +4.19%). 38 of 38 analysts covering rate Buy/Strong Buy, 0 Sell. Nothing new/negative — thesis unchanged, contract not triggered.

**Earnings window (step 5):** No held or watchlist-candidate name reports within 2 trading days (nearest is V 07-28, 7 trading days out).

**Watchlist re-verification (fresh 50-day SMA / 20-day ATR%, Alpaca `data.alpaca.markets/v2/stocks/<SYM>/bars` with explicit `start=2026-04-18&end=2026-07-16&feed=iex`, bars through 2026-07-16 close):**

| Ticker | Last close (07-16) | vs 50-day SMA | 20-day ATR% | Technical gate | Notes |
|--------|-----------|----------------|-------------|-----------------|-------|
| META | $664.16 | +10.02% | 3.55% | **FAIL** | Still over the 10%-chase gate, though eased from Thursday's +13.05% blowout. |
| AAPL | $333.23 | +10.49% | 2.71% | **FAIL (new)** | Rallied further overnight; now extended AND valuation-gated. **Purged today** — see below. |
| NVDA | $207.46 | -1.10% | 3.17% | **FAIL** | Reversed again — 4th data point in the "unconfirmed marginal bounce" pattern. |
| LRCX | $320.95 | -4.33% | 5.92% | **FAIL** | Reversed from Thursday's marginal +0.34% pass. |
| PWR | $631.02 | -11.12% | 3.28% | FAIL | Worse than yesterday (-8.92%); earnings 07-30 catalyst still stands. |
| MSFT | $401.12 | -0.17% | 2.90% | FAIL (barely) | Improved from -1.60% yesterday — essentially flat to its 50-day. |
| COST | $945.46 | -3.41% | 1.79% | FAIL | Improved from -6.51% yesterday; no fresh catalyst. |
| VST (re-entry watch) | $152.54 | -0.98% | 3.78% | FAIL (barely) | Not yet a clean re-entry; ATR still over the 3% gate too. |

**No watchlist candidate clears the technical entry gate today — a first in this cycle where even the two previously-marginal names (META, AAPL) both fail outright, not just barely.**

**AAPL deep-dive — drop-dead clock has arrived, applying the pre-stated rule:** The 2026-07-03 weekly review set an explicit rule: "drop AAPL 2026-07-17 if no clean valuation gate clears." Two full weeks of daily re-verification never cleared it — GuruFocus overvaluation went from 15.6% (07-03) → 18.4-20.0% (07-15) → 22.2% (07-16) → and today's TTM P/E sits at 39.67x (up from 38.1x this week), a premium to Apple's own 5-year median (30.4x). The stock also crossed into a technical extension fail today (+10.49% vs 50-day, worse than yesterday's already-marginal +9.02%), removing the one gate that had been passing. Real, dated catalysts exist (China's regulatory approval of Apple Intelligence via a compressed Qwen model, the renewed >USD 30B Broadcom chip-supply agreement through 2031) — this is not a rejection of the business, it is the discipline of honoring a pre-committed rule rather than re-litigating it because the news flow is good. **AAPL purged from the watchlist this run** (mechanical application of the 07-03 rule; not deferred to this afternoon's weekly review since the rule's date has been reached regardless of which routine hits it first). Full detail in `strategy.md`.

**META deep-dive:** Still extended (+10.02% vs 50-day), though the buffer eased from Thursday's +13.05% blowout on the Louisiana data-center news. GuruFocus continues to read META as modestly undervalued — extension, not price, remains the sole blocker. Not a live candidate today; re-check next pre-market, drop-dead 2026-07-24 unchanged.

**NVDA deep-dive:** Fourth consecutive data point in the "fails to hold a confirmed breakout" pattern: +0.87% (07-07) → -2.67% (07-14) → +1.19% (07-15) → +1.39% (07-16) → **-1.10% (07-17)**. Chip-sector-wide weakness (per this morning's futures commentary) is the proximate driver. No genuine multi-session confirmation has emerged in over 3 weeks of tracking; continuing to require a real, non-marginal breakout before treating this as an entry signal. Earnings confirmed 2026-08-26 — no blackout concern.

**LRCX / PWR / MSFT / COST:** No material change in rationale from yesterday; see table above for updated numbers. PWR retains its earnings (07-30) + transformer-capacity catalyst, keeping it off the stale-decoration purge list despite a worsening technical gate.

**VST re-entry watch (new section):** Now that VST is closed (stopped out 07-16 on a sector-wide, not company-specific, chip/AI-power selloff per the closed-trades post-mortem), it graduates from "held position" to "re-entry watchlist candidate." Today's numbers (-0.98% vs 50-day, ATR 3.78%) are close to but not yet a clean pass on either gate. The Helix Digital Infrastructure / Cogentrix thesis is still considered intact — continuing to monitor for a stabilization signal before any re-entry.

**Cash-drag check (step 6):** Cash is 82.618% — well above the 25-40% target band for a 2-position portfolio, now for the tenth consecutive session since the LLY entry (2026-07-13) and the first session with only 2 positions since VST's stop-out. Today is explicitly the *worst* session yet for candidate quality: every single watchlist name — including the two that had been marginal technical passes as recently as Wednesday (META, AAPL) — now fails its entry gate outright, and the broader tape (chip-sector futures down, escalating Iran conflict, oil +12% on the week) is not constructive for initiating new risk today regardless. Staying in cash today is an explicit, reasoned decision, not a passive default: there is no candidate to deploy into, and the macro backdrop independently argues for patience. 2 of 3 weekly new-position slots remain unused this week (through today).

**Sector/risk posture:** Healthcare (LLY) 9.360%, Financials (V) 8.022%, cash 82.618% — all within the 60% sector cap and 5% cash floor; Energy/Utilities 0% (VST closed). Drawdown: 0.1239% vs running HWM USD 100,218.48 (2026-07-13 close) — not triggered, 9.8761pp headroom. Intraday shock check (pre-open, real test at market-open/midday): equity vs last_equity USD 100,082.55 = +0.0118% — no shock. Weekly new-position count: 1/3 (LLY, filled Monday 2026-07-13).

**No trades planned today.**

```json
{
  "plan_date": "2026-07-17",
  "trades": []
}
```
EXECUTED: 2026-07-17T13:36 ET — no trades (plan empty: no watchlist candidate cleared its technical entry gate); stop audit 2/2 PASS (LLY `e3547b9e`, V `2b0a93ba`); shock check −0.0428%, no shock; drawdown −0.1784%, not triggered; 2 positions held.

## 2026-07-17 16:30 ET — WEEKLY REVIEW (macro/sector research)

**S&P 500 weekly performance (WebSearch):** S&P 500 fell ~1.5% for the week, Nasdaq −2.9%, led by a broadening semiconductor selloff — the Philadelphia SE Semiconductor Index has tumbled ~17% in July alone, ~20% off its late-June record high. Drivers: AI-capex-sustainability skepticism (hyperscalers feared to slow spend), a new Chinese open-weight model (Moonshot's Kimi K3) stoking competitive-moat concerns, Netflix's post-earnings drop (revenue narrowly missed, stock −10%+), and Middle East escalation pushing oil >USD 80/bbl. Bright spot: 8 of 11 S&P sectors actually rose on the week, and of the 49 S&P 500 companies that had reported Q2 earnings by Friday, 90% beat estimates — the index-level decline is a narrow, semiconductor/mega-cap-tech story, not a broad risk-off. [CNBC](https://www.cnbc.com/2026/07/16/stock-market-today-live-updates.html), [Yahoo Finance](https://finance.yahoo.com/markets/live/stock-market-today-friday-july-17-dow-sp-500-nasdaq-092345307.html), [TheStreet](https://www.thestreet.com/stock-market-today/stock-market-today-dow-jones-sp-500-nasdaq-updates-july-17-2026)

**Best performers this week (WebSearch):** Energy and healthcare/defensive names led — Travelers +6.43%, UnitedHealth +2.62%, Walmart +2.10%; energy majors (Valero, ConocoPhillips, ExxonMobil) all +~2% on the oil spike. 46 S&P 500 names hit 52-week highs Thursday, led by Apple (+12.4% trailing month) — ironic given Bull purged AAPL from the watchlist this same week on valuation/extension grounds; the stock's continued run since the purge does not change the P/E-driven rationale (39.67x TTM, ~22% GuruFocus-overvalued), but is worth tracking as a "did discipline cost us" data point. [Trefis](https://www.trefis.com/stock/spy/articles-v3/607705/46-sp-500-stocks-hit-52-week-highs-on-thursday/2026-07-17)

**LLY (held):** Announced a definitive agreement to acquire AtaiBeckley (psychedelic/mental-health drug developer) for up to USD 3.8B this week — pipeline diversification beyond the core GLP-1 franchise, not a distraction from it. Retevmo (oncology) received full FDA approval. Citi raised its price target to USD 1,600 (from USD 1,500). 20-analyst consensus remains Buy. Thesis unchanged, no new risk flagged. [24/7 Wall St.](https://247wallst.com/investing/2026/07/13/prediction-1-new-reason-eli-lilly-stock-could-still-be-headed-higher/), [Motley Fool](https://www.fool.com/investing/2026/07/07/why-eli-lilly-stock-climbed-to-a-record-high-today/)

**V (held):** Hit a fresh multi-year high (USD 366.88 intraday Friday) on continued momentum from the Stablecoin Platform launch this week, which drew a fresh Bernstein Buy reaction; Weiss Ratings upgraded V to Buy July 6. Two routine insider sales (CEO McInerney, General Counsel Rottenberg, both small % of holdings, early July) — no 10b5-1 red flags raised in any source found, consistent with the standing lesson to check filing type before treating insider sales as bearish. Thesis unchanged. [MarketBeat](https://www.marketbeat.com/instant-alerts/visa-nysev-stock-price-up-23-still-a-buy-2026-07-13/), [Daily Political](https://www.dailypolitical.com/2026/07/13/visa-nysev-trading-up-2-3-heres-why.html)

**Read for the weekly review:** the chip selloff that dragged SPY down this week is exactly the layer Bull holds zero exposure to (LLY healthcare, V financials) — the same structural gap that cost Bull ~1.3pp in early July's AI-semi rally now works in Bull's favor on the way down. See `weekly-review.md` for the full since-inception reversal this produces.

## 2026-07-20 08:15 ET — PRE-MARKET

**Market posture (WebSearch, "S&P 500 futures pre-market July 20 2026"):** S&P 500 futures +0.13-0.5%, Nasdaq-100 futures +1% Monday morning. US stock futures higher despite an escalating Iran military campaign and renewed oil-supply concerns — Polymarket showed 68% odds of an "up" open. [CNBC](https://www.cnbc.com/2026/07/19/stock-market-today-live-updates.html), [Benzinga](https://www.benzinga.com/news/26/07/60543800/stock-market-will-sp-500-open-up-or-down-today-10)

**Week-ahead outlook (WebSearch):** Sector rotation continues — semiconductor index remains in a technical bear market on AI-monetization skepticism; energy has outperformed as a geopolitical hedge. 10yr yield elevated (~4.57%) with the market pricing the Fed on hold through the July 29 FOMC (a small hike probability priced in but not the base case). Fed blackout period begins this week. Heavy Q2 earnings docket: Tesla, Alphabet, Intel, MSFT, META and others report this week/next. [CNBC](https://www.cnbc.com/2026/07/17/stock-market-next-week-outlook-for-july-20-24-2026.html), [TheStreet](https://www.thestreet.com/stock-market-today/stock-market-today-dow-jones-sp-500-nasdaq-updates-july-20-2026)

**Iran / oil (WebSearch):** Ceasefire remains collapsed since 2026-07-08 (Iran struck commercial ships in the Strait of Hormuz). US has struck Iran again and reinstated a naval blockade of Iranian ports (CENTCOM, 07-15). WTI ~USD 75-80, Brent ~USD 79-85. Volatile, unresolved — treat as an ongoing risk-off catalyst, not escalating further today but not de-escalating either. [The Hill](https://thehill.com/policy/energy-environment/5960020-iran-ceasefire-gas-prices-strait-of-hormuz/)

**10yr Treasury:** 4.57% (2026-07-20) — still comfortably below the 4.75% new-buy gate.

**LLY (held, WebSearch):** No new negative developments. AtaiBeckley acquisition (up to USD 3.8B) and Retevmo FDA approval remain the active catalysts; Q1 2026 revenue USD 19.80B (+55.5% YoY), FY26 guidance USD 82-85B. Mounjaro USD 8.66B (+125% YoY), Zepbound USD 4.16B (US +80%). Ex-dividend USD 1.73 set for 2026-08-14. Nothing changed since yesterday — thesis unchanged.

**V (held, WebSearch):** Trading USD 358.56, day range USD 357.00-364.63, 52-week range USD 293.89-365.14. Stablecoin Platform launch and AI Financial Assistant remain the active catalysts. Consensus Buy, median PT USD 410 (+18% upside). Earnings confirmed 2026-07-28. Nothing new since yesterday — thesis unchanged.

**Watchlist re-verification** (fresh 50-day SMA / 20-day ATR% via Alpaca `data.alpaca.markets` bars, explicit start/end 2026-04-20 to 2026-07-17 close):

| Ticker | Close (07-17) | vs 50-day SMA | 20-day ATR% | Gate |
|--------|---------------|---------------|-------------|------|
| LLY | 1178.57 | +6.21% | 2.85% | HELD |
| V | 358.51 | +7.62% | 2.15% | HELD |
| UNH | 426.06 | **+5.76%** | **2.51%** | **PASS — 5-of-5 entry signals** |
| META | 646.03 | **+6.87%** | 3.52% | **PASS (extension resolved), ATR gate triggers half-size** |
| VST | 155.23 | +0.84% | 3.92% | Marginal, single session, not confirmed |
| NVDA | 202.80 | -3.38% | 3.25% | FAIL (5th failed-confirmation data point) |
| PWR | 628.24 | -11.16% | 3.39% | FAIL |
| MSFT | 394.02 | -1.85% | 2.85% | FAIL |
| COST | 940.84 | -3.74% | 1.84% | FAIL |
| LRCX | 313.12 | -6.87% | 5.98% | FAIL (valuation also disqualifies, P/E >60x) |

**UNH deep-dive:** Reported Q2 2026 earnings 2026-07-16 — adjusted EPS USD 6.38 vs ~USD 4.85-4.52 consensus (beat by 30%+), revenue USD 112.0B, GAAP EPS USD 6.04. Raised FY2026 adjusted EPS guidance to USD 19.50-20.00. Next earnings not until 2026-10-27 (Yahoo Finance/Hudson Labs) — no blackout concern. GuruFocus: PEG ratio 1.73-2.07 (under the 2.5 threshold; industry median 1.38, so still a relative premium but within our rule), GF Value USD 603.55-603.71 vs price ~USD 424-426 (~30% undervalued on DCF), P/E 31.61x (premium to the 25.5x healthcare-industry average but below peer average 38.9x and the 40.6x fair ratio). Analyst sentiment: 23 of 26 brokerages Buy/Strong Buy, average PT USD 438.83 (~5% premium to spot), multiple PT raises post-earnings (KeyBanc, Truist, TD Cowen). Entry signals: (1) earnings momentum — beat+raise, PASS; (2) catalyst — Medicare Advantage utilization/MLR trends improving, ongoing; (3) valuation — PEG <2.5, PASS; (4) technical — +5.76% vs 50-day, not extended, PASS; (5) macro tailwind — defensive/healthcare sector led this week's chip-sector rotation, PASS. **5-of-5, cleanest signal of any candidate this cycle.** Sector-correlation check vs LLY: UNH is managed care/insurance (utilization, MLR, Medicare Advantage), LLY is GLP-1/pharma — different revenue drivers within the same GICS sector, reasonable sub-sector diversification, not a doubled bet. [GuruFocus](https://www.gurufocus.com/news/8961945/is-unitedhealth-group-unh-undervalued-after-q2-earnings-beat-eps-of-604-vs-452-estimate-gf-score-86100), [Schaeffer's](https://www.schaeffersresearch.com/content/news/2026/07/16/unitedhealth-stock-surges-after-blowout-q2-beat-and-raise)

**META deep-dive:** Extension resolved from +13.05% (07-16 blowout) to +6.87% today — a genuine pullback inside the "not >10% above 50-day" gate, not a broad-market move (META is +21% for the month per Motley Fool, so this pullback is relative to its own recent run, not a crash). Catalysts: "Meta Compute" AI-cloud unit to sell excess AI compute/models (pushed shares +8-10% on the news), in-house "Iris" AI chips entering production September (targeting 14GW capacity, reducing third-party accelerator dependence), reported talks for a USD 10B AI-infrastructure deal with Anthropic. GuruFocus: PEG 0.82 (11% above its own 10-year median of 0.74, but 20% below the Interactive Media industry median of 1.03 — genuinely cheap on a growth-adjusted basis), GF Value USD 809.70-812.66 vs a referenced price of USD 550-583 in the GuruFocus pieces (dated slightly earlier than today's USD 646 close — even adjusting for META's run since then, this still implies real undervaluation, ~25%+ upside to fair value at today's price). Entry signals: (1) earnings momentum — no fresh beat/raise yet (earnings 07-29), partial; (2) catalyst — Meta Compute + Iris chip + Anthropic talks, strong PASS; (3) valuation — PEG 0.82 well under threshold, PASS; (4) technical — +6.87%, not extended, PASS; (5) macro tailwind — mixed: META's own catalyst is diverging positively from the broader AI-semi digestion (a name-specific story, not sector-wide), acceptable but not a clean sector tailwind. Roughly 3.5-4 of 5. **Earnings risk:** 2026-07-29 is 7 trading days from today — outside the 2-trading-day blackout rule, so not blocked, but a position opened today will very likely still be held into the print unless trimmed first. Per the standing AVGO (2026-06-04) and META's own (2026-06-10) gap-risk lessons, this is real risk that the rule doesn't forbid but prudence should size for: halving for the 3.52% ATR (already required) plus treating this as a small starter rather than a standard 7-9% starter, with `review_by` set to 2026-07-27 (2 trading days before earnings) to force an explicit hold/trim/exit journal entry ahead of the print — not a silent hold-through-earnings by default. [Motley Fool](https://www.fool.com/investing/2026/07/18/meta-platforms-stock-up-21-july-driving-surge/), [GuruFocus](https://www.gurufocus.com/stock/META/valuation)

**NVDA/PWR/MSFT/COST/LRCX:** All remain gated — see table. NVDA's -3.38% is a 5th consecutive failed-confirmation data point (no 2-session-confirmed breakout in over 3 weeks). LRCX's -6.87% technical fail is moot regardless given its P/E >60x valuation veto. MSFT and PWR both now have confirmed earnings dates in the next 7-10 days (07-29 and 07-30 respectively) as forward catalysts, keeping them off the stale-decoration purge list even while failing their technical gates.

**VST re-entry watch:** First session crossing back above its 50-day (+0.84%, from -0.98% last week) — a meaningful swing but only one data point, and ATR (3.92%) actually worsened slightly from last week (3.78%). Per the standing lesson that no AI-adjacent name has held a confirmed breakout for even 2 consecutive sessions this cycle, treating a single-session cross as noise until it repeats. Not a buy today.

**Monday conviction-weighted review:** LLY → **A** (first review since 07-13 entry: thesis intact and working — Medicare Bridge live, AtaiBeckley deal, Retevmo approval, 3 PT raises this month). V → **A** (upgraded from B: fresh multi-year high, Stablecoin Platform + Weiss upgrade, price now confirming cleanly at +7.62% vs 50-day). No C-rated positions — no forced-trim trigger this week.

**Thesis contract review:** LLY (review_by 2026-08-05, earnings) — not due, not triggered, HOLD. V (review_by 2026-07-28, earnings) — not due, not triggered, HOLD.

**Earnings window check:** LLY (08-05) and V (07-28) both >2 trading days out — no forced decision today. UNH's next earnings (10-27) is far outside any window. META's earnings (07-29) is outside the 2-day blackout (7 trading days out) — entry permitted, gap-risk addressed via reduced size and an early review_by (see above).

**Cash-drag check (step 6):** Cash is 82.717% — above the 25-40% target band for a fourth consecutive week. Today resolves this with an explicit, gate-cleared decision: both UNH and META independently cleared their full entry-signal checklists for the first time this cycle (not forced or rationalized) — proceeding with both rather than deferring further, since deferring a genuinely-qualified setup just to "wait" would be the passive-default behavior the cash-drag lesson warns against.

**Sizing:** UNH — high-conviction (5-of-5 signals, no ATR halving needed): 25 shares @ ~USD 426.055 reference close = USD 10,651.375 (10.66% of equity). Risk at 10% stop: ~1.066% of equity, within the 1.2% risk-budget cap. META — small starter (halved for ATR 3.52% >3%, further conservative given 7-trading-day earnings proximity): 6 shares @ ~USD 646.03 reference close = USD 3,876.18 (3.88% of equity). Risk at 10% stop: ~0.388% of equity, comfortably within budget. Combined new-buy deployment ~14.54% of equity — within the 25% daily cap. Weekly new-position count: 0/3 used this week; this plan uses 2/3. Sector caps: Healthcare (LLY 9.4% + UNH 10.66%) ≈ 20.1%, Communication Services (META) 3.88% — both far below the 60% cap.

**Today's plan:**

```json
{
  "plan_date": "2026-07-20",
  "trades": [
    {"action": "buy", "symbol": "UNH", "qty": 25, "thesis": "Q2 2026 beat-and-raise (07-16, adj EPS USD 6.38 vs ~USD 4.85 est, FY26 guidance raised to USD 19.50-20.00); PEG 1.73-2.07 (<2.5); GF Value ~30% undervalued; technical +5.76% vs 50-day (not extended), ATR 2.51% (<3%); 5-of-5 entry signals; managed-care diversifier vs LLY's GLP-1/pharma exposure",
     "invalidation": "closes below the 50-day SMA (~USD 403, drifts) on volume, or Medicare Advantage MLR trends reverse the utilization-easing thesis, or the 10% trailing stop fires",
     "review_by": "2026-08-17"},
    {"action": "buy", "symbol": "META", "qty": 6, "thesis": "Extension gate newly clears (+6.87% vs 50-day, down from +13.05% blowout); PEG 0.82, GF Value ~USD 810 vs USD 646; Meta Compute AI-cloud unit + Iris in-house chip (production Sept) are genuine catalysts; sized small and halved for ATR 3.52% (>3%) plus earnings 07-29 gap-risk proximity",
     "invalidation": "closes back below the 50-day SMA (~USD 605, drifts) on volume, or Q2 earnings (07-29) misses/guides down, or the 10% trailing stop fires",
     "review_by": "2026-07-27"}
  ]
}
```
EXECUTED: 2026-07-20T13:39:02Z — Both trades filled. Breaking-news gate (WebSearch): no thesis-breaking news for UNH or META this morning (nothing beyond the already-known 07-16 UNH earnings beat and META's July AI-catalyst run) — cleared. Pre-execution re-check: equity USD 99,941.19 vs last_equity USD 100,017.31 = -0.0761% (no shock, threshold -4%); UNH quote ask USD 421.51/bid USD 421.14 (tight spread, reliable) — marketable limit USD 422.77; META quote ask stuck at USD 675 across 2 polls 20s apart while bid (~USD 639.5) and latest trade (~USD 639.8-639.9) moved together — treated ask as unreliable per the 2026-07-07 lesson and used latest-trade USD 639.82 x 1.003 = USD 641.74 marketable limit instead. UNH buy-limit 25sh @ 422.77 filled avg USD 422.28 (order 2f0a6ce1). META buy-limit 6sh @ 641.74 filled avg USD 641.323333 (order b99c60a5). Trailing stops placed and verified live: UNH 10% stop 225cb079 (HWM USD 421.455, stop USD 379.3095); META 10% stop 14301809 (HWM USD 641.5267, stop USD 577.37403). Stop audit 4/4 PASS (LLY e3547b9e, V 2b0a93ba, UNH 225cb079, META 14301809, all confirmed live in `orders open`). Guardrail math: UNH 10.58% of equity, META 3.85% of equity, combined daily deployment 14.43% (cap 25%); weekly new-position count 0/3 -> 2/3; cash after buys ~68.3% (min 5%); risk budget UNH ~1.057% / META ~0.385% (cap 1.2% each); sector exposure Healthcare (LLY+UNH) ~19.96%, Communication Services (META) ~3.85% (cap 60% each); drawdown ~0.28% vs HWM USD 100,218.48 (breaker at -10%, not triggered). All guardrails ✓.

## 2026-07-21 08:12 ET — PRE-MARKET (plan drafted, no trades yet)

**Step 0 — guards:** Live-switch guard: `ALPACA_BASE_URL` contains "paper" ✓. Lock: `_lock` was free (`{}`); wrote lock for this run (expires 08:19:30 ET). Control switch: `STATUS: ACTIVE`, no `NOTE:`/`QUERY:` pending, `CROSS_BULL_LEARNING:` blank. Strategy already `STATUS: ACTIVE` — no first-run init needed.

**Step 2 — portfolio sync (live Alpaca, ~08:12 ET):** Equity USD 99,757.50, cash USD 68,291.16 (68.454%), long MV USD 31,466.34 (31.545%), buying power USD 361,270.39, last_equity (07-20 close) USD 99,812.75. Positions: LLY 8sh @ avg USD 1,174.35625, current USD 1,140.02 (−2.924%, −USD 274.69). V 22sh @ avg USD 355.058182, current USD 358.75 (+1.040%, +USD 81.22). UNH 25sh @ avg USD 422.28, current USD 422.50 (+0.052%, +USD 5.50). META 6sh @ avg USD 641.323333, current USD 649.37 (+1.255%, +USD 48.28).

**Step 3 — risk posture:** Drawdown circuit breaker: HWM USD 100,218.48 (2026-07-13 close, from `history 1A 1D`) vs current equity USD 99,757.50 = **0.460% drawdown**, NOT triggered (9.540pp headroom). Sector cap: Healthcare (LLY+UNH) 19.734%, Financials (V) 7.913%, Communication Services (META) 3.907%, cash 68.454% — all well within the 60% cap. Intraday shock check: equity USD 99,757.50 vs last_equity USD 99,812.75 = **−0.0553%** — no shock (threshold −4%).

**Step 3b — thesis contract review:** LLY (review_by 2026-08-05), V (review_by 2026-07-28), UNH (review_by 2026-08-17), META (review_by 2026-07-27) — none due today, none triggered (all prices well above their stated invalidation levels). HOLD all four, no contract renewal needed.

**Step 3c — Monday conviction review:** N/A — today is Tuesday, not Monday.

**Step 4 — research (WebSearch, all dated 2026-07-21 unless noted):**
- **Market posture:** S&P 500 futures +0.2%, Nasdaq 100 futures +0.4% pre-market — modest risk-on tone. 10yr Treasury 4.59% (still below the 4.75% new-buy gate). Iran conflict: mediators proposing a fresh 10-day ceasefire to revive the June 17 MOU; oil eased ~1-1.4% on the news (Brent ~USD 88.01, WTI ~USD 82.29) even as fresh strikes and a Houthi "maritime embargo" threat against Saudi Arabia continue. Treat as active/unresolved until an actual deal is signed. [Benzinga, CNBC, Schwab]
- **LLY (what changed since yesterday):** Novo Nordisk filed suit against Eli Lilly 2026-07-21 alleging misleading GLP-1 advertising (comparing Lilly's highest doses to Novo's lower doses in ads). This is a litigation/PR headline, not a product or regulatory setback — Novo is separately pushing its own oral pill + price cuts + high-dose Wegovy to compete. No change to the AtaiBeckley acquisition, Medicare Bridge, or Retevmo approval, all still intact. Today's −2.924% pullback (stock at USD 1,140.02, down from USD 1,146.90 07-20 close) tracks this headline plus general profit-taking, not a thesis break. Next dividend ex-date 08-14 (USD 1.73). Earnings still confirmed 2026-08-05. [CNBC, Stocktwits, Motley Fool]
- **V (what changed since yesterday):** Nothing thesis-breaking — stock continues near multi-year highs (session range USD 356.01-363.00), stablecoin platform + Samsung co-branded card rollout continuing. Q3 2026 earnings confirmed for after-close Tuesday 2026-07-28 (matches existing review_by). [MarketBeat, FinancialContent]
- **UNH (what changed since yesterday):** Nothing new/negative — analyst price-target raises continuing on the 07-16 beat-and-raise (Morgan Stanley to USD 529, Wells Fargo to USD 526, Truist/Oppenheimer/KeyBanc to USD 500), Medicare Advantage cost trends the key driver; commercial-plan medical-cost trend (>11%) remains the one soft spot but is not new. Thesis unchanged. [Stocktwits/Yahoo]
- **META (what changed since yesterday):** July AI-momentum rally continues (+21% MTD, +USD 270B market cap), driven by the Meta Compute cloud-capacity-sale story and Iris in-house chip (production Sept). One session (reported as of 07-18/07-20 coverage) saw a 3.1% intraday pullback tied to broad AI-spending-concern selling, but current live quote (USD 649.37) is up +0.545% today vs 07-20 close — no confirmed reversal. Thesis unchanged. Earnings 2026-07-29 (6 trading days out) — review_by 2026-07-27 will force the pre-earnings call. [Motley Fool, Yahoo, Cryptonomist]
- **Earnings calendar confirmed:** LLY 2026-08-05 (unchanged), V 2026-07-28 after close (unchanged, 5 trading days out), UNH 2026-10-27 (unchanged, far out), META 2026-07-29 (unchanged, 6 trading days out), VST 2026-08-07 (confirmed via Vistra IR, 10am ET call).
- **Watchlist re-verification (fresh Alpaca `bars` pull, explicit `start=2026-04-20&end=2026-07-20` — a bare `limit`-only query returned `bars: null` this run; noting for future agents that `start`/`end` params are required):**

| Ticker | Close (07-20) | vs 50-day SMA | ATR20 | Verdict |
|--------|---------------|----------------|-------|---------|
| VST | 157.99 | **+2.63%** (2nd consecutive positive session; +0.97% 07-17) | 4.06% | **CLEARS — planned buy** |
| MSFT | 402.29 | +0.25% (1st positive session, unconfirmed; pre-market already -1.19% back below) | 2.98% | Not yet — needs 2nd confirming session |
| NVDA | 203.28 | -3.12% | 3.25% | FAILS (6th straight failed-confirmation data point) |
| PWR | 632.56 | -10.15% | 3.59% | FAILS |
| COST | 935.80 | -4.14% | 1.94% | FAILS |
| LRCX | 306.76 | -8.82% | 6.22% | FAILS (valuation also disqualifying, GF Value ~USD 132 vs price >USD 300) |

- **VST deep dive:** PEG ratio ~0.4-0.6 across GuruFocus/Macroaxis/StockAnalysis (well below the 2.5 cap; industry median PEG 1.97, VST ~70% below). Analyst consensus Buy (13 analysts); Scotiabank raised PT to USD 298 (07-16), Bernstein initiated Buy (07-03), Wells Fargo/BofA/KeyBanc all Buy. Catalysts: USD 4.7B Cogentrix Energy acquisition (expands generation footprint), Helix Digital Infrastructure consortium (KKR+NVIDIA+Kuwait), hyperscaler AI capex raised to USD 750B for 2026 (structural power-demand tailwind per DOE data-center-demand projections). One caution note: a one-year moratorium on large data-center permits in New York is a regional headwind, not sector-wide — doesn't change the thesis. Next earnings 2026-08-07 (16 trading days out — well outside the 2-day blackout).

**Step 5 — earnings-window rule:** No held name or VST reports within 2 trading days (nearest is V, 07-28, 5 trading days out). No blackout applies to today's planned VST buy or to any held position.

**Step 6 — cash-drag check:** Cash 68.454%, well above the 25-40% target band (4 positions held, band applies). Above-band for many consecutive sessions. Tape is modestly constructive (S&P futures +0.2%) and 1 weekly slot remains — VST's 5-of-5 gate clearing today is a qualifying entry, not a forced one; this addresses the cash-drag pattern with genuine confirmation rather than further deferral.

**Step 7 — plan:** BUY VST 25 shares. Sizing: starter conviction (re-entry, not "high" — thesis intact but this is a fresh 2-session technical confirmation, not a fresh catalyst), halved for ATR 4.06% (>3% threshold) per the volatility check. Reference price USD 158.05 (07-20 close) → 25sh × USD 158.05 = USD 3,951.25 ≈ **3.96% of equity** (well inside the 20% position cap and 15% single-order cap). Risk budget: 25sh stop-out at 10% below entry ≈ USD 395.13 ≈ **0.396% of equity** (well inside the 1.2% cap). Daily deployment 3.96% (cap 25%). Weekly new-position count 2/3 → **3/3** (uses the last slot this week). Sector exposure post-buy: Energy/Utilities ~3.96% (0% today), all sectors still far below the 60% cap. Whole-share quantity chosen so a trailing stop is possible.

**Volatility check:** VST 20-day ATR 4.06% > 3% threshold → position size halved (per above), and journaled here as required.

**Planned trades for today:**

```json
{
  "plan_date": "2026-07-21",
  "trades": [
    {"action": "buy", "symbol": "VST", "qty": 25, "thesis": "Re-entry after the 07-16 sector-wide stop-out; now confirmed via 2 consecutive sessions above the 50-day SMA (+0.97% 07-17, +2.63% 07-20), clearing the standing multi-session-confirmation bar; PEG ~0.4-0.6 (well below 2.5 cap); Buy consensus among 13 analysts (Scotiabank PT raised to USD 298, Bernstein initiated Buy); USD 4.7B Cogentrix acquisition + Helix Digital Infrastructure consortium + hyperscaler AI capex raised to USD 750B for 2026 are intact catalysts; sized as a halved starter for ATR 4.06% (>3%)",
     "invalidation": "closes below the 50-day SMA (~USD 154, drifts) on volume, or the 10% trailing stop fires, or the Cogentrix acquisition / Helix consortium thesis is disrupted",
     "review_by": "2026-08-05"}
  ]
}
```

**Step 8 — notify:** Telegram to be sent per playbook — market posture + planned trade.
**Step 9 — commit:** pending.

EXECUTED: 2026-07-21T13:38:27Z — BUY VST filled. Breaking-news gate (WebSearch): no thesis-breaking news for VST this morning — earnings still confirmed 08-07, analysts remain bullish (Scotiabank PT USD 298), only a broader risk-off tape (Iran ceasefire "over" headline) noted, gate cleared. Pre-execution re-check: equity USD 99,770.37 vs last_equity USD 99,812.75 = -0.0425% (no shock, threshold -4%); VST quote initially noisy in the opening minutes (bid/ask swinging 154.52-166.55, consistent with the standing opening-rush data-quality lesson) — polled 4x over ~40s until it settled to bid USD 160.72/ask USD 161.10 (0.24% spread, consistent with latest trade ~USD 160.9-161.7); used settled ask for the marketable limit. VST buy-limit 25sh @ USD 161.58 (ask USD 161.10 x 1.003) filled avg USD 161.21 (order c235bb22). 10% trailing stop placed and verified live: order 87f49386, HWM USD 161.53 (ratcheted from fill), stop USD 145.377. Stop audit 5/5 PASS (LLY e3547b9e, V 2b0a93ba, UNH 225cb079, META 14301809, VST 87f49386 all confirmed live in `orders open`). Guardrail math: VST position USD 4,031.50 = 4.041% of equity (cap 20%, single-order cap 15%); risk budget 10% stop-out ≈ USD 403.15 = 0.404% of equity (cap 1.2%); daily deployment 4.041% (cap 25%); weekly new-position count 2/3 -> 3/3 (UNH, META, VST this week — at cap, not exceeding); cash after buy ≈ USD 64,259.66 ≈ 64.4% (min 5%); sector exposure Energy/Utilities 0% -> ~4.04% (cap 60%); drawdown 0.446% vs HWM USD 100,218.48 (breaker at -10%, not triggered); earnings window clear (VST reports 08-07, 12 trading days out). All guardrails ✓.

## 2026-07-22 ~08:15 ET — PRE-MARKET

- **Live-switch guard:** `ALPACA_BASE_URL` contains "paper" ✓.
- **Lock:** `_lock` was free (`{}`); wrote lock for this run (expires ~08:23 ET).
- **Control switch:** `STATUS: ACTIVE`, no `NOTE:` or `QUERY:` pending in `control.md`.
- **Account (live, ~08:13 ET):** Equity USD 100,272.61, cash USD 64,260.90 (64.083%), long market value USD 36,011.71 (35.917%: LLY+V+UNH+META+VST). Buying power USD 357,876.37. last_equity (prior session close) USD 100,322.08.

**Step 2 — portfolio sync (positions, live Alpaca data):**

| Symbol | Qty | Avg entry | Current | Unrealized P/L | % of equity |
|--------|-----|-----------|---------|-----------------|--------------|
| LLY | 8 | 1174.35625 | 1173.00 | −USD 10.85 (−0.115%) | 9.359% |
| V | 22 | 355.058182 | 355.01 | −USD 1.06 (−0.014%) | 7.790% |
| UNH | 25 | 422.28 | 437.40 | +USD 378.00 (+3.581%) | 10.906% |
| META | 6 | 641.323333 | 645.54 | +USD 25.30 (+0.657%) | 3.863% |
| VST | 25 | 161.21 | 160.3698 | −USD 21.01 (−0.521%) | 3.999% |

Sector exposure: Healthcare (LLY+UNH) 20.264%, Financials (V) 7.790%, Communication Services (META) 3.863%, Energy/Utilities (VST) 3.999%, Cash 64.083%. All well within the 60% sector cap.

**Step 3 — risk posture check:**
- **Drawdown circuit breaker:** `history 1A 1D` high-water mark is USD 100,322.08 (07-21 close — the API's last daily bar reflects the prior close pre-open, consistent with the standing off-by-one labeling noted in past runs). Current live equity USD 100,272.61 is USD 49.47 below that HWM = **0.0493% drawdown**. NOT triggered (9.95pp headroom) ✓.
- **Intraday shock check:** equity USD 100,272.61 vs last_equity USD 100,322.08 = **−0.0493%** — no shock (threshold −4%; the real test is at market-open/midday once the session is live).
- **Sector cap:** no position group above 60% (see table above) ✓.

**Step 3b — thesis contract review:** LLY (review_by 2026-08-05), V (review_by 2026-07-28), UNH (review_by 2026-08-17), META (review_by 2026-07-27), VST (review_by 2026-08-05) — none due today, none triggered by price or news (see Step 4 below). HOLD all five, contracts renewed implicitly (no new review_by needed since none expired).

**Step 3c — Monday-only conviction review:** N/A — today is Wednesday.

**Step 4 — research (WebSearch, all facts dated 2026-07-21/07-22):**
- **Market posture:** S&P 500 futures −0.2 to −0.33% pre-market, Nasdaq-100 futures −0.6%, ahead of Alphabet/Tesla earnings today. Brent crude has climbed above USD 92/bbl (up from ~USD 88.01 at 07-21's pre-market pull), reviving inflation concerns and driving broad risk-off tone despite otherwise-strong corporate earnings. 10yr Treasury flat at 4.626% (07-22) — still comfortably below the 4.75% new-buy gate.
- **Iran/oil (Active Macro Watch, still unresolved):** as of 07-21, regional mediators proposed a 10-day ceasefire; the US conducted a 10th straight day of strikes, Iran retaliated with missile/drone attacks on Kuwait. Brent pulled back to ~USD 88 on ceasefire hopes 07-21 morning but has since pushed back above USD 92 by 07-22 pre-market — the de-escalation has NOT held, oil is trending higher again. Continue treating this as an active, unresolved risk-off catalyst; no signed deal yet.
- **LLY — what changed since yesterday:** essentially nothing material. Same Novo Nordisk GLP-1-ad-claims lawsuit headline as 07-21 (no new developments); AtaiBeckley acquisition still described as an "initial USD 2.8B" deal (structure consistent with the "up to USD 3.8B" earn-out figure already on file). Price −0.115% pre-market vs yesterday's close. Thesis unchanged.
- **V — what changed since yesterday:** nothing material — price flat (−0.014%). Consensus remains Strong Buy (31 of 39 analysts Strong Buy). Q3 earnings reconfirmed for Tuesday 2026-07-28 after market close (analysts expect diluted EPS USD 3.22, +8.1% YoY). Stablecoin Platform / AI Financial Assistant catalysts intact. Thesis unchanged.
- **UNH — what changed since yesterday:** continued post-earnings momentum, +3.5% cited today, GF Score 86/100, still viewed as undervalued; BofA reiterated Buy at PT USD 512 (up from USD 475). No new negative news. Next earnings not until 2026-10-27 (unchanged, far out). Thesis strengthening, not breaking.
- **META — what changed since yesterday:** price essentially flat (−0.14%). One clickbait-style headline ("Meta looks set to abandon a USD 174B investment") verified via a second source and found to be misleading — the USD 174B figure refers to Meta's *share buyback* spend, not AI capex; Meta's 2026 capex guidance (USD 115–135B, roughly double 2025) is unchanged and rising, i.e. Meta is prioritizing AI infrastructure spend over buybacks, not retrenching. Not a thesis break — if anything mildly reinforces the AI-investment thesis. Earnings reconfirmed 2026-07-29 (5 trading days out, outside the 2-day blackout). Thesis unchanged.
- **VST — what changed since yesterday:** price down modestly pre-market (−0.52%), tracking the broader Iran/oil risk-off tape rather than any company-specific news — 07-21's close was also "modestly lower" on the same Iran ceasefire-collapse headline per the search results. Scotiabank PT USD 298 (Outperform) and the nuclear-fleet/hyperscaler PPA thesis (Meta, AWS) remain intact. Earnings 2026-08-07 (12 trading days out). Thesis unchanged.
- **Earnings calendar (confirmed today):** LLY 2026-08-05 (unchanged), V 2026-07-28 (reconfirmed, after close), UNH 2026-10-27 (unchanged, already reported this cycle), META 2026-07-29 (reconfirmed), VST 2026-08-07 (unchanged). No held name reports within 2 trading days — no earnings blackout applies today.

**Step 5 — earnings-window rule:** No held name reports within 2 trading days (nearest is V at 4 trading days out). No blackout; no forced hold/trim/exit decision required today beyond the standing thesis-contract holds above.

**Step 6 — cash-drag check:** Cash 64.083%, above the 10–20% target band for a 5-position portfolio (per `strategy.md` cash policy, band tightens once 6–8 positions are held; we're at 5). However, **this week's 3-new-position cap is already used (UNH, META 07-20; VST 07-21) — 3/3.** No new position is permitted today regardless of setup quality; the cap, not conviction, is the binding constraint. Staying in cash today is a forced, not a discretionary, decision — correctly documented rather than worked around.

**Step 7 — plan:** **No trades today — weekly new-position cap (3/3) already reached this week (Mon 2026-07-20 – Fri 2026-07-24); next slot opens Monday 2026-07-27.** No held position triggers a thesis-contract review, earnings blackout, or −7%/circuit-breaker action. All 5 positions HOLD, all 5 trailing stops confirmed live (see stop audit below).

**Stop audit (`orders open`, live Alpaca data):** LLY `e3547b9e` (HWM 1196.29 / stop 1076.661), V `2b0a93ba` (HWM 364.91 / stop 328.419), UNH `225cb079` (HWM 436.945 / stop 393.2505, ratcheted up from 392.625), META `14301809` (HWM 655.84 / stop 590.256), VST `87f49386` (HWM 164.44 / stop 147.996) — all 5 status `new` (live). **5/5 PASS.**

**Planned trades for today:**

No trades planned.

```json
{
  "plan_date": "2026-07-22",
  "trades": []
}
```

**Step 8 — notify:** Telegram sent per playbook — market posture + no trades planned (weekly cap reached).

## 2026-07-23 ~08:15 ET — PRE-MARKET

- **Live-switch guard:** `ALPACA_BASE_URL` contains "paper" ✓.
- **Lock:** `_lock` was free (`{}`); wrote lock for this run (expires ~08:23 ET).
- **Control switch:** `STATUS: ACTIVE`, no `NOTE:` or `QUERY:` pending in `control.md`. `CROSS_BULL_LEARNING:` blank.
- **Account (live, ~08:13 ET):** Equity USD 99,849.96, cash USD 64,260.90 (64.354%), long market value USD 35,589.06 (35.646%). last_equity field on the account endpoint returned an anomalous "0" this pull (a data quirk, not a real balance) — used `portfolio.md`'s recorded 07-22 close (USD 99,947.32) as the reference for the intraday shock check instead.

**Step 2 — portfolio sync (positions, live Alpaca data ~08:13 ET):**

| Symbol | Qty | Avg entry | Current | Unrealized P/L | % of equity |
|--------|-----|-----------|---------|-----------------|--------------|
| LLY | 8 | 1174.35625 | 1156.00 | −USD 146.85 (−1.563%) | 9.263% |
| V | 22 | 355.058182 | 353.21 | −USD 40.66 (−0.521%) | 7.782% |
| UNH | 25 | 422.28 | 429.03 | +USD 168.75 (+1.598%) | 10.741% |
| META | 6 | 641.323333 | 615.99 | −USD 152.00 (−3.950%) | 3.701% |
| VST | 25 | 161.21 | 165.95 | +USD 118.50 (+2.940%) | 4.155% |

Sector exposure: Healthcare (LLY+UNH) 20.004%, Financials (V) 7.782%, Communication Services (META) 3.701%, Energy/Utilities (VST) 4.155%, Cash 64.354%. All well within the 60% sector cap.

**Step 3 — risk posture check:**
- **Drawdown circuit breaker:** `history 1A 1D` high-water mark USD 100,322.08 (2026-07-21 close — the API's last daily bar still reflects 07-21; no 07-22 bar has posted yet, consistent with the standing pre-open lag noted in past runs). Current live equity USD 99,849.96 → drawdown **0.4706%**. NOT triggered (9.5294pp headroom) ✓.
- **Intraday shock check:** equity USD 99,849.96 vs last known close USD 99,947.32 (07-22, per `portfolio.md`, since the account endpoint's `last_equity` field returned a bad "0" this pull) = **−0.0974%** — no shock ✓ (threshold −4%).
- **Sector cap:** no group above 60% (see table above) ✓.

**Step 3b — thesis contract review:** LLY (review_by 2026-08-05), V (review_by 2026-07-28), UNH (review_by 2026-08-17), META (review_by 2026-07-27), VST (review_by 2026-08-05) — none due today, none triggered. Verified META's invalidation level specifically given today's price weakness: fresh Alpaca bars (`start=2026-04-20&end=2026-07-23`, feed=iex) put the 50-day SMA at **USD 606.06** (through 07-22 close USD 627.15, +3.48% above); today's live price USD 615.99 is still **+1.64% above** the 50-day SMA — invalidation ("closes back below the 50-day SMA") has **not** triggered, but the buffer has compressed hard from +6.87% at entry (07-20) to roughly +1.6-3.5% now. HOLD all five, no contract renewal needed (none expired).

**Step 3c — Monday-only conviction review:** N/A — today is Thursday.

**Step 4 — research (WebSearch, all facts dated 2026-07-23 unless noted):**
- **Market posture:** S&P 500 futures edging slightly lower pre-market on rising bond yields and firm energy prices. 10yr Treasury **~4.66-4.68%**, near a 19-month high and **trending toward (not yet past) the 4.75% new-buy gate** — worth watching closely at every future pre-market; today it remains below the gate. Initial jobless claims fell to 208K (10-week low), a strong print reducing near-term rate-cut odds, landing inside the Fed's blackout period ahead of the July 28-29 FOMC. Crude inventories showed a surprise 2.6M-barrel build; US SPR at a 43-year low. Overall mood: cautious/mildly risk-off on higher-for-longer yields plus energy jitters. [Yahoo Finance, CNBC, TradingEconomics, US News]
- **Iran conflict/oil (Active Macro Watch — escalated further, not stabilized):** Brent crude up ~4.6% to USD 98.44/bbl (highest since late May), WTI up ~3.8% to USD 90.14/bbl — both materially above the USD 92 (Brent) reference from 07-22. US carried out a 12th consecutive day of strikes on Iranian targets; Houthis (Iran-backed) claimed attacks on two Saudi oil tankers in the Red Sea after threatening a blockade, opening a second shipping-risk front alongside the Strait of Hormuz. Both Washington and Tehran are downplaying peace-talk prospects. **Ceasefire hopes confirmed not holding — this remains an active, worsening, unresolved risk-off catalyst.** [CNBC, DNYUZ]
- **LLY (what changed since yesterday):** nothing material. Novo Nordisk ad-claims lawsuit (filed 07-21) has no new developments. AtaiBeckley acquisition still pending close (Q3 2026), no update since the 07-16 announcement. Routine USD 1.73 dividend declared (ex-date 08-14) — not thesis-relevant. Earnings still confirmed 2026-08-05. Thesis unchanged.
- **V (what changed since yesterday):** nothing negative found ahead of the 2026-07-28 (after close) print — confirmed unchanged. Analyst sentiment remains bullish into earnings: 31 Strong Buy / 4 Moderate Buy / 4 Hold of 39 analysts, average PT USD 401.87 (~15% upside). Q3 FY26 consensus EPS ~USD 3.22 (+8.05% YoY); Visa has beaten EPS estimates for 4 straight quarters. No new negative pre-earnings chatter. Thesis unchanged; earnings is now **3 trading days out** (Fri 24, Mon 27, Tue 28) — still outside the 2-trading-day blackout window, but close; the 07-27 pre-market/midday routines should watch for the window closing.
- **UNH (what changed since yesterday):** nothing material — one Trefis commentary piece (07-20) flagged UNH's P/E (~32.1x) near the top of its own historical range with limited room for disappointment, a valuation-caution note rather than new fundamental news. Next earnings still far out (2026-10-27). Thesis unchanged.
- **META (what changed since yesterday — real, negative, and worth flagging):** JPMorgan analyst Doug Anmuth downgraded META from Overweight to Neutral, cutting the price target from USD 825 to USD 725, citing intensifying full-stack AI competition and a harder-than-modeled path to AI-capex ROI beyond advertising. Today's ~2.5% pre-earnings decline is being attributed to pre-earnings jitters over the raised FY26 capex guidance (USD 125-145B, up from USD 115-135B, blamed on higher component pricing) plus doubts about AI monetization outside advertising — Wedbush has also been publicly favoring AMZN over META as the "superior AI hyperscaler" pick. This is a continuation of an existing AI-capex-ROI-skepticism narrative, not a brand-new adverse event, but the JPMorgan downgrade itself is new information not previously logged. **No thesis-contract action is due today** (review_by is 2026-07-27, 2 trading days before earnings, and neither the invalidation price level nor the review date has triggered — see Step 3b), but this downgrade and the compressing 50-day-SMA buffer should weigh directly on that 07-27 hold/trim/exit decision. Earnings 2026-07-29 confirmed unchanged, now 4 trading days out.
- **VST (what changed since yesterday):** nothing material. Morgan Stanley trimmed its PT slightly to USD 210 from USD 212 (kept Overweight); Seaport raised its PT to USD 230 from USD 227 (kept Buy) — small, offsetting analyst tweaks, net sentiment still constructive. No Cogentrix/Helix-specific news today. Earnings confirmed 2026-08-07 (unchanged). Thesis unchanged.
- **Earnings calendar reconfirmed:** V 2026-07-28 (after close, unchanged), META 2026-07-29 (after close, unchanged) — both independently reconfirmed via search today.

**Step 5 — earnings-window rule:** No held name reports within 2 trading days today (V is 3 trading days out, META is 4). No blackout applies; no forced hold/trim/exit decision required beyond the standing thesis-contract holds in Step 3b. (Flagging for the record: V's window will close as of Monday 07-27's pre-market — that run must make the explicit call.)

**Step 6 — cash-drag check:** Cash 64.354%, well above the 10-20% target band for a 5-position portfolio. However, **this week's 3-new-position cap is already used (UNH, META 07-20; VST 07-21) — 3/3.** No new position is permitted today regardless of setup quality; the cap, not conviction or the elevated cash level, is the binding constraint today. This is a forced, not a discretionary, decision.

**Step 7 — plan:** **No trades today — weekly new-position cap (3/3) already reached this week (Mon 2026-07-20 – Fri 2026-07-24); next slot opens Monday 2026-07-27.** No held position triggers a thesis-contract review, earnings blackout, or −7%/circuit-breaker action today. All 5 positions HOLD. Flag for Monday 07-27 pre-market: (1) V's earnings window closes that day (1 trading day out from the 07-28 print) — force the hold/trim/exit call then if not already handled; (2) META's review_by (2026-07-27) lands that same day and must weigh the JPMorgan downgrade, the compressed 50-day-SMA buffer, and the 07-29 earnings proximity explicitly.

**Stop audit (`orders open`, live Alpaca data):** LLY `e3547b9e` (HWM 1196.29 / stop 1076.661), V `2b0a93ba` (HWM 364.91 / stop 328.419), UNH `225cb079` (HWM 436.945 / stop 393.2505), META `14301809` (HWM 655.84 / stop 590.256), VST `87f49386` (HWM 167.81 / stop 151.029, ratcheted up from 167.6954/150.92586) — all 5 status `new` (live). **5/5 PASS.**

**Planned trades for today:**

No trades planned.

```json
{
  "plan_date": "2026-07-23",
  "trades": []
}
```

**Step 8 — notify:** Telegram sent per playbook — market posture (Iran/oil escalation, 10yr approaching the 4.75% gate) + no trades planned (weekly cap reached) + META downgrade flag.
**Step 9 — commit:** done.

EXECUTED: 2026-07-23T13:39:00Z — No trades (plan empty: weekly new-position cap 3/3 already reached this week, next slot Monday 07-27). Market-open re-check: equity USD 99,799.47 vs 07-22 close USD 99,947.32 (account's own `last_equity` field returned an anomalous "0" this pull, used `portfolio.md`'s recorded prior close instead) = -0.1479% (no shock, threshold -4%); drawdown 0.5209% vs HWM USD 100,322.08 (not triggered, breaker at -10%); LLY -0.722%, V -1.630%, UNH +1.549%, META -5.542% (weakest, JPMorgan downgrade to Neutral/PT 725), VST +3.492% — none within -7% cut range (midday's job regardless); sector exposure Healthcare 20.088%, Financials 7.699%, Communication Services 3.642%, Energy/Utilities 4.179%, cash 64.390% (all within 60% cap); stop audit 5/5 PASS (LLY e3547b9e, V 2b0a93ba, UNH 225cb079, META 14301809, VST 87f49386, all confirmed live in `orders open`, quantities match positions). All guardrails ✓.

## 2026-07-24 ~08:14 ET — PRE-MARKET

- **Live-switch guard:** `ALPACA_BASE_URL` contains "paper" ✓.
- **Lock:** `_lock` was free (`{}`); wrote lock for this run (expires ~08:22 ET).
- **Control switch:** `STATUS: ACTIVE`, no `NOTE:` or `QUERY:` pending in `control.md`. `CROSS_BULL_LEARNING:` blank.
- **Account (live, ~08:13 ET):** Equity USD 99,957.68, cash USD 64,260.90 (64.288%), long market value USD 35,696.78 (35.712%), last_equity USD 99,933.16 (07-23 close, this pull looked sane — no anomalous "0" this time).

**Step 2 — portfolio sync (positions, live Alpaca data ~08:13 ET):**

| Symbol | Qty | Avg entry | Current | Unrealized P/L | % of equity |
|--------|-----|-----------|---------|-----------------|--------------|
| LLY | 8 | 1174.35625 | 1180.3896 | +USD 48.27 (+0.514%) | 9.448% |
| META | 6 | 641.323333 | 605.40 | −USD 215.54 (−5.601%) | 3.634% |
| UNH | 25 | 422.28 | 425.00 | +USD 68.00 (+0.644%) | 10.630% |
| V | 22 | 355.058182 | 353.33 | −USD 38.02 (−0.487%) | 7.777% |
| VST | 25 | 161.21 | 168.92 | +USD 192.75 (+4.783%) | 4.224% |

Sector exposure: Healthcare (LLY+UNH) 20.078%, Financials (V) 7.777%, Communication Services (META) 3.634%, Energy/Utilities (VST) 4.224%, Cash 64.288%. All well within the 60% sector cap.

**Step 3 — risk posture check:**
- **Drawdown circuit breaker:** `history 1M 1D` high-water mark USD 100,322.08 (2026-07-21 close, unchanged). Current live equity USD 99,957.68 → drawdown **0.3633%**. NOT triggered (9.6367pp headroom) ✓.
- **Intraday shock check:** equity USD 99,957.68 vs account's own `last_equity` USD 99,933.16 (07-23 close — sane value this pull, no anomaly) = **+0.0245%** — no shock ✓ (threshold −4%).
- **Sector cap:** no group above 60% (see table above) ✓.

**Step 3b — thesis contract review:** LLY (review_by 2026-08-05), UNH (review_by 2026-08-17), VST (review_by 2026-08-05) — none due today, none triggered, thesis unchanged for all three per today's research below. META (review_by 2026-07-27) and V (review_by 2026-07-28) are not yet due either, but see Step 5 below — V's earnings (07-28) is now exactly 2 trading days out from today, inside the earnings-window rule, so an explicit hold/trim decision is made today rather than waiting for Monday.

**Step 3c — Monday-only conviction review:** N/A — today is Friday.

**Step 4 — research (WebSearch, all facts dated 2026-07-24 unless noted):**
- **Market posture:** Mixed/cautiously constructive pre-market — S&P 500 futures +0.2%, Dow futures +0.4%, but earlier session action showed S&P/Nasdaq contracts down ~0.4% on rising borrowing costs and oil-driven inflation pressure. Polymarket implied a 66% probability of a higher open today despite the crosscurrents. **10yr Treasury rose to 4.71%** — a 4th consecutive rising session, the highest level since January 2025, and now trending very close to (though technically still just below) the **4.75% new-buy gate**. Crude inventories rose 2.0M barrels, keeping inflation worries alive. [TradingEconomics/CNBC via search]
- **Iran/oil (Active Macro Watch — escalating further, not resolving):** Brent crude trading near **USD 100-101/bbl** after Iran rejected a US ceasefire offer; Houthi attacks on tankers in the Red Sea opened a second shipping-risk front alongside the Strait of Hormuz, and Iran-backed forces have threatened to blockade Saudi shipping. Trump has threatened to extend US strikes on Iran. This is now day 13+ of an escalating, unresolved conflict with no peace-talk progress — treat as an active, worsening risk-off catalyst, consistent with the standing macro watch. [Al Jazeera, Bloomberg, PoliticalWire]
- **LLY (what changed since yesterday):** nothing materially new — the Novo Nordisk misleading-ad-claims lawsuit (filed 07-21) remains the only overhang, no new developments reported. Thesis (Medicare Bridge live, AtaiBeckley acquisition pending, Retevmo approval, Q1 revenue +55.5% YoY beat) unchanged and strongly intact. Earnings confirmed 2026-08-05 (unchanged).
- **META (what changed since yesterday):** nothing materially new overnight — price essentially flat (USD 605.40 vs yesterday's USD 604.83 close). One forward-looking piece (Motley Fool, 07-22) speculates Meta could announce a cloud-computing business at its 07-29 earnings — an unconfirmed catalyst, not new information to act on. No fresh downgrades or negative catalysts found today beyond the standing JPMorgan Neutral/PT-725 call already logged 07-23. Thesis unchanged; review_by 2026-07-27 (Monday) still 1 trading day away — will be handled then.
- **UNH (what changed since yesterday):** incrementally positive — confirmation that UnitedHealthcare will eliminate prior-authorization requirements for 30% of services now, with a further 30% cut targeted by end of 2026; read as a real, company-specific goodwill/utilization-sentiment catalyst reinforcing the managed-care thesis, not just macro tailwind. Stock +3.02% on 07-21 on the back of the Q2 beat-and-raise and stable Medicare Advantage reimbursement sentiment. Thesis unchanged, strengthening if anything. Earnings still 2026-10-27 (far out).
- **V (what changed since yesterday — earnings-window relevant):** No negative news. Visa's stablecoin platform + AI Financial Assistant rollout continues to draw bullish coverage; Barclays reiterated Buy in early July; stock +10.31% over the trailing 4 weeks. Earnings confirmed **2026-07-28** (after close) — **today, 07-24, is exactly 2 trading days out** (Mon 07-27, Tue 07-28), which puts V inside the earnings-window rule a session earlier than previously logged (07-23 pre-market called it "3 trading days out"). Making the explicit hold/trim decision now rather than deferring to Monday: thesis is intact, sentiment is unambiguously bullish (31 Strong Buy / 4 Moderate Buy / 4 Hold of 39 analysts, no dissenting signal), and there is no company-specific reason to trim ahead of the print. **Decision: HOLD full 22-share position through earnings, no trim.** Acknowledged risk: trailing stops do not protect against overnight earnings gaps (per the 2026-06-04 AVGO lesson) — the 10% trailing stop (stop USD 328.419, HWM USD 364.91) remains the only downside protection if the print disappoints. review_by renewed to 2026-07-29 (the trading day immediately after the print, to force a fresh post-earnings read).
- **VST (what changed since yesterday):** nothing material — stock has now gained 5 consecutive sessions, closing 07-23 at USD 168.98 (+1.34% that day). 13-analyst Buy consensus intact, PT USD 232.23. Position is +4.783% unrealized. No Cogentrix/Helix-specific news today. Earnings confirmed 2026-08-07 (unchanged, 12 trading days out). Thesis unchanged.
- **Earnings calendar reconfirmed:** V 2026-07-28 (after close, unchanged), META 2026-07-29 (after close, unchanged), VST 2026-08-07 (unchanged), LLY 2026-08-05 (unchanged), UNH 2026-10-27 (unchanged) — all independently reconfirmed via search today.

**Step 5 — earnings-window rule:** No new buy is being considered today regardless (see Step 6 — weekly cap already used), so the "no new buy within 2 trading days of earnings" clause is moot for today's decision set. For **held** names: **V now falls inside the 2-trading-day window** (earnings 07-28, today is 2 trading days out) — explicit hold decision made above (HOLD, no trim, thesis intact, stop is the only downside protection against gap risk). META remains 3 trading days out (earnings 07-29) — not yet inside the window; its review_by (07-27) is 1 trading day away and will force the same explicit call then.

**Step 6 — cash-drag check:** Cash 64.288%, well above the 25-40% target band in `strategy.md`. However, **this week's 3-new-position cap is already used (BUY UNH 07-20, BUY META 07-20, BUY VST 07-21) — 3/3.** No new position is permitted today regardless of setup quality or elevated cash — the cap, not conviction, is the binding constraint. This is now the fourth consecutive session this week citing the same forced (not discretionary) reason; next slot opens Monday 2026-07-27, where a fresh, un-gated buy decision should be made rather than deferring again by default.

**Step 7 — plan:** **No trades today — weekly new-position cap (3/3) already reached this week (Mon 2026-07-20 – Fri 2026-07-24); next slot opens Monday 2026-07-27.** V gets an explicit hold decision today (earnings-window rule, see Step 5); no other held position triggers a thesis-contract review, blackout action, or −7%/circuit-breaker cut. All 5 positions HOLD; all 5 trailing stops confirmed live (see stop audit below).

**Stop audit (`orders open`, live Alpaca data):** LLY `e3547b9e` (HWM 1196.29 / stop 1076.661), V `2b0a93ba` (HWM 364.91 / stop 328.419), UNH `225cb079` (HWM 436.945 / stop 393.2505), META `14301809` (HWM 655.84 / stop 590.256), VST `87f49386` (HWM 169.06 / stop 152.154) — all 5 status `new` (live), quantities match positions. **5/5 PASS.**

**Planned trades for today:**

No trades planned.

```json
{
  "plan_date": "2026-07-24",
  "trades": []
}
```

**Step 8 — notify:** Telegram sent per playbook — market posture (10yr yield 4.71% nearing the 4.75% gate, Iran/oil escalation continuing, mixed futures) + no trades planned (weekly cap reached) + V hold-through-earnings decision flagged.
**Step 9 — commit:** done.

## 2026-07-27 ~08:20 ET — PRE-MARKET (Monday)

- **Live-switch guard:** `ALPACA_BASE_URL` contains "paper" ✓.
- **Lock:** `_lock` was free (`{}`); wrote lock for this run (expires ~08:28 ET).
- **Control switch:** `STATUS: ACTIVE`, no `NOTE:` or `QUERY:` pending in `control.md`. `CROSS_BULL_LEARNING:` blank.
- **Account (live, ~08:20 ET):** Equity USD 100,096.50, cash USD 64,260.90 (64.198%), long market value USD 35,835.60 (35.800%), last_equity USD 99,829.56 (07-24 close).

**Step 2 — portfolio sync (positions, live Alpaca data ~08:20 ET):**

| Symbol | Qty | Avg entry | Current | Unrealized P/L | % of equity |
|--------|-----|-----------|---------|-----------------|--------------|
| LLY | 8 | 1174.35625 | 1202.09 | +USD 221.87 (+2.362%) | 9.608% |
| META | 6 | 641.323333 | 604.82 | −USD 219.02 (−5.692%) | 3.626% |
| UNH | 25 | 422.28 | 422.10 | −USD 4.50 (−0.043%) | 10.542% |
| V | 22 | 355.058182 | 358.68 | +USD 79.68 (+1.020%) | 7.884% |
| VST | 25 | 161.21 | 165.86 | +USD 116.25 (+2.884%) | 4.143% |

Sector exposure: Healthcare (LLY+UNH) 20.150%, Financials (V) 7.884%, Communication Services (META) 3.626%, Energy/Utilities (VST) 4.143%, Cash 64.198%. All well within the 60% sector cap.

**Step 3 — risk posture check:**
- **Drawdown circuit breaker:** `history 1A 1D` high-water mark USD 100,322.08 (2026-07-21 close, unchanged). Current live equity USD 100,096.50 → drawdown **0.2249%**. NOT triggered (9.7751pp headroom) ✓.
- **Intraday shock check:** equity USD 100,096.50 vs last_equity USD 99,829.56 (07-24 close) = **+0.2674%** — no shock ✓ (threshold −4%).
- **Sector cap:** no group above 60% (see table above) ✓.

**Step 3b — thesis contract review:** LLY (review_by 2026-08-05), UNH (review_by 2026-08-17), VST (review_by 2026-08-05) — none due today, none triggered. V (review_by 2026-07-29, renewed 07-24 pre-market) not yet due — earnings 07-28 is 1 trading day out, hold decision already made and unchanged (thesis intact, no negative news this weekend). **META (review_by 2026-07-27) is due TODAY** — see Step 5 for the forced decision.

**Step 3c — Monday conviction-weighted holding review:**
- **LLY: A.** Thesis strongly intact — retatrutide succeeded in two additional Phase 3 obesity trials (next-gen obesity drug filing planned 2027), Goldman reiterated Buy (PT USD 1,283), JPMorgan raised PT to USD 1,400. Trading near record highs (USD 1,202.09, +2.362% unrealized). No change from last Monday's A rating.
- **V: A.** Thesis intact — Strong Buy consensus unchanged (31 Strong Buy/4 Moderate Buy/4 Hold of 39 analysts), new Airwallex embedded-finance partnership (07-23) is incremental positive, stablecoin platform narrative continuing to draw coverage. Reports earnings tomorrow (07-28) — hold-through-earnings decision already made and unchanged. No change from last Monday's A rating.
- **UNH: A.** First Monday review since the 07-20 entry. Thesis intact and reinforcing — Q2 beat-and-raise (07-16) still the active catalyst, three analyst PT raises since entry (Morgan Stanley to USD 529, Oppenheimer to USD 500, Goldman to USD 490). Position essentially flat (−0.043%) — normal variance, not a concern; working as expected for a defensive-growth managed-care name.
- **META: B.** First Monday review since the 07-20 entry. Thesis (ad ecosystem strength: +19% impressions, +12% pricing; Meta Compute AI-cloud unit; Iris in-house chip) remains intact, but conviction is dented by a rough week (−7.87% over the past 5 sessions, −9.68% YTD) driven by sector-wide AI-capex-ROI anxiety (Alphabet's capex guidance raise) rather than a company-specific break, plus a binary earnings catalyst in 2 trading days that the position has not yet cleared. Rated B (thesis intact but conviction not yet re-confirmed) rather than A pending the post-earnings read forced by the renewed review_by (see Step 5).
- **VST: A.** First Monday review since the 07-21 re-entry. Thesis intact and outperforming — position +2.884% unrealized, Bernstein and Morgan Stanley both reaffirmed Buy in the past few days (Morgan Stanley trimmed PT slightly to USD 210 but kept Overweight), Scotiabank raised PT to USD 298. No negative company-specific news.

No position has been rated C, so the 3-consecutive-Monday-C forced-trim rule does not apply to any holding this week.

**Step 4 — research (WebSearch, all facts dated 2026-07-27 unless noted):**
- **Market posture — sharply more constructive than last week:** S&P 500 futures +0.79-0.9%, Dow futures +1%, Nasdaq-100 futures +~1.4%. The US suspended its 13-night airstrike campaign against Iran to allow room for diplomatic talks, and a senior Iranian official confirmed Tehran would halt retaliatory strikes — the first real de-escalation signal after 13+ days of active conflict. Brent crude collapsed **−4.41% to USD 87.64/bbl**, WTI −4.93% to USD 84.91/bbl — both well off the ~USD 100/bbl highs from last week. Prediction markets price an 88% chance of an "Up" open today. **10yr Treasury eased to 4.63-4.64%** — a sharp reversal from the 4.71% reading Thursday that was approaching the 4.75% new-buy gate; the gate is no longer a near-term concern. [Benzinga](https://www.benzinga.com/markets/equities/26/07/60688523/stock-market-today-sp-500-dow-jones-futures-rise-as-us-iran-halt-retaliatory-strikes-microchip-technology-amd-nucor-in-focus), [Yahoo Finance](https://finance.yahoo.com/markets/live/stock-market-today-monday-july-27-dow-sp-500-nasdaq-080412540.html)
- **LLY (what changed since Friday):** retatrutide (next-gen triple-agonist obesity drug) succeeded in two additional Phase 3 trials; Eli Lilly plans to file for approval in 2027 — a genuine pipeline-extension catalyst beyond the current Zepbound/Mounjaro franchise. Goldman Sachs reiterated Buy (PT USD 1,283); JPMorgan's PT sits even higher at USD 1,400. Thesis unchanged and strengthening. Earnings confirmed 2026-08-05 (unchanged).
- **META (what changed since Friday — review_by due today):** no new negative catalyst since Friday's close; price essentially flat (Friday range USD 594.10-609.98, closed 604.82). 24/7 Wall St (07-25) frames the setup ahead of Wednesday's print: Meta enters near record highs on strong ad fundamentals (+19% impressions, +12% pricing) but the capex question (FY26 guide USD 125-145B, whether Reality Labs losses + AI infra costs compress Q1's 41.4% operating margin) is the central swing factor. Earnings confirmed 2026-07-29 after close (unchanged) — **today, 07-27, is exactly 2 trading days out (Mon→Tue→Wed), inside the earnings-window rule.** See Step 5 for the explicit decision.
- **UNH (what changed since Friday):** nothing materially new — continued analyst PT-raise momentum from the 07-16 beat-and-raise (Morgan Stanley USD 529, Oppenheimer USD 500, Goldman USD 490, all reported this week). Standard caution flagged by analysts on rising commercial medical costs and regulatory risk — a standing sector risk, not a new company-specific issue. Thesis unchanged. Earnings still 2026-10-27 (far out).
- **V (what changed since Friday — earnings tomorrow):** new Airwallex embedded-finance partnership for freight/shipping platforms announced 07-23 (incremental positive, not thesis-moving on its own). Consensus remains Strong Buy (31/4/4 of 39 analysts). Q3 FY26 earnings confirmed for tomorrow, 2026-07-28 after close; consensus EPS USD 3.22 (+8.1% YoY on the older estimate cited last week) to USD 3.23 per the freshest StockStory preview, revenue growth expected to decelerate to ~11.9% YoY from 14.3% prior quarter — a deceleration to watch but not a red flag on its own (consistent with a maturing base). No negative news. Hold-through-earnings decision (made 07-24, thesis intact) stands unchanged; review_by 2026-07-29 will force the post-earnings read.
- **VST (what changed since Friday):** Vistra closed 07-25 in a USD 162.36-169.76 range; Scotiabank raised PT to USD 298 (from USD 293, Outperform), Bernstein reaffirmed Buy, Morgan Stanley reaffirmed Overweight (trimmed PT slightly to USD 210 from USD 212 — a minor, non-thesis-breaking revision already logged last week). Earnings confirmed 2026-08-07 (unchanged, well outside the 2-day blackout). Thesis unchanged.
- **Earnings calendar reconfirmed:** V 2026-07-28 (after close, 1 trading day out), META 2026-07-29 (after close, 2 trading days out — inside window today), LLY 2026-08-05 (unchanged), UNH 2026-10-27 (unchanged), VST 2026-08-07 (unchanged). Watchlist-only names reporting this week: MSFT 07-29, LRCX 07-29, PWR 07-30 — all inside or entering the 2-day blackout, moot regardless since none clear the technical gate today (see Step 7).

**Step 5 — earnings-window rule (forced decision, META review_by = today):**

**META — explicit hold/trim/exit decision:** Earnings land Wednesday 07-29 after close, 2 trading days from today — inside the blackout window (no new buy, which is moot since META is already held). For the **existing 6-share position** (3.626% of equity, a small starter already halved for ATR at entry): thesis remains intact — the ad-engine fundamentals (+19% impressions, +12% pricing) are the core bull case and are unrelated to the capex-ROI debate that has weighed on the stock. The position is small in dollar terms (max loss at the trailing stop is capped, and a full earnings-gap loss on 6 shares is a bounded, known risk relative to total equity). No company-specific negative catalyst has emerged since entry — the stock's ~8% pullback this week tracks the same sector-wide AI-capex anxiety already priced into the Monday conviction rating (B) above, not a fresh thesis break. Current buffer to the trailing stop: HWM USD 655.84 / stop USD 590.256 vs current USD 604.82 = **2.406% buffer** — thin but not at a level that argues for a pre-emptive trim beyond what the stop already protects. **Decision: HOLD the full 6-share position through earnings, no trim.** Acknowledged risk per the standing 2026-06-04 AVGO lesson: the trailing stop does not protect against an overnight earnings gap; that risk is accepted given the position's small size. **review_by renewed to 2026-07-30** (the trading day immediately after the print) to force a fresh post-earnings read.

**V:** already decided 07-24 (HOLD through earnings, no trim); unchanged today, no new action needed. review_by 2026-07-29 stands.

**Step 6 — cash-drag check:** Cash 64.198%, well above the 25-40% target band — now into a **5th consecutive week** above the band. Weekly new-position slots are fully available (0/3 used this week, cap reset Monday). The tape today is genuinely constructive (Iran de-escalation, oil down ~4.5%, 10yr eased comfortably below the 4.75% gate, futures broadly higher) — precisely the condition that should trigger either a qualifying entry or an explicit sentence explaining why not. **Pulled fresh 50-day SMA and 20-day ATR% for every non-held watchlist name with a live technical gate** (via Alpaca `data.alpaca.markets` bars, 2026-05-01 to 2026-07-25 close):

| Ticker | Price | 50-day SMA | vs 50-day | 20-day ATR% | Gate |
|--------|-------|-----------|-----------|-------------|------|
| NVDA | 207.07 | 209.17 | **−1.00%** | 3.29% | FAIL |
| MSFT | 381.81 | 399.11 | **−4.34%** | 2.75% | FAIL |
| COST | 935.35 | 969.69 | **−3.54%** | 1.79% | FAIL |
| LRCX | 305.42 | 338.42 | **−9.75%** | 5.98% | FAIL |
| PWR | 625.69 | 694.47 | **−9.90%** | 3.14% | FAIL |

Every single watchlist name still fails the technical-confirmation gate (all below their 50-day SMA) — NVDA is the closest at only −1.00%, but a "closest to passing" name is not a passing name. **No qualifying entry exists today despite the constructive tape and available slots.** Staying in cash today is the correct, disciplined call, not a passive default — the gate failure is fresh data pulled this morning, not a stale assumption. If NVDA closes back above its 50-day SMA with 2 consecutive confirmed sessions (per the standing multi-session-confirmation lesson), it becomes the next candidate to watch.

**Step 7 — plan:** **No trades today.** META's forced review_by decision: HOLD, no trim, review_by renewed to 2026-07-30. V's hold-through-earnings decision from 07-24 stands unchanged. Monday conviction ratings recorded (LLY A, V A, UNH A, META B, VST A) — no position has 3 consecutive Mondays at C, so no forced trim applies. Every non-held watchlist candidate fails the technical gate this morning (see table above) — cash stays elevated by discipline, not by default.

**Stop audit (`orders open`, live Alpaca data):** LLY `e3547b9e` (HWM 1206.94 / stop 1086.246), V `2b0a93ba` (HWM 364.91 / stop 328.419), UNH `225cb079` (HWM 436.945 / stop 393.2505), META `14301809` (HWM 655.84 / stop 590.256), VST `87f49386` (HWM 169.76 / stop 152.784) — all 5 status `new` (live), quantities match positions. **5/5 PASS.**

**Planned trades for today:**

No trades planned.

```json
{
  "plan_date": "2026-07-27",
  "trades": []
}
```

**Step 8 — notify:** Telegram sent per playbook — market posture (Iran de-escalation, oil down sharply, 10yr eased below the gate, futures broadly higher) + no trades planned (every watchlist name still fails its technical gate) + META's forced hold-through-earnings decision.
**Step 9 — commit:** done.

## 2026-07-28 ~08:22 ET — PRE-MARKET (Tuesday)

- **Live-switch guard:** `ALPACA_BASE_URL` contains "paper" ✓.
- **Lock:** `_lock` was free (`{}`); wrote lock for this run.
- **Control switch:** `STATUS: ACTIVE`, no `NOTE:` or `QUERY:` pending in `control.md`. `CROSS_BULL_LEARNING:` blank.
- **Account (live, ~08:22 ET):** Equity USD 99,983.51, cash USD 64,260.90 (64.271%), long market value USD 35,722.61 (35.729%), last_equity USD 99,748.02 (07-27 close).

**Step 2 — portfolio sync (positions, live Alpaca data ~08:22 ET):**

| Symbol | Qty | Avg entry | Current | Unrealized P/L | % of equity |
|--------|-----|-----------|---------|-----------------|--------------|
| LLY | 8 | 1174.35625 | 1209.85 | +USD 283.95 (+3.022%) | 9.680% |
| META | 6 | 641.323333 | 598.38 | −USD 257.66 (−6.696%) | 3.591% |
| UNH | 25 | 422.28 | 420.74 | −USD 38.50 (−0.365%) | 10.520% |
| V | 22 | 355.058182 | 366.49 | +USD 251.50 (+3.220%) | 8.064% |
| VST | 25 | 161.21 | 154.89 | −USD 158.00 (−3.920%) | 3.872% |

Sector exposure: Healthcare (LLY+UNH) 20.201%, Financials (V) 8.064%, Communication Services (META) 3.591%, Energy/Utilities (VST) 3.872%, Cash 64.271%. All well within the 60% sector cap.

**Step 3 — risk posture check:**
- **Drawdown circuit breaker:** `history 1A 1D` high-water mark USD 100,322.08 (2026-07-21 close, unchanged). Current live equity USD 99,983.51 → drawdown **0.3375%**. NOT triggered (9.6625pp headroom) ✓.
- **Intraday shock check:** equity USD 99,983.51 vs last_equity USD 99,748.02 (07-27 close) = **+0.236%** — no shock ✓ (threshold −4%).
- **Sector cap:** no group above 60% (see table above) ✓.

**Step 3b — thesis contract review:** LLY (review_by 2026-08-05), UNH (review_by 2026-08-17), VST (review_by 2026-08-05) — none due today, none triggered. V (review_by 2026-07-29, renewed 07-24) not yet due — earnings land TODAY (07-28) after close; hold-through-earnings decision made 07-24 stands unchanged (no negative news since). META (review_by 2026-07-30, renewed 07-27) not yet due — earnings tomorrow (07-29) after close; hold decision made 07-27 stands unchanged.

**Step 3c — Monday conviction review:** N/A (Tuesday). Ratings unchanged from 07-27: LLY A, V A, UNH A, META B, VST A.

**Step 4 — research (WebSearch, all facts dated 2026-07-28 unless noted):**
- **Market posture — mixed, risk-off in chips specifically:** Nasdaq-100 futures down ~1% pre-bell as US tech stocks slide on a sell-off in Korean memory makers — South Korea's Kospi tumbled over 10%, SK Hynix and Samsung sank 14% and 13% respectively, on AI-circular-financing anxiety (Nvidia's USD 350B OpenAI chip-purchase commitment cited as a trigger) plus reports that Chinese firms are advancing domestic DUV lithography, reigniting China-competition fears in memory. S&P 500 futures roughly flat-to-modestly positive, Dow futures up, on firm PMI data (services/manufacturing ~53-54) and easing yields. **10yr Treasury eased to 4.62%**, a third consecutive down session, comfortably below the 4.75% new-buy gate. The Fed's two-day FOMC meeting begins today; no rate change expected at tomorrow's (07-29) decision, ~35% market-implied odds of a cut. [Yahoo Finance](https://finance.yahoo.com/markets/live/stock-market-today-tuesday-july-28-dow-sp-500-nasdaq-082832371.html), [Bloomberg](https://www.bloomberg.com/news/articles/2026-07-28/korean-stocks-sink-as-chipmakers-plung-on-deepening-ai-fatigue)
- **LLY (what changed since yesterday):** nothing thesis-breaking. Eli Lilly declared a cash dividend of USD 1.73 (ex-date 08-14). Novo Nordisk is now pursuing an injunction to block certain Lilly ad claims — this is an escalation of the ad-claims suit already flagged 07-21 (litigation/PR overhang, not a product or regulatory setback). Analysts continue raising price targets on the obesity/diabetes franchise. Thesis unchanged and strengthening. Earnings confirmed 2026-08-05.
- **META (what changed since yesterday):** no new negative catalyst; stock recovered modestly from yesterday's −7.324% close to −6.696% this morning. Q2 earnings tomorrow (07-29) after close — consensus EPS USD 7.18, revenue USD 60.22B (~27% YoY growth, decelerating from Q1's 33%); FY26 capex guide USD 125-145B remains the central investor concern (an 8% raise at the midpoint was the trigger for the post-Q1 selloff). Ad impressions/price-per-ad growth and AI-capex commentary will be the key swing factors tomorrow. Meta has beaten EPS 6 straight quarters; prediction markets price ~87% odds of another beat. Hold decision from 07-27 (review_by 2026-07-30) stands unchanged — no action today, decision is due tomorrow after the print.
- **UNH (what changed since yesterday):** nothing material. Price range USD 412.54-423.70 yesterday, currently USD 420.74. Buy-consensus intact (27 analysts, avg PT USD 475.23, +13.8% upside). Standing regulatory-scrutiny watch (Medicare Advantage MLR, coverage-denial-rate reviews) is a known sector risk, not a new company-specific issue. Thesis unchanged. Earnings still 2026-10-27 (far out).
- **V (what changed since yesterday — earnings TODAY):** Visa reports Q3 FY26 results today after close (~5:00 PM ET webcast). Zacks consensus EPS USD 3.23 (+8.4% YoY), revenue USD 11.35B (+11.6% YoY); FIFA World Cup 2026 (June) cited as a likely cross-border-volume tailwind for the quarter. No negative news since yesterday. Hold-through-earnings decision (made 07-24, thesis intact) stands unchanged; review_by 2026-07-29 will force tomorrow's post-earnings read — the trailing stop (buffer 10.38% to stop USD 328.419) is the only protection against an overnight earnings gap tonight.
- **VST (what changed since yesterday):** VST fell 4.46% yesterday (07-27) to close USD 156.09 (now USD 154.89 this morning) — WebSearch confirms this was broad AI-power-sector weakness (Constellation Energy, Talen Energy, and NRG Energy all down too on the same day), not a VST-specific setback; GuruFocus still flags VST as undervalued on GF Value after the drop. Scotiabank raised its PT to USD 298 (from USD 293, Outperform) during the same window. Next earnings 2026-08-07 (unchanged, outside the blackout). Thesis unchanged; trailing-stop buffer has compressed to ~1.36% (current USD 154.89 vs stop USD 152.784) — worth watching but no action triggered (not near the −7% line, which is midday-only in any case).
- **Earnings calendar reconfirmed:** V 2026-07-28 (today, after close), META 2026-07-29 (tomorrow, after close), LLY 2026-08-05 (unchanged), UNH 2026-10-27 (unchanged), VST 2026-08-07 (unchanged). Watchlist-only names reporting this week: MSFT 07-29, LRCX 07-29 (both 1 trading day out, inside blackout), PWR 07-30 (2 trading days out, inside blackout) — all moot regardless since none clear the technical gate today (see Step 6).

**Step 5 — earnings-window rule:** No new buy is planned in any name (moot — no buys planned today regardless). Held names inside the 2-trading-day window: **V** (earnings today) — hold-through-earnings decision made 07-24, reconfirmed above, no new negative catalyst, HOLD full position, no trim. **META** (earnings tomorrow) — hold decision made 07-27, reconfirmed above, HOLD full position, no trim. Neither contract is due today (V due 07-29, META due 07-30) but both are re-checked here per the earnings-window rule's spirit — no thesis break found for either.

**Step 6 — cash-drag check:** Cash 64.271%, well above the 25-40% target band — now a **6th consecutive week** above the band. Weekly new-position slots fully available (0/3 used this week). The tape today is mixed, not constructive for new tech/semi entries specifically (deepening Asian chip-sector rout bleeding into US chipmakers pre-bell), though the broader S&P/Dow futures and easing 10yr are neutral-to-supportive. **Pulled fresh 50-day SMA and 20-day ATR% for every non-held watchlist name** (via Alpaca `data.alpaca.markets` bars, 2026-05-15 to 2026-07-27 close):

| Ticker | Price | 50-day SMA | vs 50-day | 20-day ATR% | Gate |
|--------|-------|-----------|-----------|-------------|------|
| NVDA | 196.56 | 208.03 | **−5.51%** | 3.46% | FAIL |
| MSFT | 389.15 | 398.58 | **−2.36%** | 2.70% | FAIL |
| COST | 951.56 | 966.57 | **−1.55%** | 1.79% | FAIL |
| LRCX | 291.41 | 339.14 | **−14.07%** | 6.17% | FAIL |
| PWR | 620.08 | 689.57 | **−10.08%** | 3.23% | FAIL |

Every watchlist name still fails the technical gate; NVDA and LRCX are materially worse than Monday's readings (NVDA −5.51% vs −1.00%, LRCX −14.07% vs −9.75%) as today's chip-sector selloff hits them directly — the opposite of a qualifying setup. COST and MSFT narrowed slightly but remain firmly below their 50-day. **No qualifying entry exists today; staying in cash is the correct, actively-re-verified call, not a passive default.** A deepening sector-wide selloff is a reason for additional caution on AI-semi/tech names specifically, not a reason to force an entry to reduce cash drag.

**Step 7 — plan:** **No trades today.** V's hold-through-earnings decision (earnings today after close) stands unchanged; review_by 07-29 forces tomorrow's post-earnings read. META's hold decision (earnings tomorrow after close) stands unchanged; review_by 07-30 forces the post-earnings read the day after. No watchlist candidate clears its technical gate — several got materially worse on today's chip-sector rout. FOMC decision tomorrow (07-29, no change expected) is a mild watch item, not a blocker (10yr well below the 4.75% gate).

**Stop audit (`orders open`, live Alpaca data):** LLY `e3547b9e` (HWM 1206.94 / stop 1086.246), V `2b0a93ba` (HWM 364.91 / stop 328.419), UNH `225cb079` (HWM 436.945 / stop 393.2505), META `14301809` (HWM 655.84 / stop 590.256), VST `87f49386` (HWM 169.76 / stop 152.784) — all 5 status `new` (live), quantities match positions. **5/5 PASS.**

**Planned trades for today:**

No trades planned.

```json
{
  "plan_date": "2026-07-28",
  "trades": []
}
```

EXECUTED: 2026-07-28T13:36 ET — no new trades (plan empty: every watchlist name still fails the technical gate); 🚨 VST trailing stop filled 09:34:48 AM ET (25sh, USD 161.21→USD 150.0496, −6.924%, −USD 279.01) on a TD Cowen PT cut layered on prior-session AI-power-sector weakness — see closed-trades.md/lessons.md; stop audit 4/4 PASS on remaining positions (LLY, META, UNH, V); 4 positions held, cash 68.116%.

**Step 8 — notify:** Telegram sent per playbook — market posture (chip-sector selloff pre-bell, 10yr eased to 4.62%, FOMC begins today) + no trades planned (all watchlist candidates fail the gate, several worse than Monday) + V earnings today / META earnings tomorrow, both hold decisions reconfirmed unchanged.
**Step 9 — commit:** done.

## 2026-07-30 ~08:13 ET — PRE-MARKET (Thursday)

- **Live-switch guard:** `ALPACA_BASE_URL` contains "paper" ✓.
- **Lock:** `_lock` was free (`{}`); wrote lock for this run.
- **Control switch:** `STATUS: ACTIVE`, no `NOTE:` or `QUERY:` pending in `control.md`. `CROSS_BULL_LEARNING:` blank.
- **Account (live, ~08:13 ET):** Equity USD 99,606.68, cash USD 71,553.62 (71.837%), long market value USD 28,053.06 (28.163%), buying power USD 364,763.05. Alpaca's `last_equity` field returned USD 100,103.63 — a stale figure, two sessions behind the actual settled 07-29 close (USD 99,884.47). Per the standing 07-23 lesson, USD 99,884.47 (portfolio.md's own recorded 07-29 close) is used below as the shock-check reference, not the API field.

**Step 2 — portfolio sync (positions, live Alpaca data ~08:13 ET):**

| Symbol | Qty | Avg entry | Current | Unrealized P/L | % of equity |
|--------|-----|-----------|---------|-----------------|--------------|
| LLY | 8 | 1174.35625 | 1188.50 | +USD 113.15 (+1.204%) | 9.546% |
| UNH | 25 | 422.28 | 417.10 | −USD 129.50 (−1.227%) | 10.469% |
| V | 22 | 355.058182 | 368.98 | +USD 306.28 (+3.921%) | 8.150% |

Sector exposure: Healthcare (LLY+UNH) 20.015%, Financials (V) 8.150%, Cash 71.837%. All well within the 60% sector cap.

**Step 3 — risk posture check:**
- **Drawdown circuit breaker:** `history 1A 1D` high-water mark USD 100,322.08 (2026-07-21 close, unchanged). Current live equity USD 99,606.68 → drawdown **0.7130%**. NOT triggered (9.287pp headroom) ✓.
- **Intraday shock check:** equity USD 99,606.68 vs recorded 07-29 close USD 99,884.47 = **−0.278%** — no shock ✓ (threshold −4%; market not yet open, pre-market quote move only).
- **Sector cap:** no group above 60% (see table above) ✓.

**Step 3b — thesis contract review:** LLY (review_by 2026-08-05, earnings), UNH (review_by 2026-08-17), V (review_by 2026-08-15, renewed 07-29 post-earnings) — none due today, none triggered.

**Step 3c — Monday conviction review:** N/A — today is Thursday.

**Step 4 — research (WebSearch, all facts dated 2026-07-30 unless noted):**
- **Market posture — two-track tape, tech-earnings relief vs. a sharp Middle East re-escalation:** S&P 500 futures +0.4% pre-market as Microsoft's blowout Azure-driven beat eased AI-capex-ROI concerns broadly, but the tape stayed cautious on a fresh US strike wave against Iran and an Iranian ballistic-missile attack on US forces overnight — oil jumped again (Brent ~USD 87-90/bbl, WTI above USD 82-84, both up another ~3.4-3.6% today on top of yesterday's ~8% spike). This is a genuine re-escalation, not the de-escalation-then-reversal pattern seen in late July — treat as an active, worsening risk-off catalyst on top of the AI-capex debate. [Benzinga](https://www.benzinga.com/markets/prediction-markets/26/07/60788305/sp500-july-30-open-up-or-down-polymarket-fed-bond-yields-big-tech-earnings-oil), [Yahoo Finance](https://finance.yahoo.com/markets/live/stock-market-today-thursday-july-30-dow-sp-500-nasdaq-082255995.html), [CNBC](https://www.cnbc.com/2026/07/29/oil-prices-today-brent-wti-iran-us-hormuz.html)
- **FOMC (07-29, confirmed via Fed press release):** held the federal funds rate steady at 3.50-3.75% for a 5th consecutive meeting, but the vote was 9-3 — all three dissents (Cleveland's Hammack, Minneapolis's Kashkari, Dallas's Logan) wanted a ¼-point hike, a materially more hawkish committee split than a simple hold. Fed officials' year-end rate projections span 3.6-4.1%; markets broadly expect a hike at the September meeting despite today's hold. [Federal Reserve](https://www.federalreserve.gov/newsevents/pressreleases/monetary20260729a.htm), [CNBC](https://www.cnbc.com/2026/07/29/fed-rate-decision-july-2026.html)
- **10yr Treasury:** 4.70% as of today, up ~2bps from yesterday — still comfortably below the 4.75% new-buy gate, but the closest reading yet after several consecutive rising sessions. Re-check explicitly at every future pre-market; a breach would block new buys outright regardless of setup quality. [TradingEconomics](https://tradingeconomics.com/united-states/government-bond-yield)
- **LLY (what changed since yesterday):** nothing thesis-breaking. An initial WebSearch snippet claimed Lilly "reported Q2 results today" — cross-checked directly against Lilly's own investor-relations press release (BioSpace/investor.lilly.com) and the earnings date is confirmed **2026-08-05**, unchanged; the snippet was a stale/garbled aggregation, not new information. Dividend USD 1.73 (ex-date 08-14) already known. Thesis unchanged, review_by 08-05 stands.
- **UNH (what changed since yesterday):** nothing material. Analysts continue raising price targets post the 07-16 beat-and-raise (JPMorgan to USD 516 from USD 466, Wells Fargo to USD 526 from USD 485). No negative news. Thesis unchanged.
- **V (what changed since yesterday):** nothing new beyond 07-29's resolved read — stock +1.5% on the post-earnings reaction, workforce-reduction restructuring (2,600 roles) already priced in. Strong Buy consensus intact. Thesis unchanged, review_by 08-15 stands.
- **Watchlist re-verification (fresh Alpaca bars through 07-29 close, 2026-05-01 to 2026-07-29, plus live pre-market quotes where available):**

| Ticker | 07-29 close | 50-day SMA | vs 50-day (07-29 close) | Pre-market move | ATR20% | Gate |
|--------|-------------|-----------|--------------------------|------------------|--------|------|
| NVDA | 190.10 | 207.10 | −8.209% | ~194.15 (live) | 3.55% | FAIL (chip-sector drag continues) |
| MSFT | 391.00 | 397.85 | −1.722% | AI blowout, +7.05% AH to ~418.59 (Azure +43%) | 2.55% | Reported 07-29 AC — single-session pop, unconfirmed (needs 2 consecutive sessions per standing lesson); no chase, no entry today regardless |
| COST | 974.37 | 966.58 | **+0.806%** (only 1st positive session — 07-28 close was still −0.12%, NOT yet 2 consecutive) | — | 1.77% | FAIL (needs a 2nd confirming session) — also independently flagged as expensive by multiple sources today (~46x P/E) |
| LRCX | 252.09 (reg.) | 337.10 | −25.22% | Beat + blowout guidance (WFE 2026 outlook raised to USD 140B); stock −7.04% intraday then +5.31% AH to ~265.75 | 6.36% | Reported 07-29 AC — deeply extended below 50-day even after the AH pop, single-session unconfirmed, valuation still disqualifying |
| PWR | 588.20 (07-28 close) | 683.37 | −17.918% (pre-earnings) | Reported THIS MORNING (EPS 4.24 vs 3.33 est, revenue USD 9.56B vs USD 8.70B est — big beat); stock only modestly higher intraday so far | 3.47% | Earnings day itself — inside the blackout regardless of price reaction, no post-earnings SMA data exists yet |

No watchlist candidate qualifies for entry today: NVDA still fails technically despite a pre-market bounce; MSFT and LRCX both popped hard on earnings but a single post-earnings session is unconfirmed by the standing multi-session-confirmation lesson (and chasing an earnings gap violates the no-chasing discipline in `knowledge-base.md` §6.1 regardless); COST has only 1 of the 2 required confirming sessions and is independently flagged as richly valued (~46x P/E) by today's coverage; PWR reported minutes ago and has no post-earnings technical read yet.

**Step 5 — earnings-window rule:** No new buy planned (moot — no watchlist name clears its gate today). No held position reports within the next 2 trading days: LLY confirmed 2026-08-05 (7 trading days out), UNH 2026-10-27, V's earnings-window contract already resolved 07-29.

**Step 6 — cash-drag check:** Cash 71.837%, still the 6th consecutive week above the 25-40% target band. Weekly slots fully available (0/3 used this week). Every watchlist candidate fails its gate again this morning for a distinct, freshly-checked reason (see table above) — two names (MSFT, LRCX) even had blowout earnings overnight, and the discipline call is still to wait for a second confirming session rather than chase the gap, consistent with the standing NVDA-pattern lesson. Staying in cash remains the correct, actively-re-verified call, not a passive default.

**Step 7 — plan:** **No trades today.** All 3 positions HOLD. No thesis contracts due. MSFT and LRCX are the two names to watch most closely for a second confirming session at the next pre-market — both now have a real overnight catalyst, not just a technical wobble.

**Stop audit (`orders open`, live Alpaca data):** LLY `e3547b9e` (HWM 1,232.00/stop 1,108.80), UNH `225cb079` (HWM 436.945/stop 393.2505), V `2b0a93ba` (HWM 373.96/stop 336.564) — all 3 status `new` (live), quantities match positions exactly (8/25/22). **3/3 PASS.**

**Planned trades for today:**

No trades planned.

```json
{
  "plan_date": "2026-07-30",
  "trades": []
}
```

EXECUTED: 2026-07-30T09:36 ET — no trades (plan empty: no watchlist candidate cleared its technical entry gate); shock check −0.5437% vs recorded 07-29 close, no shock; drawdown 0.9774% off HWM, not triggered; stop audit 3/3 PASS (LLY `e3547b9e`, UNH `225cb079`, V `2b0a93ba`); 3 positions held (LLY +0.466%, UNH −2.129%, V +2.713%), none near the −7% line; weekly new-position count unchanged 0/3.

**Step 8 — notify:** Telegram sent per playbook — market posture (MSFT blowout easing AI-capex fears vs. a sharp Iran/US re-escalation overnight, oil up again), FOMC held rates steady on a hawkish 9-3 split, 10yr at 4.70% (closest yet to the 4.75% gate, not breached), no trades planned.
**Step 9 — commit:** done.

## 2026-08-03 ~08:21 ET — PRE-MARKET (Monday)

**Step 0 — guards:** `ALPACA_BASE_URL` contains "paper" ✓. Lock was free (`{}`); wrote lock for pre-market. `STATUS: ACTIVE` in `control.md`, no `NOTE:`/`QUERY:` pending. `CROSS_BULL_LEARNING:` blank.

**Step 2 — portfolio sync (live Alpaca data, ~08:21 ET):**

| Symbol | Qty | Avg entry | Current | Unrealized P/L | % of equity |
|--------|-----|-----------|---------|-----------------|--------------|
| LLY | 8 | 1174.35625 | 1164.1243 | −USD 81.86 (−0.871%) | 9.365% |
| UNH | 25 | 422.28 | 416.60 | −USD 142.00 (−1.345%) | 10.475% |
| V | 22 | 355.058182 | 371.00 | +USD 350.72 (+4.490%) | 8.209% |

Equity USD 99,443.61 | Cash USD 71,553.62 (71.958%) | Long MV USD 27,889.99 (28.049%) | Buying power USD 364,306.46. `last_equity` (Alpaca field) USD 99,159.20, reasonably close to Friday's recorded close (USD 99,176.30) — no stale-data anomaly this run.

**Step 3 — risk posture check:**
- **Drawdown circuit breaker:** `history 1A 1D` high-water mark USD 100,322.08 (2026-07-21 close, unchanged). Current equity USD 99,443.61 → drawdown **0.8756%**. NOT triggered (9.1244pp headroom) ✓.
- **Intraday shock check:** equity USD 99,443.61 vs `last_equity` USD 99,159.20 = **+0.2868%** — no shock (threshold −4%; market not yet open).
- **Sector cap:** Healthcare (LLY+UNH) 19.840% (USD 19,727.9944), Financials (V) 8.209% (USD 8,162.00), cash 71.958% — all well within the 60% cap.
- **10yr Treasury:** eased to **4.68%** as of today (tradingeconomics.com, dated 2026-08-03), down ~7bps from Friday's ~4.75% read — comfortably back below the 4.75% new-buy gate that was the closest-ever read last Friday. Gate re-opened; moot today regardless since no watchlist name clears its technical setup (see below).

**Step 3b — thesis contract review:**
- **LLY: forced decision — earnings confirmed 2026-08-05 (Wednesday, before market open), exactly 2 trading days from today.** This is both the earnings-window rule trigger and LLY's own review_by date landing on the same day. WebSearch found no negative pre-print catalyst: FY26 revenue guidance already raised to USD 82-85B (previously known, GLP-1/Medicare Bridge demand), dividend USD 1.73 declared (ex-date 08-14, already known), consensus estimates USD 6.06-6.71 EPS / USD 20.3-20.7B revenue for the quarter. Technical setup is roughly flat vs the 50-day (+0.115% as of Friday's close per fresh Alpaca bars) — not extended, not broken. Position is essentially breakeven (−0.871% from entry). **Decision: HOLD full position through earnings, no trim.** Thesis (Medicare GLP-1 Bridge, Retevmo, AtaiBeckley, raised guidance) is intact and no new information argues for trimming ahead of a print with no negative signal. Gap risk is real (AVGO 2026-06-04 precedent) and the only protection over the print is the 10% trailing stop (HWM USD 1,232.00/stop USD 1,108.80, ~4.77% buffer to current price) — acknowledged, not actionable further under current guardrails. **review_by renewed to 2026-08-06** (forces a fresh post-earnings read at the very next pre-market).
- UNH (review_by 2026-08-17) and V (review_by 2026-08-15) — neither due, neither triggered.

**Step 3c — Monday conviction review:**
- **LLY: A.** Thesis intact and working (essentially flat into a well-guided earnings print, no negative catalyst); see forced hold decision above.
- **UNH: A.** Q2 beat-and-raise thesis continues to validate; no fresh negative news (see step 4); −1.345% from entry is normal variance, not a thesis concern.
- **V: A.** Q3 beat-and-moderate thesis intact, Strong Buy consensus, fresh multi-year highs (+4.490% from entry); a same-day insider-sale headline noted below is consistent with V's established pattern of scheduled/10b5-1-style sales, not a fresh bearish signal.
- No position at 3 consecutive C's — no forced trim today.

**Step 4 — research (WebSearch, all facts dated 2026-08-03 unless noted):**
- **Market posture:** US equity futures pointing higher — S&P 500 futures +0.42-0.6% pre-market, Polymarket-style prediction markets showing ~86% odds of an "up" open. 10yr Treasury eased to 4.68% (see above). University of Michigan consumer confidence at a 5-month high (55.2, July), though 1-year inflation expectations remain elevated at 4.2%. Broadly constructive, risk-on tone to start the week. [Benzinga](https://www.benzinga.com/markets/prediction-markets/26/08/60863465/stock-market-will-sp-500-open-up-or-down-today-12), [Simply Wall St](https://simplywall.st/stocks/us/media/nyse-rddt/reddit/news/us-stock-market-today-sp-500-futures-rise-as-earnings-optimi)
- **10yr Treasury:** eased to 4.68% today (tradingeconomics.com), down from Friday's ~4.73-4.75% read — the new-buy gate is not breached, re-opened with some room after being the closest-ever read last Friday. [TradingEconomics](https://tradingeconomics.com/united-states/government-bond-yield)
- **LLY (what changed since Friday):** nothing thesis-breaking. Earnings confirmed for Wednesday 2026-08-05 before market open (call at 10:00 AM ET); FY26 revenue guidance already raised to USD 82-85B (known); dividend USD 1.73 (ex-date 08-14, known). No negative pre-print catalyst found. See forced hold decision above. [Markets Daily](https://www.themarketsdaily.com/2026/07/29/eli-lilly-and-company-lly-expected-to-announce-earnings-on-wednesday.html), [TipRanks](https://www.tipranks.com/stocks/lly/earnings)
- **UNH (what changed since Friday):** nothing material — still trading on the 07-16 Q2 beat-and-raise (adj. EPS USD 6.38 vs ~USD 4.85 est., FY26 EPS guidance raised to USD 19.50-20.00, buybacks increased to at least USD 5B). Average analyst PT USD 475.23 (high USD 529, low USD 313). No fresh negative news. Thesis unchanged. [Investing.com](https://www.investing.com/equities/united-health-group)
- **V (what changed since Friday):** a same-day headline reports an insider sold ~USD 20.9M in Visa stock (Defense World, dated 2026-08-03); this is consistent with the established pattern of a prior 57,272-share sale dated 2026-07-30 also reported this week — treating as a routine/scheduled-plan-style sale per the standing 2026-06-10 lesson (verify 10b5-1 status before reading insider sales as bearish) rather than a fresh bearish signal, especially set against continued Strong Buy consensus and shares at a post-January high (+7.09% trailing month). No thesis change. [Defense World](https://www.defenseworld.net/2026/08/03/insider-selling-visa-nysev-insider-sells-20902561-84-in-stock.html), [TopOne Markets](https://www.top1markets.com/news/visa-stock-analysis-q3-2026)
- **Watchlist re-verification (fresh Alpaca bars through 2026-07-31 close, explicit date range 2026-05-01 to 2026-08-01):**

| Ticker | Last close (07-31) | 50-day SMA | vs 50-day | ATR20% | Gate |
|--------|--------------------|-----------|-----------|--------|------|
| NVDA | 200.74 | 206.16 | −2.628% | 3.51% | FAIL (improved from Friday's −5.575%, still below) |
| MSFT | 464.70 | 399.36 | **+16.363%** | 2.73% | FAIL (more extended than Friday's +13.336% — the post-earnings run continues, further past the 10% chase threshold) |
| COST | 951.61 | 959.75 | −0.848% | 1.67% | FAIL (essentially unchanged from Friday's −0.904%) |
| LRCX | 293.49 | 337.90 | −13.142% | 6.03% | FAIL (narrowed slightly from Friday's −11.815%... actually widened; still deeply below, valuation still disqualifying) |
| PWR | 667.40 | 681.13 | −2.015% | 3.49% | FAIL (narrowed from Friday's −3.542%, still below) |

No watchlist candidate qualifies for entry today — NVDA and PWR continue to narrow their SMA gap but remain below it; MSFT is now more extended, not less; COST and LRCX are effectively unchanged/still deeply failing. **No qualifying entry exists today.**

**Step 5 — earnings-window rule:** No new buy planned (moot — no watchlist candidate clears its gate). LLY (held) reports 2026-08-05, exactly 2 trading days out — forced hold decision made above (HOLD, no trim). UNH (2026-10-27) and V (~late October, estimated) are both well outside the window.

**Step 6 — cash-drag check:** Cash 71.958%, still well above the 25-40% target band — now the 7th+ consecutive week at an elevated level. Every watchlist candidate fails its technical/valuation gate again this morning for a distinct, freshly-re-verified reason (see table above); staying in cash remains the correct, actively-re-verified call, not a passive default. 0/3 weekly new-position slots used (new week, week of 2026-08-03).

**Step 7 — plan:** **No trades today.** All 3 positions HOLD. LLY's forced earnings-window decision (HOLD, no trim, review_by renewed to 2026-08-06) is the only thesis-contract action this run. Monday conviction review: LLY A, UNH A, V A — no forced trim.

**Stop audit (`orders open`, live Alpaca data):** LLY `e3547b9e` (HWM USD 1,232.00/stop USD 1,108.80), UNH `225cb079` (HWM USD 436.945/stop USD 393.2505), V `2b0a93ba` (HWM USD 373.96/stop USD 336.564) — all 3 status `new` (live), quantities match positions exactly (8/25/22). **3/3 PASS** — no recreation needed.

**Planned trades for today:**

No trades planned.

```json
{
  "plan_date": "2026-08-03",
  "trades": []
}
```

**Step 8 — notify:** Telegram sent per playbook.
**Step 9 — commit:** done.

EXECUTED: 2026-08-03T09:36 ET — no trades (plan empty: no watchlist candidate cleared its technical gate). Market open confirmed (`clock` `is_open: true`). Breaking-news gate: moot, no planned trades to gate. Account re-check: equity USD 99,176.68 vs Alpaca `last_equity` USD 99,159.20 = **+0.0176%** — no intraday shock (threshold −4%). Drawdown: HWM USD 100,322.08 (2026-07-21 close, unchanged) vs current equity USD 99,176.68 = **1.1417%** — NOT triggered (8.8583pp headroom). All 3 positions HOLD (LLY −3.189%, UNH −1.691%, V +4.242%), none near the −7% cut (midday's job regardless). Sector exposure: Healthcare (LLY+UNH) 19.635% (USD 19,473.78), Financials (V) 8.211% (USD 8,142.64), cash 72.154% (USD 71,553.62) — all well within the 60% sector cap. Stop audit (`orders open` vs `positions`): 3/3 PASS — LLY `e3547b9e` (HWM USD 1,232.00/stop USD 1,108.80, qty 8 matches), UNH `225cb079` (HWM USD 436.945/stop USD 393.2505, qty 25 matches), V `2b0a93ba` (HWM USD 373.96/stop USD 336.564, qty 22 matches). No stop fills since pre-market, no exits, no `closed-trades.md` reconciliation needed. Weekly new-position count unchanged: 0/3 used this week (week of 2026-08-03).

